0001903596-23-000316.txt : 20230417 0001903596-23-000316.hdr.sgml : 20230417 20230417164354 ACCESSION NUMBER: 0001903596-23-000316 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 73 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230417 DATE AS OF CHANGE: 20230417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: American Cannabis Company, Inc. CENTRAL INDEX KEY: 0000945617 STANDARD INDUSTRIAL CLASSIFICATION: TELEVISION BROADCASTING STATIONS [4833] IRS NUMBER: 901116625 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26108 FILM NUMBER: 23824438 BUSINESS ADDRESS: STREET 1: 200 UNION ST. STREET 2: SUITE 200 CITY: LAKEWOOD STATE: CO ZIP: 80228 BUSINESS PHONE: 303-974-4770 MAIL ADDRESS: STREET 1: 200 UNION ST. STREET 2: SUITE 200 CITY: LAKEWOOD STATE: CO ZIP: 80228 FORMER COMPANY: FORMER CONFORMED NAME: Brazil Interactive Media, Inc. DATE OF NAME CHANGE: 20130617 FORMER COMPANY: FORMER CONFORMED NAME: NATUREWELL INC DATE OF NAME CHANGE: 20000731 FORMER COMPANY: FORMER CONFORMED NAME: LA JOLLA DIAGNOSTICS INC DATE OF NAME CHANGE: 19950523 10-K 1 acc_10k.htm
0000945617 false FY 2022 --12-31 0000945617 2022-01-01 2022-12-31 0000945617 2022-12-31 0000945617 2023-04-17 0000945617 2021-12-31 0000945617 2021-01-01 2021-12-31 0000945617 2020-12-31 0000945617 us-gaap:CommonStockMember 2020-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000945617 us-gaap:RetainedEarningsMember 2020-12-31 0000945617 us-gaap:CommonStockMember 2021-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000945617 us-gaap:RetainedEarningsMember 2021-12-31 0000945617 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000945617 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000945617 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000945617 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000945617 us-gaap:CommonStockMember 2022-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000945617 us-gaap:RetainedEarningsMember 2022-12-31 0000945617 us-gaap:AllOtherSegmentsMember 2022-01-01 2022-12-31 0000945617 us-gaap:AllOtherSegmentsMember 2021-01-01 2021-12-31 0000945617 us-gaap:OfficeEquipmentMember 2022-12-31 0000945617 us-gaap:OfficeEquipmentMember 2021-12-31 0000945617 us-gaap:SoftwareDevelopmentMember 2022-12-31 0000945617 us-gaap:SoftwareDevelopmentMember 2021-12-31 0000945617 us-gaap:FurnitureAndFixturesMember 2022-12-31 0000945617 us-gaap:FurnitureAndFixturesMember 2021-12-31 0000945617 us-gaap:MachineryAndEquipmentMember 2022-12-31 0000945617 us-gaap:MachineryAndEquipmentMember 2021-12-31 0000945617 us-gaap:LeaseholdImprovementsMember 2021-12-31 0000945617 us-gaap:LicenseMember 2020-12-31 0000945617 us-gaap:LicenseMember 2022-12-31 0000945617 us-gaap:LicenseMember 2022-01-01 2022-12-31 0000945617 ammj:BrandMember 2022-12-31 0000945617 ammj:BrandMember 2022-01-01 2022-12-31 0000945617 ammj:May2022ToApril2023Member 2022-01-01 2022-12-31 0000945617 ammj:May2023ToApril2024Member 2022-01-01 2022-12-31 0000945617 ammj:May2024ToApril2025Member 2022-01-01 2022-12-31 0000945617 ammj:May2025ToApril2026Member 2022-01-01 2022-12-31 0000945617 ammj:May2026ToApril2027Member 2022-01-01 2022-12-31 0000945617 ammj:January2023Member 2022-01-01 2022-12-31 0000945617 ammj:January2024Member 2022-01-01 2022-12-31 0000945617 ammj:January2025Member 2022-01-01 2022-12-31 0000945617 ammj:January2026Member 2022-01-01 2022-12-31 0000945617 ammj:January2027Member 2022-01-01 2022-12-31 0000945617 ammj:June2022ToJune2023Member 2022-01-01 2022-12-31 0000945617 ammj:June2023ToJune2024Member 2022-01-01 2022-12-31 0000945617 ammj:June2024ToJune2025Member 2022-01-01 2022-12-31 0000945617 us-gaap:SubsequentEventMember 2023-01-01 2023-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

 

     
(Mark One)

 

[X]

  

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended December 31, 2022

 

Or

 

[ ]  

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From                            to                     

 

 

 

Commission File Number 000-26108

 

AMERICAN CANNABIS COMPANY, INC.
(Exact name of registrant as specified in its charter)

     
Delaware
(State or other jurisdiction of
incorporation or organization)		   90-1116625
(I.R.S. Employer
Identification No.)

 

200 Union Street, Ste. 200
Lakewood, Colorado
(Address of principal executive offices)

  

 

80228
(Zip Code)

 

(303) 974-4770
(Registrant's telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

None

 

Title of each class

 

Securities registered pursuant to Section 12(g) of the Act:

 

Common Stock, $0.00001 Par Value

(Title of each class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [ ] No [x]

 
 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [ ] No [x]

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [x] No [ ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K ((§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer[ ]   Accelerated filer [ ]  

Non-accelerated filer [ ]

(Do not check if a smaller reporting company)

   Smaller reporting company [x]

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). [ ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [x]

 

The aggregate market value of common equity held by non-affiliates of the Registrant as of December 31, 2022 was approximately $5,076,892.

As at December 31, 2022, there were 92,152,938 shares of common stock, par value $0.00001, issued and outstanding. On April 17, 2023, 92,152,938 shares of common stock, par value $0.00001, were issued and outstanding.

 
 

 

 

 

TABLE OF CONTENTS

 

ITEM 1.   BUSINESS     1
           
ITEM 1A.   RISK FACTORS     6
           
ITEM 1B.   UNRESOLVED STAFF COMMENTS     6
           
ITEM 2.   PROPERTIES     6
           
ITEM 3.   LEGAL PROCEEDINGS     6
           
ITEM 4.   MINE SAFETY DISCLOSURES     6
           
    PART II      
ITEM 5.   MARKET FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES MARKET INFORMATION AND HOLDERS     7
           
ITEM 6.   SELECTED FINANCIAL DATA     7
           
ITEM 7.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS     7
           
ITEM 7A.   QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK     16
           
ITEM 8.   FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA     16
           
ITEM 9.   CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE     41
           
ITEM 9A.   CONTROLS AND PROCEDURES     41
           
ITEM 9B.   OTHER INFORMATION     42
           
    PART III      
           
ITEM 10.   DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE     42
           
ITEM 11.   EXECUTIVE COMPENSATION     43
           
ITEM 12.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS     45
           
ITEM 13.   CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE     45
           
ITEM 14.   PRINCIPAL ACCOUNTING FEES AND SERVICES     46
           
    PART IV      
           
ITEM 15.   EXHIBITS, FINANCIAL STATEMENT SCHEDULES      46

 

 

 
 

  

PART I.

 

ITEM 1. BUSINESS

 

This annual report on Form 10-K (including, but not limited to, the following disclosures regarding our Business) contains forward looking statements regarding our business, financial condition, results of operations and prospects.

 

Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this annual report on Form 10-K. Additionally, statements concerning future matters such as the development of new products, enhancements or technologies, sales levels, expense levels and other statements regarding matters that are not historical are forward-looking statements.

 

Forward-looking statements in this annual report on Form 10-K reflect our good faith judgment based on facts and factors currently known to us. Forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this annual report on Form 10-K. We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this annual report on Form 10-K. Readers are urged to carefully review and consider the various disclosures made in this annual report on Form 10-K, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

 

Company Background

 

American Cannabis Company, Inc. and subsidiary is a publicly listed company quoted on the OTC Markets OTCQB Trading Tier under the symbol “AMMJ”. We are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in regulated cannabis industry in states and countries where cannabis is regulated and/or has been decriminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and manage a strategic group partnership that offers both exclusive and non-exclusive customer products commonly used in the industry. We also are licensed operators of three medical cannabis dispensaries and a cannabis cultivation facility in Colorado Springs, CO.

 

We are a Delaware corporation formed on September 24, 2001 with the name Naturewell, Inc. Pursuant to a merger transaction on March 13, 2013, the Company changed its name to Brazil Interactive Media, Inc. (“BIMI”), and operated as the owner of a Brazilian interactive television technology and television production company named BIMI, Inc. Pursuant to an Agreement and Plan of Merger dated May 15, 2014, between the Company, Cannamerica Corp. (“Merger Sub”), a wholly-owned subsidiary of BIMI, and Hollister & Blacksmith, Inc. a wholly owned subsidiary of American Cannabis Consulting (“American Cannabis Consulting”) we changed our name to American Cannabis Company, Inc. Pursuant to the Merger Agreement, which was consummated and became effective on September 29, 2014, Merger Sub was merged with and into American Cannabis Consulting through a reverse triangular merger transaction, we changed our name to “American Cannabis Company, Inc.”, and our officers and directors in office prior to the Merger Agreement resigned and American Cannabis Consulting appointed new officers and directors to serve our Company. In concert with the Merger Agreement, we consummated a complete divestiture of BIMI, Inc. pursuant to a Separation and Exchange Agreement dated May 16, 2014 (the “Separation Agreement”) between the Company, BIMI, Inc., a Delaware corporation and wholly-owned subsidiary of the Company, and Brazil Investment Holding, LLC (“Holdings”), a Delaware limited liability company. On October 10, 2014, we changed our stock symbol from BIMI to AMMJ.

 

Industry and Regulatory Overview

 

As of the date of this filing, thirty-nine states, including the state of Colorado, the District of Columbia, and four U.S. Territories, currently have laws broadly legalizing cannabis in some form for either medicinal or recreational use governed by state-specific laws and regulations. Although legalized in some states, cannabis is a “Schedule 1” drug under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal under federal law.

 

On August 29, 2013, The Department of Justice set out its prosecutorial priorities in light of various states legalizing cannabis for medicinal and/or recreational use. The “Cole Memorandum” provided that when states have implemented strong and effective regulatory and enforcement systems to control the cultivation, distribution, sale, and possession of cannabis, conduct in compliance with those laws and regulations is less likely to threaten the federal priorities. Indeed, a robust system may affirmatively address those priorities by, for example, implementing effective measures to prevent diversion of cannabis outside of the regulated system and to other states, prohibiting access to cannabis by minors, and replacing an illicit cannabis trade that funds criminal enterprises with a tightly regulated market in which revenues are tracked and accounted for. In those circumstances, consistent with the traditional allocation of federal-state efforts in this area, the Cole Memorandum provided that enforcement of state law by state and local law enforcement and regulatory bodies should remain the primary means of addressing cannabis-related activity. If state enforcement efforts are not sufficiently robust to protect against the harms set forth above, the federal government may seek to challenge the regulatory structure itself in addition to continuing to bring individual enforcement actions, including criminal prosecutions, focused on those harms.

 1 

 

 

On January 4, 2018, Attorney General Jeff Sessions issued a memorandum for all United States Attorneys concerning cannabis enforcement under the CSA. Mr. Sessions rescinded all previous prosecutorial guidance issued by the Department of Justice regarding cannabis, including the August 29, 2013 “Cole Memorandum”.

 

In rescinding the Cole Memorandum, Mr. Sessions stated that U.S. Attorneys must decide whether or not to pursue prosecution of cannabis activity based upon factors including: the seriousness of the crime, the deterrent effect of criminal prosecution, and the cumulative impact of particular crimes on the community. Mr. Sessions reiterated that the cultivation, distribution, and possession of marijuana continues to be a crime under the U.S. Controlled Substances Act.

 

On March 23, 2018, President Donald J. Trump signed into law a $1.3 trillion-dollar spending bill that included an amendment known as “Rohrabacher-Blumenauer,” which prohibits the Justice Department from using federal funds to prevent certain states “from implementing their own State laws that authorize the use, distribution, possession or cultivation of medical cannabis.”

 

On December 20, 2018, President Donald J. Trump signed into law the Agriculture Improvement Act of 2018, otherwise known as the “Farm Bill.” Prior to its passage, hemp, a member of the cannabis family, was classified as a Schedule 1 controlled substance, and so illegal under the federal CSA.

 

With the passage of the Farm Bill, hemp cultivation is now broadly permitted. The Farm Bill explicitly allows the transfer of hemp-derived products across state lines for commercial or other purposes. It also puts no restrictions on the sale, transport, or possession of hemp-derived products, so long as those items are produced in a manner consistent with the law.

 

Under Section 10113 of the Farm Bill, hemp cannot contain more than 0.3 percent THC. THC is the chemical compound found in cannabis that produces the psychoactive “high” associated with cannabis. Any cannabis plant that contains more than 0.3 percent THC would be considered non-hemp cannabis—or marijuana—under the CSA and would not be legally protected under this new legislation and would be treated as an illegal Schedule 1 drug.

 

Additionally, there will be significant, shared state-federal regulatory power over hemp cultivation and production. Under Section 10113 of the Farm Bill, state departments of agriculture must consult with the state’s governor and chief law enforcement officer to devise a plan that must be submitted to the Secretary of the United States Department of Agriculture (hereafter referred to as the “USDA”). A state’s plan to license and regulate hemp can only commence once the Secretary of USDA approves that state’s plan. In states opting not to devise a hemp regulatory program, USDA will construct a regulatory program under which hemp cultivators in those states must apply for licenses and comply with a federally run program. This system of shared regulatory programming is similar to options states had in other policy areas such as health insurance marketplaces under Affordable Care Act, or workplace safety plans under Occupational Health and Safety Act—both of which had federally-run systems for states opting not to set up their own systems.

The Farm Bill outlines actions that are considered violations of federal hemp law (including such activities as cultivating without a license or producing cannabis with more than 0.3 percent THC). The Farm Bill details possible punishments for such violations, pathways for violators to become compliant, and even which activities qualify as felonies under the law, such as repeat offenses.

 

One of the goals of the previous 2014 Farm Bill was to generate and protect research into hemp. The 2018 Farm Bill continues this effort. Section 7605 re-extends the protections for hemp research and the conditions under which such research can and should be conducted. Further, section 7501 of the Farm Bill extends hemp research by including hemp under the Critical Agricultural Materials Act. This provision recognizes the importance, diversity, and opportunity of the plant and the products that can be derived from it but also recognizes that there is still a lot to learn about hemp and its products from commercial and market perspectives.

 

As a result of the November 2020 federal elections and the election of Joseph R. Biden as president, there is speculation that the federal government may move to amend parts of the CSA and de-schedule cannabis as a Schedule 1 drug.

 

In late January 2021, Senate Majority Leader Chuck Schumer said lawmakers are in the process of merging various cannabis bills, including his own legalization legislation. He is working to enact reform in this Congressional session. This would include the Marijuana Freedom and Opportunity Act, which would federally de-schedule cannabis, reinvest tax revenue into communities most affected by the drug war, and fund efforts to expunge prior cannabis records. It is likely that the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act would be incorporated.

 2 

 

 

Other federal legislation under review for possible submission includes the SAFE Banking Act (or Secure and Fair Enforcement Act), a bill that would allow cannabis companies to access the federally insured banking system and capital markets without the risk of federal enforcement action, and the Strengthening the Tenth Amendment Through Entrusting States Act (or STATES Act), a bill that seeks protections for businesses and individuals in states that have legalized and comply with state laws).

 

The fall of 2022 saw several key developments in federal and state marijuana regulation. In October 2022, President Biden granted clemency to certain low-level federal marijuana offenders and directed the Attorney General to review the status of marijuana under federal law. While some observers consider President Biden’s grant of clemency to represent a significant change in federal marijuana policy, as a legal matter, it did little to alter the growing disparity between federal and state marijuana regulation. Then, in November 2022, voters in five states considered ballot initiatives to legalize recreational marijuana at the state level, two of which were adopted. Congress also subsequently enacted the Medical Marijuana and Cannabidiol Research Expansion Act, which aims to facilitate research on marijuana and cannabidiol (CBD). Legislators and commentators have proposed a number of other legal reforms that would alter federal marijuana regulation and potentially reduce the divergence between federal and state law.

 

As of the date of this filing, cannabis remains an illegal Schedule 1 drug under the CSA, and none of the legislative initiatives being discussed have become federal law.

 

Notably, with respect to our business, on November 1, 2019, Colorado Bill HB-19-1090 was passed and made effective. This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses. Other states that have legalized cannabis for recreational and/or medicinal use restrict public companies from owning interests in state cannabis licenses altogether or have enacted regulations that make it difficult for corporations to comply with application requirements, including all shareholders submitting to and passing background checks.

 

On September 18, 2020, Colorado’s Marijuana Enforcement Division (MED), approved the Company’s application for the suitability, establishing the Company as one of the few publicly traded companies authorized to acquire and operate various cannabis licenses throughout Colorado, in both the recreational and medical markets.

 

Business Overview

 

We now primarily operate within the regulated cannabis industry with three operation divisions: (i) consulting and professional services; (ii) the sale of products and equipment commonly utilized in the cultivation, processing, transportation or retail sale of cannabis; and, (iii) our licensed owner operator medical marijuana dispensaries and cultivation facilities located in Colorado Springs, Colorado under the trade name “Naturaleaf.” Our operations are limited to only those state jurisdictions where medical and/or recreational cannabis business has been legalized.

Consulting Services

 

We offer consulting services for companies associated with the cannabis industry in all stages of development. Our service offerings include the following:

 

  o Cannabis Business Planning. Our commercial cannabis business planning services are structured to help those pursuing state based operational licensing to create and implement effective, long-range business plans. We work with our clients to generate a comprehensive strategy based on market need and growth opportunities, and be a partner through site selection, site design, the development of best operating practices, the facility build-out process, and the deployment of products. We understand the challenges and complexities of the regulated commercial cannabis and hemp markets and we have the expertise to help client businesses thrive.

 

  o Cannabis Business License Applications. Our team has the experience necessary to help clients obtain approval for their state license and ensure their company remains compliant as it grows. We have crafted successful, merit-based medical marijuana business license applications in multiple states, and we understand the community outreach and coordination of services necessary to win approval. As part of the process for crafting applications, we collaborate with clients to develop business protocols, safety standards, a security plan, and a staff training program. Depending on the nature of our clients’ businesses and needs, we can work with our clients to draft detailed cultivation plans, create educational materials for patients, or design and develop products that comply with legal state guidelines

 

  o Cultivation Build-out Oversight Services. We offer cultivation build-out consulting as part of our Cannabis and Hemp Business Planning service offerings. We help clients ensure their project timeline is being met, facilities are being designed with compliance and the regulated cannabis industry in mind, and that facilities are built to the highest of quality standards for cannabis and hemp production and/or distribution. This enables a seamless transition from construction to cultivation, ensuring that client success is optimized and unencumbered by mismanaged construction projects.

 

  o Cannabis Regulatory Compliance. Based on our understanding of regulated commercial cannabis and hemp laws nationwide, we can help client cultivation operations, retail dispensaries and/or infused-product kitchen businesses to meet and maintain regulatory compliance for both medical and recreational markets. We partner with our clients to establish standard operating procedures in accordance with their state’s regulation and help them implement effective staff hiring and training practices to ensure that employees adhere to relevant guidelines.

 

  o Compliance Audit Services. Our regulatory compliance service offerings include compliance auditing. The regulated cannabis and hemp industries are developing rapidly with evolving laws and regulations and navigating through current and new regulations and systems can be tedious and daunting. To assist our clients in addressing these challenges, we offer compliance audits performed by our experienced and knowledgeable staff; our team members maintain comprehensive oversight of the cannabis and hemp industries while staying up to date on current and new laws and regulations. Our compliance audits assess various regulatory topics, including: (1) licensing requirements; (2) visitor intake procedures; (3) seed-to-sale inventory tracking; (4) proper waste disposal procedures; (5) recordkeeping and documentation requirements; (6) cannabis transportation procedures; (7) packaging and labeling requirements; (8) security requirements; (9) product storage; (10) mandatory signage; and (11) preparedness for state and local inspections.

 

 3 

 

 

  o Cannabis Business Growth Strategies. Our team shares its collective knowledge and resources with our clients to create competitive, forward-looking cannabis and hemp business growth strategies formulated to minimize risk and maximize potential. We customize individual plans for the unique nature of our client businesses, their market and big-picture goals, supported with a detailed analysis and a thorough command of workflow best practices, product strategies, sustainability opportunities governed by a core understanding or regulatory barriers and/or opportunities.

 

  o Cannabis Business Monitoring. The regulated commercial cannabis and hemp industries are constantly growing and shifting, and the ongoing monitoring of a cannabis and hemp business allows it to remain responsive to evolving consumer demands and state regulations as well as potential operations problems. We offer fully integrated business analysis solutions. Our monitoring services include sales tracking, market assessment, loss prevention strategies, review of operational efficiency and workflow recommendations. Additionally, our services include Strength, Weakness, Opportunity and Threat (“SWOT”) analysis, where we analyze client operations to pinpoint strengths, weaknesses, opportunities and threats. Our SWOT analyses allow clients to focus their efforts and resources on the most critical areas along these dimensions.

 

Equipment and Supplies

 

In addition to professional consulting services, we operate an equipment and supplies division for customers in the cannabis industry. Our Group Purchasing Organization, American Cultivator CO., enables customers to procure commonly used cultivation supplies at competitive prices. Our major product offerings include the following:

 

  o The Satchel™. The Satchel was invented in response to regulatory changes in Colorado and elsewhere that require childproof exit containers. The Satchel is a pouch-like case designed as a high-quality, child-proof exit package solution for the regulated cannabis industry. The Satchel meets child-safety requirements of the Consumer Products Safety Commission (“CPSC”), making it compliant in all states, and the Satchel’s drawstring and toggle lock fulfills the requirements of the Poison Prevention Packaging Act of 1970 (16 CFR part 1700). There are few products meeting regulatory standards, and even fewer that offer distinctive quality. The Satchel will meet all current exit packaging regulations, featuring a child-proof closure that completely conceals the contents inside. On March 29, 2016, the U.S. Patent and Trademark Office issued us Patent No. 9,296,524 B2 for the Satchel.
  o SoHum Living Soil®. The right grow methodology is critical to the success of any cannabis cultivation operation, and SoHum Living Soil™ is our solution to ensure that our customers can implement an optimal methodology that will maximize quality and yields while simplifying the cultivation process and reducing risk of operator error and test failure. The SoHum medium is a fully amended Just-add-water soil that contains none of the synthetic components found in other potting mixes and requires no chemical additives to spur growth. Compared with comparable methodologies, SoHum Living Soil™ offers a number of key advantages, including: (1) consistent Pyto-pharmaceutical-grade product quality; (2) improved plant resistance to disease; and (3) reduced operator error.

 

  o High Density Cultivation System (HDCS™). A key metric in the success of a cultivation operation is the maximization of available space to grow. Our High-Density Cultivation System is a solution designed to ensure that space is used in the most efficient manner possible. The system takes advantage of the existence of vertical space, with racks installed vertically and placed on horizontal tracking to eliminate multiple isles and create multiple levels of space with which to grow plants. The High-Density Cultivation System allows customers to increase production capacity without the need to add additional square footage to the operation.

  

  o The Cultivation Cube™. The Cultivation Cube™ is a self-contained, scalable cultivation system that is compliant with regulatory guidelines. The Cultivation Cube™ allows commercial cannabis cultivation operations to maximize space, yield and profit through an innovative design that provides a fully integrated growing solution. The Cultivation Cube utilizes more lights per square foot than traditional grow systems, which translates to profit increases per square foot. The Cultivation Cube™ is also stackable, which allows customers to achieve vertical gains and effectively doubles productive square-footage. It is an ideal solution for commercial-scale cultivation within limited space, with numerous advantages over other traditional grow systems, including: (1) flexibility to fit customer build-out sites; (2) efficient speed-to-market with fast delivery and setup; (3) increased security with limited access units; (4) risk mitigation through precision environmental controls; and, (5) is compatible with lean manufacturing principles and operations.

 

  o Other Products. We offer our clients a diverse array of commonly utilized product offerings from across all areas of the regulated cannabis industry, including cultivation operations, medicinal and recreational cannabis dispensary operations, and infused products. Examples of products available include HID Ballasts, reflectors, MH and HPS bulbs, T5 fixtures, mediums, nutrients and fertilizers, growing containers, flood tables, reservoirs, and various other supplies, including cleaning products and office supplies.

 

 4 

 

  Naturaleaf  

 

On December 16, 2020, the Company announced that it executed a non-binding letter of intent to purchase assets of Naturaleaf, a long-standing licensed operator in the Colorado Springs medical cannabis market since 2009. Assets include three (3) retail dispensaries located throughout the city along with one 10,000 square foot cultivation operation with non-volatile extraction capabilities.

 

On March 11, 2021, we entered into an asset purchase agreement with Medihemp, LLC (“Medihemp”) and its wholly owned subsidiary SLAM Enterprises, LLC (“SLAM”), and Medical Cannabis Caregivers, Inc. (“Medical Cannabis”), each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf.”

 

Medihemp and SLAM respectively own fixed assets and operates two retail Medical Marijuana Centers located at 1004 S. Tejon Street, Colorado Springs, CO 80903, and 2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909.

 

Medical Cannabis owns and operates fixed assets and operates a retail Medical Marijuana Center located at 5875 Lehman Drive, Ste. 100, Colorado Springs, CO 80918.

 

Medical Cannabis also owns and operates a Medical Marijuana Optional Premises Cultivation license, and a Medical Marijuana-Infused Product Manufacturer license, along with fixed assets all located at 2611 Durango Drive, Colorado Springs, CO 80910.

 

On April 30, 2021, the Colorado MED and the City of Colorado Springs granted approval for the change of ownership, and we completed the asset purchase agreement. By virtue of the closing, we acquired, own, and operate the fixed assets and associated intellectual property of Naturaleaf, including assignment of the following licenses issued by the Colorado Marijuana Enforcement Division (“MED”) and the corresponding City of Colorado Springs (“City”):

 

  o Medihemp and SLAM’s and Medical Cannabis’ respective Medical Marijuana Center licenses;

 

  o Medical Cannabis’ Medical Marijuana Infused Product Manufacturer license; and,

 

  o Medical Cannabis’ Medical Marijuana Optional Premises Cultivation license.

 

We also entered into leases for Medihemp, SLAM, and Medical Cannabis’ respective retail Medical Marijuana Centers and entered into a separate lease for Medical Cannabis’ Durango Drive cultivation facility.

 

Sales and Marketing

 

We sell our services and products throughout the United States in states that have implemented regulated cannabis programs as well as Canada. We intend to expand our offerings to more countries, states and jurisdictions as they adopt state-regulated or Federal programs.

 

Research and Development

 

As a component of our equipment and supplies offerings, from time-to-time we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include, but are not limited to: The Satchel™, Cultivation Cube™, So-Hum Living Soils® and the HDCS™. Costs associated with the development of new products are expensed as occurred as research and development operating expenses. During the years ended December 31, 2022, and 2021 our research and development costs were de minimis.

 

Significant Customers

 

For the year ended December 31, 2022, eight customers accounted for 87.33% of the Company's total revenues from its consulting, soil, and products revenue lines for the period. As of December 31, 2021, nine customers accounted for 50.1% of the Company’s total revenues from its consulting and soil and product revenue lines for the period.

 

At December 31, 2022, three customers accounted for 84.76% of accounts receivable, net, consisting of customers for our products, soil, and consulting services product streams. At December 31, 2021, two customers accounted for 77.3% of accounts receivable, net, consisting of customers of our consulting services and soil, and products revenue streams.

 

 5 

 

Intellectual Property

 

On March 29, 2016, the U.S. Patent and Trademark Office issued patent number 9,296,524 B2 for The Satchel™, our child-proof exit package solution for the regulated cannabis industry. On March 14, 2015, the U.S. Patent and Trademark Office issued trademark #86574785 for the two-word marks and the logo associated with So-Hum Living Soil®.

 

  Competition  

 

Our competitors include professional services firms and cannabis dispensaries in the regulated cannabis industry, as well as suppliers of equipment and supplies commonly utilized in the cultivation, processing, or retail sale of cannabis. We compete in markets where cannabis has been legalized and regulated, which includes various states within the United States, it’s territories and Indian Country therein and Canada. We expect that the quantity and composition of our competitive environment will continue to evolve as the cannabis industry matures. Additionally, increased competition is possible to the extent that new states and geographies enter the marketplace as a result of continued enactment of regulatory and legislative changes that de-criminalize and regulate cannabis products. We believe that by being well established in the industry, our experience and success to date, and our continued expansion of service and product offerings in new and existing locations, are factors that mitigate the risk associated with operating in a developing competitive environment. Additionally, the contemporaneous growth of the industry as a whole will result in new customers entering the marketplace, thereby further mitigating the impact of competition on our operations and results.

 

  Employees  

 

As of December 31, 2022, we have 9 full-time employees in our Denver headquarters, and 15 full-time employees in our Colorado Springs, Colorado dispensaries and cultivation facility. None of our U.S employees are represented by a labor union.

 

ITEM 1A. RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

None. 

 

ITEM 2. PROPERTIES

 

Our headquarters are located at 200 Union Street, Ste. 200, Lakewood, CO 80228. Our offices are not leased but granted pursuant to an accommodation that creates no tenancy, leasehold, or other real property interest. Our accommodation expires on August 31, 2023. Our monthly payment in exchange for the accommodation is $3,250.

 

As a result of our acquisition of Naturaleaf, we assumed the following leases and contingent extensions:

 

  o 1004 S. Tejon Street, Colorado Springs, CO 80903; The Company assumed a lease originally entered into on February 12, 2016, which was the subject of a extension agreement dated April 5, 2022. The term of the lease was extended from May 1, 2022 until April 30, 2027. The Company's monthly rental payments from January 1, 2022 to May 1, 2022 was $3,700. From May 1, 2022 through the year ended December 31, 2022, monthly rent was $3,875. Remaining rental payments due for the extended period are:

 

May 1, 2022 to April 30, 2023 $3,875
May 1, 2023 to April 30, 2024 $4,050
May 1, 2024 to April 30, 2025 $4,225
May 1, 2025 to April 30, 2026 $4,400
May 1, 2026 to April 30, 2027 $4,575

 

  o 2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909 subject to a one-year term expiring June 30, 2023 with a monthly rent of $5,000.

 

     
  o 5870 Lehman Drive Suite 200, Colorado Springs, CO 80918 The Company and landlord  previously entered into a lease in 2017 which expired December 31, 2022. At December 31, 2022, the Company's monthly rent was $2,732. On April 26, 2022, the Company and landlord entered into an extension agreement which extended the tenancy from January 1, 2023 through January 1, 2027. Rental payments due for the extended period are:  

 

January 1, 2023 $2,898
January 1, 2024 $2,985
January 1, 2025 $3,075
January 1, 2026 $3,167
January 1, 2027 $3,262

  

  o 2611 Durango Drive, CO Springs, CO. The Company and landlord entered into a lease on March 10, 2021, which terminated on May 31, 2022. On June 23, 2021, the Company and landlord entered into an extension of the lease for a term of thirty-six months, beginning June 1, 2022 and terminating June 1, 2024. At December 31, 2022, monthly rent was $11,000. Rental payments due for the extended period are:  

 

June 1, 2022 to June 1, 2023 $11,000
June 1, 2023 to June 1, 2024 $11,880
June 1, 2025 to June 1, 2025 $12,830

  

Our corporate headquarters and our Colorado Springs, Colorado dispensary and cultivation leases are, as of the date of this filing, adequate for our operations, providing productive capacity and complete utilization for our business.

 

ITEM 3. LEGAL PROCEEDINGS

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not Applicable.

 

 6 

 

PART II.

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES MARKET INFORMATION AND HOLDERS

 

Our common stock trades on the OTC Markets OTCQB Trading Tier under the ticker symbol “AMMJ.” As of December 31, 2022, there were 496 holders of record of our common stock. The following table sets forth, for the periods indicated, the high and low closing sales prices of our common stock:

 

2022   High   Low
 Quarter ended December 31   $ 0.05   $ 0.02  
 Quarter ended September 30   $ 0.05   $ 0.03  
 Quarter ended June 30   $ 0.06   $ 0.03  
 Quarter ended March 31   $ 0.07   $ 0.04  

 

2021   High   Low  
 Quarter ended December 31   $ 0.11   $ 0.05  
 Quarter ended September 30   $ 0.17   $ 0.09  
 Quarter ended June 30   $ 0.25   $ 0.18  
 Quarter ended March 31   $ 0.39   $ 0.06  

 

DIVIDEND POLICY

 

We have never declared or paid, and do not anticipate declaring or paying, any cash dividends on our common stock. Instead, we currently anticipate that we will retain all of our future earnings, if any, to fund the operation and expansion of our business and to use as working capital and for other general corporate purposes. Any future determination as to the declaration and payment of dividends, if any, will be at the discretion of our board of directors and will depend on then-existing conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects, and other factors our board of directors may deem relevant.

 

ITEM 6. SELECTED FINANCIAL DATA

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The statements contained in this report that are not statements of historical fact, including without limitation, statements containing the words “believes,” “expects,” “anticipates” and similar words, constitute forward-looking statements that are subject to a number of risks and uncertainties. From time to time we may make other forward-looking statements. Investors are cautioned that such forward-looking statements are subject to an inherent risk that actual results may materially differ as a result of many factors, including the risks discussed from time to time in this report, including the risks described under “Risk Factors” in any filings we have made with the SEC.

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an on-going basis, we evaluate these estimates, including those related to useful lives of real estate assets, cost reimbursement income, bad debts, impairment, net lease intangibles, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. There can be no assurance that actual results will not differ from those estimates.

 

  Background  

 

American Cannabis Company, Inc. and subsidiary is a publicly listed company quoted on the OTC Markets OTCQB Trading Tier under the symbol “AMMJ”. We are based in Lakewood, Colorado and operate within the regulated cannabis industry with four operation divisions: (i) consulting and professional services; (ii) the sale of products and equipment commonly utilized in the cultivation, processing, transportation or retail sale of cannabis; and, (iii) our licensed owner operator medical marijuana dispensaries and cultivation facilities located in Colorado Springs, Colorado under the trade name “Naturaleaf.” Our operations are limited to only those state jurisdictions where medical and/or recreational cannabis business has been legalized. American Cannabis Company, Inc. is a publicly listed company quoted on the OTCQB Tier under the symbol “AMMJ”. 

Naturaleaf Acquisition

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC ("Medihemp"), and its wholly owned subsidiary SLAM Enterprises, LLC ("SLAM"), and Medical Cannabis Caregivers, Inc. ("Medical Cannabis"), each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” operating in the medicinal cannabis industry in Colorado.

 

Medihemp and SLAM, respectively own fixed assets and operate two retail Medical Marijuana Centers located in Colorado Springs, Colorado. Medical Cannabis owns fixed assets and operates a retail Medical Marijuana Center located in Colorado Springs, Colorado. Medical Cannabis also owns and operates a Medical Marijuana Optional Premises Cultivation license, and a Medical Marijuana-Infused Product Manufacturer license.

 7 

 

 

Naturaleaf agreed to sell or assign to the Company, and the Company purchased and was the assignee of the following assets:

 

  1. Three Medical Marijuana (MMC) Store Licenses;

 

  2. One Marijuana Infused Product Licenses (MIPS); and,

 

  3. One Option Premises Cultivation License (OPC); and,

 

  4. Related real property assets, goodwill, and related business assets.

  

As a result, the Company has expanded its business model to include the cultivation and retail sale of cannabis in the medicinal cannabis industry.

 

The aggregate consideration paid for the Assets was $2,890,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000.

 

On April 30, 2022, the Company and Medihemp, SLAM, and Medical Cannabis amended the material definitive agreement to restructure remaining payments due to be made by the Company under the Note. The parties agreed that in consideration of the Company's payment of $550,000, and outstanding interest of $110,000, a new promissory note in the principal amount of $550,000 and 12% interest accruing annually, due April 29, 2023, resolved all of the Company's payment obligations for the purchase price. The parties executed the amendment and the Company paid the consideration of $550,000 principal and $110,000 in interest.

 

The asset acquisition was accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations. As the acquirer for accounting purposes, the Company has estimated the fair value of Medihemp LLC and Medical Cannabis Caregivers, Inc.’s (hereafter “Naturaleaf’s”) assets acquired and conformed the accounting policies of Naturaleaf to its own accounting policies.

 

As part of the acquisition, the owners of Naturaleaf retained the outstanding cash balance on the date of the acquisition and had agreed to the payment of all outstanding accounts payables and related party advances.

 

Preliminary Valuation Analysis as of December 31, 2021

 

The Company performed a preliminary valuation analysis of the fair market value of Naturaleaf’s assets reported in its 2021 Form 10-K. The following table summarizes the preliminary allocation of the purchase price as of the acquisition date:

 

Cash   $ --  
Inventory     72,172  
Property, plant and equipment     26,715  
Long Term Deposits     6,000  
Identifiable intangible assets     800,000  
Goodwill     1,985,113  
Accounts payable     --  
Total consideration   $ 2,890,000  

 

 8 

 

The Company's preliminary assessment of goodwill from the acquisition primarily related to the future economic benefits arising from the assets acquired which are consistent with the Company's stated intentions and strategy. Other assets include inventory and fixed assets.

 

The fair value of Naturaleaf’s identifiable intangible assets was $800,000 at April 30, 2021, consisting of $500,000 in licenses and $300,000 in brand names.

 

The preliminary estimated fair values were assigned to identifiable assets acquired, and the preliminary assumptions were based on the information that was available as of the acquisition date to estimate the fair value of assets acquired and liabilities assumed.

 

Final Valuation Analysis

 

The Company performed a final evaluation of Naturaleaf tangible and intangible assets and goodwill as of the acquisition date. The following table summarizes the final fair value allocation of the purchase price as of April 30, 2021:

 

Current Assets  $15,000 
Inventory   72,172 
Property, Plant and Equipment   26,715 
Other Assets   6,000 
Total Tangible Assets   119,887 
      
Tradenames and Trademarks   660,000 
Licenses   800,000 
Total Intangible Assets   1,460,000 
      
Goodwill   1,332,113 
Total Consideration  $2,912,000 

 

 

Results of Operations

 

Year ended December 31, 2022 compared to year ended December 31, 2021

 

The following table presents our operating results for the year ended December 31, 2022 compared to December 31, 2021:

 

AMERICAN CANNABIS COMPANY, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

 

   For the Year Ended   
   December 31,  December 31,  Increase
   2022  2021  (Decrease)
Revenues         
Consulting Services  $475,837   $381,094    94,743 
Product & Equipment   17,539,377    1,037,962    16,501,415 
Cannabis Products   793,331    1,006,148    (212,817)
Total Revenues   18,808,545    2,425,204    16,338,341 
                
Cost of Revenues               
Cost of Consulting Services   61,246    36,179    25,067 
Cost of Products and Equipment   15,230,648    758,940    14,471,708 
Cost of Cannabis Products   979,437    573,937    405,500 
Total Cost of Revenues   16,271,331    1,369,056    14,902,275 
Gross Profit   2,537,214    1,056,148    1,436,066 
                
Operating Expenses               
General and Administrative   2,833,140    2,050,272    782,868 
Selling and Marketing   225,950    199,968    25,982 
Bad Debt Expense   5,438    54,435    (48,997)
Litigation Settlement Expense   -      350,000    (350,000)
Stock Based Compensation Expense   78,342    42,206    36,136 
Total Operating Expenses   3,142,870    2,696,881    445,989 
Loss from Operations   (605,656)   (1,640,733)   1,035,077
                
Other Income (Expense)               
Interest (expense)   (78,086)   (75,374)   (2,712)
Debt Forgiveness   -      240,975    (240,975) 
Other income   50,550    35,883    14,667 
Total Other (Expense) Income   (27,537)   201,484    (229,021)
Net Loss   (633,192)   (1,439,249)   806,057
Income Tax Expense   -      -      -   
NET LOSS  $(633,192)  $(1,439,249)   806,057 

 9 

 

 

Revenues

 

Total revenues were $18,808,545 for the year ended December 31, 2022, as compared to $2,425,204 for the year ended December 31, 2021. The increases in total revenue of $16,338,341 for the year ended December 31, 2022, was primarily a result of an increase of $16,501,415 in product and equipment sales associated with design and build projects for which the Company provided the design, management and installation of associated products sold for the construction of cultivation and dispensary facilities. The Company's cannabis product sales from its licensed dispensaries and cultivation facility for the year ended December 31, 2022, were $793,331, as compared to $1,006,148 for the year ended December 31, 2021, a decrease of $212,817, which was attributable to a general decline in the market for Cannabis in Colorado in 2022, as compared to 2021, and costs associated to upgrading and replacing machinery and equipment to the Company's Colorado Springs cultivation facility and maintenance to the Company's three Colorado Springs dispensary facilities.

 

Costs of Revenues

 

Costs of revenues primarily consists of labor, travel, cost of equipment and soil sold, and other costs directly attributable to providing services or soil products. Costs of revenues related to our cannabis products include cultivation costs, including labor, utilities, supplies and cultivation facility rent. During the year ended December 31, 2022, our total costs of revenues were $16,271,331, as compared to $1,369,056 for the year ended December 31, 2021, an increase of $14,902,275. The increase was due to costs incurred purchasing equipment for projects which the Company sold in conjunction with its design, management and installation of associated products for the construction of cultivation and dispensary facilities.

 

Consulting Services

 

Consulting service revenues during the year ended December 31, 2022 were $475,837 as compared to $381,094 for the year ended December 31, 2021, an increase of $94,743. The increase was caused as a result of three states legalizing cannabis during fiscal 2022, and other activity for consulting services clients whose projects were delayed as a result of COVID-19 restrictions in 2019 and 2020, which limited plans and expansion or implementation of projects.

 

Costs of consulting services were $61,246 for the year ended December 31, 2022, as compared to $36,179 for the year ended December 31, 2021, an increase of $25,067. The increase was due to the growth in consulting activity during the period.

 

Product and Equipment Revenues

 

Our product and equipment revenues for the year ended December 31, 2022, were $17,539,377 as compared to $1,037,962 for the year ended December 31, 2021, an increase of $16,501,415. The growth was the result of the Company being retained to provide equipment sales and design, management, and installation of products sold for the construction of cultivation and dispensary facilities during the period.

 

Costs of Products and Equipment were $15,230,648 for the year ended December 31, 2022, as compared to $758,940 for the year ended December 31, 2021. Costs associated with products and equipment increased by $14,471,708 as a result of increased equipment sales during the year ended December 31, 2022.

 

Cannabis Product Revenues

 

Cannabis product revenues during the year ended December 31, 2022, were $793,331 as compared to $1,006,148 for the year ended December 31, 2021, a decrease of $212,817. The decrease was due to the general decline in the market for Cannabis in Colorado in 2022, as compared to 2021, with Colorado's annual total sales of $1.8 billion in 2022 representing a 20.7% decline from 2021's record $2.2 billion sales total.

 

Costs associated with cannabis products consist of those costs incurred in the cultivation of the plants and the retail sale of the products. During the year ended December 31, 2022, such costs were $979,437, as compared to $573,937 for the year ended December 31, 2022, an increase of $405,500. This increase was due to costs associated with improvements, including upgrading and replacing machinery and equipment in the Company's Colorado Springs cultivation facility and maintenance to the Company's three Colorado Springs dispensary facilities.

 

Gross Profit

 

Total gross profit was $2,537,214 for the year ended December 31, 2022, comprised of consulting services gross profit of $414,591, products and equipment gross profit of $2,308,729, and a gross loss of $186,106 for cannabis products. This compares to a total gross profit of $1,056,148 for the year ended December 31, 2021, comprised of consulting services gross profit of $344,915, products and equipment gross profit of $279,022, and cannabis products gross profit of $432,211.

  

 

Operating Expenses

 

Total operating expenses were $3,142,870 for the year ended December 31, 2022, as compared with $2,696,881, for the year ended December 31, 2021, an increase of $445,989. The increase is attributed to the payment of $175,000 for a litigation settlement expense, combined with increases in general and administrative, legal, and accounting and advertising costs during the period.

 

 10 

 

Other Income (Expense)

 

Other expenses for the year ended December 31, 2022, was $27,536 as compared to other income of $201,484 for the year ended December 31, 2021. The decrease is a result of a decrease in debt forgiveness and increases in interest expenses resulting from travel and miscellaneous referral fees due for the sale of products and equipment.

  

Net Loss

 

Net loss for the year ended December 31, 2022, was $633,192, as compared to a net loss of $1,439,249 for the year ended December 31, 2021. The decrease in losses is a direct result of growth in cannabis product sales, product and equipment sales, and a reduction in litigation expenses.

 

LIQUIDITY AND CAPITAL RESOURCES

 

As of December 31, 2022, our primary internal sources of liquidity were our working capital, which included cash and cash equivalents of $117,547 and accounts receivable of $496,111. Additionally, considering that our fixed overhead costs are low, we have the ability to issue stock to compensate employees and management. Management believes that it will need to raise short-term capital to mitigate any periodic delays in receipt of accounts receivable, as payments from third-party vendors are scheduled on a less-than-periodic timetable. Management believes this strategy will adequately provide the necessary liquidity and capital resources to fund our operational and general, and administrative expenses for at least the next 12 months.

 

During the year ended December 31, 2022, the Company issued 2,500,000 registered shares of common stock in exchange for net proceeds of $117,629 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019, with White Lion Capital LLC. The Common Stock Purchase Agreement was terminated on October 11, 2022.

 

Operating Activities

 

Net cash used in operating activities for the years ended December 31, 2022 and 2021, was $198,965 and $957,978 respectively. Decreases in cash used were a result of reductions in inventory, accounts receivable, prepaid expenses, and an increase in litigation settlement expense depreciation and amortization, stock-based compensation, and accounts payable.

 

Investing Activities

 

For the years ended December 31, 2022 and 2021, cash used in investing activites was $103,675 and $1,465,960, respectively. The decreases were the result of reductions of cash payments related to the acquisition of the assets of Naturaleaf of $1,100,000 and expenditures of equipment and leasehold improvements for the cultivation and dispensary facilities of $357,801.

 

Financing Activities

 

During the year ended December 31, 2022, cash used in financing activities was $250,236 and cash provided by financing activities was $1,371,229 for the year ended December 31, 2021. Funds received during the year ended December 31, 2022, were from the sale of shares of the Company’s registered common stock as reduced by a payment of a note payable pursuant to an amendment of the material definitive agreement related to the purchase of the Naturaleaf assets.

 

Off-Balance Sheet Arrangements

 

As of December 31, 2022 2021, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

Non-GAAP Financial Measures

 

A reconciliation of net income(loss) to Adjusted EBITDA is provided below:

 

   Year Ended  Year Ended
   December 31, 2022  December 31, 2021
Adjusted EBITDA reconciliation:          
Net loss  $(633,192)  $(1,439,249)
Bad Debt Expense   5,438    54,435 
Depreciation and Amortization   57,631    95,262 
Interest Expense   78,806    75,374
Stock-based compensation to employees   32,135    42,207 
Stock issued for services   —      —   
Adjusted EBITDA  $(459,182)  $(1,171,971)

 

11 

 

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect amounts reported in those statements. We have made our best estimates of certain amounts contained in our consolidated financial statements. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities. However, application of our accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties, and, as a result, actual results could differ materially from these estimates. Management believes that the estimates, assumptions, and judgments involved in the accounting policies described below have the most significant impact on our consolidated financial statements.

 

We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.

 

Cash and Cash Equivalents

We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. 

 

Inventory 

Inventory is primarily comprised of products and equipment to be sold to end-customers. Inventory is valued at cost, based on the specific identification method, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to market value. As of December 31, 2022, and December 31, 2021, market values of all of our inventory were greater than cost, and accordingly, no such valuation allowances was recognized.

 

Deposits

Deposits is comprised of advance payments made to third parties, primarily for inventory for which we have not yet taken title. When we take title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale (see “Costs of Revenues” below).

 

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

 

Accounts Receivable

Accounts receivable are recorded at the net value of face amount less any allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and, based on a method of specific identification of any accounts receivable for which we deem the net realizable value to be less than the gross amount of accounts receivable recorded, we establish an allowance for doubtful accounts for those balances. In determining our need for an allowance for doubtful accounts, we consider historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, our actual experience may vary from our estimates. If the financial condition of our clients were to deteriorate, resulting in their inability or unwillingness to pay our fees, we may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that we collect retainers from our clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of December 31, 2022 and 2021, our allowance for doubtful accounts was $64,344 and $82,540  , respectively. For December 31, 2022 and 2021, we recorded bad debt expense of $5,438 and $54,435, respectively.

 

Operating Leases Right-of-use Assets

The Company recognizes its leases in accordance with ASC 842 - Leases. Under ASC 842, operating lease right-of-use (“ROU”) assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease. The initial lease liability equals the future fixed minimum lease payments discounted using the Company’s incremental borrowing rate on a secured basis. The lease term includes option renewal periods and early termination payments when it is reasonably certain that the Company will exercise those rights. The initial measurement of the ROU asset equals the initial lease liability plus any initial direct costs and prepayments, less any lease incentives. The Company elected the short-term lease exemption for contracts with lease terms of 12 months or less. The Company accounts for the lease and non-lease components of its leases as a single lease component. Lease expense is recognized on a straight-line basis over the lease term. The Company had no leases as of December 31, 2022, and 2021 that had financing components.

 

12 

 

 

Property and Equipment, net

Property and Equipment are stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Depreciation of capitalized construction in progress costs, a component of property and equipment, net, begins once the underlying asset is placed into service and is recognized over the estimated useful life. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” We did not capitalize any interest for the years ended December 31, 2022, and 2021.

 

Accounting for the Impairment of Long-Lived Assets

We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, the recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values, or management's estimates, depending upon the nature of the assets. We have not recorded any impairment charges related to long-lived assets during the years ended December 31, 2022 and 2021.

 

Revenue Recognition

We adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “Revenue from Contracts with Customers (Topic 606). Due to the nature of our contracts with customers, adopting the new accounting principles did not have a significant impact on our prior period results of operations, cash flows or financial position.

 

Our service and product revenues arise from contracts with customers. Service revenue includes Operations Divisions consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, (c) Cannabis sales division. The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.

 

We may also enter into contracts with customers that identify a single, or few, distinct performance obligations, but that also have non-distinct, underlying performance obligations. These contracts are typically fulfilled within one to six months. Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods and, accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.

 

We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues:

 

  (1) Identify the contract with the Customer. Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.

 

  (2) Identify the performance obligations in the contract. We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.

 

  (3) Determination of the transaction price. Prices are typically fixed, and no price protections or variables are offered.

 

  (4) Allocation of the transaction price to the performance obligations in the contract. Transaction prices are typically allocated to the performance obligations outlined in the contract.

 

  (5) Recognize Revenue when (or as) the entity satisfies a performance obligation. We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.

 

Advances from Clients deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from Clients deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.

 

Product and Equipment Sales

 

Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, the title has been transferred, and collectability is reasonably assured. Generally, our suppliers drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order, and (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for the customer or us under FASB ASC Topic 606. During the years ended December 31, 2022 and 2021, sales returns were $0.

 

13 

 

 

Consulting Services

 

We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete For hourly-based fixed-fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, in order to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients” account and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer-based significant financing that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.

 

Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for the completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from the local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the years ended December 31, 2022, and 2021, we incurred no losses from fixed fee engagements that terminate prior to completion. We believe that if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.

 

We primarily enter into arrangements for which fixed and determinable revenues are contingent and agreed upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.

 

Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis, and the value of the separate elements can be established by VSOE or an estimated selling price.

 

While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.

 

Reimbursable expenses, including those relating to travel, other out-of-pocket expenses, and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred, and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.

  

Cannabis Sales

 

Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. Sales discounts were not material during the years ended December 31, 2022 and 2021.

 

14 

 

 

Costs of Revenues

Our policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenues includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel, and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

 

Advertising and Promotion Costs

Advertising and promotion costs are included as a component of selling and marketing expense and are expensed as incurred. During the year ended December 31, 2022, and December 31, 2021, these costs were $225,950 and $116,122, respectively.

 

Shipping and Handling Costs

For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.

 

Stock-Based Compensation

Restricted shares are awarded to employees and entitle the grantee to receive shares of restricted common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. During the years ended December 31, 2022 and 2021, stock-based compensation expense for restricted shares for Company employees was $78,342 and $42,206, respectively. Compensation expense for warrants is based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model and is expensed over the expected term of the awards. During the year ended December 31, 2022, and 2021, no warrants were issued as stock compensation.

 

Income Taxes

Our corporate status changed from an S-Corporation, which it had been since inception, to a C-Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S-Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S-Corporation’s taxable income. Accordingly, we were only subject to income taxes for a portion of 2014. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2022 and December 31, 2021, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of December 31, 2022, and December 31, 2021, we had no liabilities related to federal or state income taxes, and the carrying value of our deferred tax asset was zero. The years 2010 to 2022 remain subject to examination by the Company’s major tax jurisdictions.

 

Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“IRC”) Section 280E, under which the Company is only allowed to deduct expenses directly related to sales of the product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.

Net Loss Per Common Share

We report net loss per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.

 

15 

 

 

Related Party Transactions

We follow FASB ASC subtopic 850-10, “Related Party Transactions”, for the identification of related parties and disclosure of related party transactions.

 

Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

Material related party transactions are required to be disclosed in the consolidated financial statements, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: (a) the nature of the relationship(s) involved; (b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which statements of operation are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; (c) the dollar amounts of transactions for each of the periods for which statements of operations are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and (d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting Company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and
Stockholders of American Cannabis Company, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheet of American Cannabis Company, Inc. (the Company) as of December 31, 2022, and the related consolidated statement of operations, shareholders’ equity, and cash flows for year ended December 31, 2022, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and the results of their operations and their cash flows for year ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.

Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has a working capital deficit, has generated net losses since its inception and further losses are anticipated. The Company requires additional funds to meet its obligations and the costs of its operations. These factors raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Emphasis of Matter on Company’s Operations

The Company is an organization that provides products and services in the legalized cannabis industry. The Company operates in an industry where laws and regulations vary significantly by jurisdiction. Currently, several states permit medicinal or recreational use of cannabis; however, the use of cannabis is prohibited on a federal level in the United States. If any of the states that permit use of cannabis were to change their laws or the federal government was to actively enforce such prohibition, the Company’s business could be adversely affected. The Company also currently accepts credit card payments for purchases of legal cannabis at their retail locations. At any given time, the credit card companies may cease to process credit card payments for these sales, which could cause significant interruption in the Company’s operations.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Acquisitions

The Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiaries, doing business as “Naturaleaf” in the medicinal cannabis industry during the year ended December 31, 2021. The Company accounted for the acquisitions under the acquisition method of accounting for business combination. The Company began assessing the fair value of assets acquired during the year ended December 31, 2021 and recorded preliminary estimates related to the acquisition. During the year ended December 31, 2022, the Company finalized their assessment of the purchase price allocation through the use of a third-party valuation specialist regarding the intangible asset and goodwill values.

How the Critical Audit Matter were Addressed in the Audit

Our audit procedures related to the following:

•        We evaluated management’s and the valuation specialist’s identification of assets acquired and liabilities assumed.

•        We obtained management’s purchase price allocation detailing fair values assigned to acquired tangible and intangible assets.

•        We obtained valuation report prepared by valuation specialist engaged by management to assist in the purchase price allocation, including determination of fair values assigned to acquired intangible assets, and examined valuation methods used and qualifications of specialist.

•        We examined the completeness and accuracy of the underlying data supporting the significant assumptions and estimates used in the valuation report, including historical and projected financial information.

•        We evaluated the accuracy and completeness of the financial statement presentation and disclosure of the acquisitions.

 

/s/ Hudgens CPA, PLLC

www.hudgenscpas.com

We have served as the Company’s auditor since 2022.

Houston, Texas

April 17, 2023

Report of Independent Registered Public Accounting Firm (PCAOB Number 324)

 

Board of Directors and Shareholders

American Cannabis Company, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of American Cannabis Company, Inc. (the “Company”) as of December 31, 2021, and the related consolidated statement of operations, shareholders’ equity, and cash flows for the year then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021, and the results of its operations and its cash flows for the year then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Substantial Doubt About the Company’s Ability to Continue as a Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has an accumulated deficit, recurring losses, and expects continuing future losses. As of December 31, 2021, the Company has an accumulated deficit of $9,447,517. During the year ended December 31, 2021, the Company also experienced negative cash flows from operating activities of $957,978. It appears these principal conditions or events, considered in the aggregate, indicate it is probable that the entity will be unable to meet its obligations as they become due within one year after the date the financial statements are issued. Management’s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

16 

 

 

Emphasis of Matter Related to the Company’s Operations

 

The Company is an organization that provides products and services in the legalized cannabis industry. The Company operates in an industry where laws and regulations vary significantly by jurisdiction. Currently, several states permit medicinal or recreational use of cannabis; however, the use of cannabis is prohibited on a federal level in the United States. If any of the states that permit use of cannabis were to change their laws or the federal government was to actively enforce such prohibition, the Company’s business could be adversely affected. The Company also currently accepts credit card payments for purchases of legal cannabis at their retail locations. At any given time, the credit card companies may cease to process credit card payments for these sales, which could cause significant interruption in the Company’s operations.

 

Basis for Opinion

 

These financial statements are the responsibility of the entity’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. the Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

17 

 

 

 

/s/ Macias Gini & O’Connell LLP

 

We have served as the Company’s auditor since 2020.

 

 324

Irvine, CA

April 25, 2022

 

18 

 

 

AMERICAN CANNABIS COMPANY, INC.

CONSOLIDATED BALANCE SHEETS.

       
   December 31,  December 31,
   2022  2021
ASSETS          
Current Assets          
Cash and Equivalents  $117,547   $670,423 
Accounts Receivable, Net   469,111    11,316 
Deposits   9,595    2,895 
Inventory   352,971    278,608 
Prepaid Expenses and Other Current Assets   73,933    51,353 
Total Current Assets   1,023,157    1,014,595 
           
Property and Equipment - Net   427,669    375,832 
           
Other Assets          
Intangible Assets   1,223,242    745,937 
Goodwill   1,332,113    1,985,113 
Right of Use Assets - Operating Leases, net   604,020    95,722 
Long Term Deposits   6,000    6,000 
Total Other Assets   3,165,375    2,832,772 
TOTAL ASSETS  $4,616,201   $4,223,199 
           
LIABILITIES AND SHAREHOLDERS' EQUITY          
Current Liabilities          
Accounts Payable  $679,163   $242,679 
Advances from Clients   280,705    111,892 
Accrued and Other Current Liabilities   233,348    161,718 
Stock payable   74,343    42,207 
Right of Use Liabilities, all current   181,661    95,722 
Litigation Settlement, current   100,000    175,000 
Note payable, current   550,000    1,100,000 
Total Current Liabilities   2,099,220    1,929,218 
           
LONG TERM LIABILITIES          
Litigation Settlement   75,000    175,000 
Right of Use Liabilities, LT   422,359    - 
LTD Note Payable   150,000    - 
Total Long Term Liabilities   612,960    175,000 
TOTAL LIABILITIES   2,746,579    2,104,218 
           
Shareholders' Equity          
Preferred Stock, $0.01 par value, 5,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2022 and 2021   -      -   
Common stock, $0.00001 par value; 500,000,000 shares authorized; 92,152,938 and 81,902,938 shares issued and outstanding at December 31, 2022 and 2021, respectively   922    819 
Additional paid-in capital   11,949,409    11,565,679 
Accumulated deficit   (10,080,709)    (9,447,517)
Total Shareholders' Equity   1,869,622    2,118,981 
           
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY  $4,616,201   $4,223,199 

 

 

The accompanying notes are an integral part of these  consolidated financial statements  

19 

 

 

AMERICAN CANNABIS COMPANY, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

       
   For the Year Ended
   December 31,  December 31,
   2022  2021
Revenues      
Consulting Services  $475,837   $381,094 
Product & Equipment   17,539,377    1,037,962 
Cannabis Products   793,331    1,006,148 
Total Revenues   18,808,545    2,425,204 
           
Cost of Revenues          
Cost of Consulting Services   61,246    36,179 
Cost of Products and Equipment   15,230,648    758,940 
Cost of Cannabis Products   979,437    573,937 
Total Cost of Revenues   16,271,331    1,369,056 
Gross Profit   2,537,214    1,056,148 
           
Operating Expenses          
General and Administrative   2,833,140    2,050,272 
Selling and Marketing   225,950    199,968 
Bad Debt Expense   5,438    54,435 
Litigation Settlement Expense   -      350,000 
Stock Based Compensation Expense   78,342    42,206 
Total Operating Expenses   3,142,870    2,696,881 
Loss from Operations   (605,656)   (1,640,733)
           
Other Income (Expense)          
Interest (expense)   (78,086)   (75,374)
Debt Forgiveness   -      240,975 
Other income   50,550    35,883 
Total Other (Expense) Income   (27,536)   201,484 
Net Loss   (633,192)   (1,439,249)
Income Tax Expense   -      -   
NET LOSS  $(633,192)  $(1,439,249)
Basic and diluted net loss per common share  $(0.01)  $(0.02)
Basic and diluted weighted average common shares outstanding   85,727,938    78,387,733 

 

The accompanying notes are an integral part of these consolidated financial statements.

 20 

 

 

 

 

 

AMERICAN CANNABIS COMPANY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

       
   For the Year Ended
   December 31,  December 31,
   2022  2021
CASH FLOWS FROM OPERATING ACTIVITIES          
Net Loss  $(633,192)  $(1,439,249)
Adjustments to reconcile net loss to net cash used in operating activities:          
Allowance for Bad Debt Expenses   64,344    54,345 
Depreciation and amortization   227,533   95,562 
Stock-based compensation to employees   266,207    42,207 
Litigation Settlement Expense   -   350,000 
Operating lease expense   192,432   (95,722)
Debt Forgiveness   -      (240,975)
Changes in operating assets and liabilities:          
Accounts receivable   (522,139)   (40,795)
Inventory   (74,363)   (144,034)
Prepaid expenses and other current assets   (29,282)   (1,051)
Accounts Payable   436,484    229,524 
Advances from Clients
   168,813    23,409 

Litigation payable

   

(175,000

)   

-

 
Accrued and other current liabilities   71,630    113,349 
Operating Lease Liability   (192,432)   95,722 
Net Cash Used In Operating Activities  $(198,965)  $(957,978)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment   (103,675)    (357,801)
Acquisition of Assets   -    (1,100,000)
Intangible Assets   -    (8,159)
Net Cash Used in Investing Activities  $(103,675)   $(1,465,960)
    -    - 
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from note payable   -    130,186 
Payment of note payable   (550,000)   - 
LTD Note Payable   150,000    - 
Proceeds from sale of common stock   149,764    1,241,043 
Net Cash (Used in) Provided by Financing Activities  $(250,236)  $1,371,229 
           
NET (DECREASE) INCREASE IN CASH   (552,875)   (1,052,709)
           
CASH AT BEGINNING OF PERIOD   670,423    1,723,132 
           
CASH AT END OF PERIOD  $117,547   $670,423 
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Cash paid for income taxes  $-   $- 
Cash paid for interest  $-   $- 
Initial recognition of leases  $700,730   $- 
Stock issued for Receivables  $-    690,000 
Stock issued for Acquisition  $-    1,100,000 

  

The accompanying notes are an integral part of these  consolidated financial statements

 

21 

 

 

AMERICAN CANNABIS COMPANY, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

FOR THE YEARS  ENDED DECEMBER 31, 2022 AND 2021

 

                
                
         Additional     Total
   Common Stock  Paid-In'  Accumulated  Shareholders
   Shares  Amount  Capital  Deficit  Equity
Balance, December 31, 2020   70,727,938   $707   $9,634,748   $(8,008,268)  $1,627,187 
Stock-issued for asset acquisition   3,000,000    30    689,970    -      690,000 
Stock issued for cashless exercise of warrants   125,000    1    (1)   -      -   
Shares issued cash   8,050,000    81    1,240,962    -      1,241,043 
Net Loss   -      -      -      (1,439,249)   (1,439,249)
Balance, December 31, 2021   81,902,938   $819   $11,565,679   $(9,447,517)  $2,118,981 
              Additional          Total  
    Common Stock    Paid-In    Accumulated     Shareholders  
    Shares    Amount    Capital    Deficit    Equity  
Balance, December 31, 2021   81,902,938   $819   $11,565,679   $(9,447,517)  $2,118,981 
Stock-based compensation   2,000,000    20    46,206    -      46,226

 

 

Stock issued for services   4,750,000    48    169,931    -      169,979 
Stock issued for cash   2,500,000    25    117,603    -      117,628 
Stock issued for consultant   1,000,000    10    49,990    -      50,000 
Net Loss   -      -      -      (633,192)   (633,192)
Balance, December 31, 2022   92,152,938   $922   $11,949,409   $(10,080,709)  $1,869,622 

 

The accompanying notes are an integral part of these  consolidated financial statements

 

22 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Note 1. Description of Business.

 

American Cannabis Company, Inc. and its wholly owned subsidiary Company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and sell both exclusive and non-exclusive customer products commonly used in the industry.

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.

 

Naturaleaf agreed to sell or assign to the Company the following assets:

 

  1. Three Medical Marijuana (MMC) Store Licenses;

 

  2. One Marijuana Infused Product Licenses (MIPS); and

 

  3. One Option Premises Cultivation License (OPC); and

 

  4. Related real property assets, goodwill, and related business assets.

 

As a result, the Company has expanded its business model to include the cultivation and retail sale of cannabis in the medicinal cannabis industry.

 

Note 2. Basis of Presentation and Summary of Significant Accounting Policies

 

Basis of Accounting

 

The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.

 

Principal of Consolidation

 

The consolidated financial statements for the years ended December 31, 2022 and 2021, include the accounts of American Cannabis Company, Inc. and its wholly owned subsidiary, Hollister & Blacksmith, Inc., doing business as American Cannabis Company, Inc. Intercompany accounts and transactions have been eliminated.

 

23 

 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Going Concern

 

Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements - Going Concern ("ASC 205-40") requires management to assess the Company’s ability to continue as a going concern for one year after the date the financial statements are issued. Under ASC 205-40, management has the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet future financial obligations as they become due within one year after the date that the financial statements are issued. As required by this standard, management’s evaluation shall initially not take into consideration the potential mitigating effects of management’s plans that have not been fully implemented as of the date the financial statements are issued.

 

Our assessment included the preparation of a detailed cash forecast that included all projected cash inflows and outflows. During 2022, we secured additional cash financings through the sales and issuances of our common stock through. However, we continue to focus on growing our revenues. Accordingly, operating expenditures may exceed the revenue we expect to receive for the foreseeable future. We also have a history of operating losses, negative operating cash flows, and negative working capital, and expect these trends to continue into the foreseeable future.

 

As of the date of this Annual Report on Form 10-K, while we believe we have adequate capital resources to complete our near-term operations, there is no guarantee that such capital resources will be sufficient until such time we reach profitability. We may access capital markets to fund strategic acquisitions or ongoing operations on terms we believe are favorable. The timing and amount of capital that may be raised are dependent on market conditions and the terms and conditions upon which investors would require to provide such capital. We may utilize debt or sell newly issued equity securities through public or private transactions.

  

There can be no assurance that we can obtain additional funding on satisfactory terms or at all. In addition, no assurance can be given that any such financing, if obtained, will be adequate to meet our capital needs and support our growth. If additional funding cannot be obtained on a timely basis and on satisfactory terms, our operations would be materially negatively impacted; however, we have successfully accessed capital markets in the past, and we are confident in our ability to access capital markets again if needed.

 

The Company has an accumulated deficit of $10,080,709 and recurring losses and expects continuing future losses. In addition, the Company has a working capital deficit of $1,076,063. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s primary source of operating funds in 2022 and 2021 has been funds generated from proceeds from the sale of common stock and operations. The Company has experienced net losses from operations since its inception. The Company has an accumulated deficit at December 31, 2022, and requires additional financing to fund future operations.

 

The Company’s existence is dependent upon management’s ability to develop profitable operations and to obtain additional funding sources. There can be no assurance that the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

 

The accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. 

 24 

 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

 

Use of Estimates in Financial Reporting

 

The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in preparing the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.

 

Segment Information

 

Accounting Standards Codification subtopic Segment Reporting 280-10 ("ASC 280-10") establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information for those segments to be presented in interim financial reports issued to stockholders. ASC 280-10 also establishes standards for related disclosures about products and services and geographic areas. Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions on how to allocate resources and assess performance. The following table represents the Company’s Naturaleaf business.

 

 Schedule of Segment Reporting Information, by Segment

              
   For the Years ended
   Dec 31, 2022  Dec 31, 2021
       
Revenues  $793,330   $1,006,148 
           

Cost of Goods Sold 

   979,437    553,336 
           
Gross Profit   (186,107)   452,812 
           
Expense          
Depreciation Expense   46,111    19,811 
Stock-based Compensation   —      —   
Selling and Marketing   44,758    66,205 
Payroll and Related expenses   256,255    222,496 
General and Admin Expenses   538,528    231,341 
Total Expense   885,652    539,853 
           
Net Loss from Operations  $(1,071,759)  $(87,041)
           

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of December 31, 2022, and 2021, the Company had cash balances in excess of FDIC-insured limits of $250,000.

 

25 

 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Accounts Receivable, net

 

Accounts receivable are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods.

 

This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. At December 31, 2022, and 2021, the Company’s allowance for doubtful accounts was $4,071 and $82,540, respectively. The Company recorded bad debt expense during the years ended December 31, 2022, and 2021, of $5,438 and $54,435, respectively.

 

Deposits

 

Deposits are comprised of advance payments made to third parties, for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale.

 

Inventory

 

Inventory is comprised of products and equipment owned by the Company to be sold to end-customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in first-out and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of December 31, 2022 and 2021, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third party vendors for retail sales at dispensaries is determined using the first in first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production related depreciation and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At December 31, 2022, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary

 

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

 

26 

 

 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Significant Clients and Customers

 

For the year ended December 31, 2022, eight customers accounted for 87.33% of the Company's total revenues from its consulting, soil, and products revenue lines for the period. At December 31, 2021, nine customers accounted for 50.1% of the Company’s total revenues from its consulting and soil and product revenue lines for the period.

 

At December 31, 2022, three customers accounted for 84.76% of accounts receivable, net, consisting of customers for our products, soil, and consulting services product streams. At December 31, 2021, two customers accounted for 77.3% of accounts receivable, net, consisting of customers of our consulting services and soil, and products revenue streams.

 

Property and Equipment, net

 

Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in-progress construction are capitalized as incurred, and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of December 31, 2022, and 2021.

 

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed. The Company accounts for goodwill under ASC Topic 350, Intangibles-Goodwill and Other. The Company tests goodwill for impairment annually or more frequently whenever events or circumstances indicate impairment may exist. Goodwill is stated at cost less accumulated impairment losses. The Company completes its goodwill impairment test annually in the fourth quarter. The Company evaluated its Naturaleaf Acquisition that closed on April 30, 2021, and recognized $1,332,113 in goodwill connected with the acquisition during the year ended December 31, 2022.

The Company does not have any other indefinite-lived intangible assets. 

In accordance with FASB ASC 350, “Intangibles – Goodwill and Other,” we perform goodwill impairment testing at least annually, unless indicators of impairment exist in interim periods. The impairment test for goodwill uses a two-step approach. Step one compares the estimated fair value of a reporting unit with goodwill to its carrying value. If the carrying value exceeds the estimated fair value, step two must be performed. Step two compares the carrying value of the reporting unit to the fair value of all of the assets and liabilities of the reporting unit (including any unrecognized intangibles) as if the reporting unit was acquired in a business combination. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of its goodwill, an impairment loss is recognized in an amount equal to the excess.

 

Intangible Assets, net

 

Definite life intangible assets at December 31, 2022, include licenses, trademarks, goodwill and brand names recognized as part of the Naturaleaf Acquisition. Intangible assets are recorded at cost. Licenses, trademarks and brand names represent the estimated fair value of these items at the date of acquisition, April 30, 2021. Intangible assets are amortized on a straight-line basis over their estimated useful life. Licenses are assigned a life of 15 years, and tradenames are assigned a life of 5 years. During the year ended December 31, 2022, the Company recognized an amortization expense of $186,000.

 

27 

 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Accounting for the Impairment of Long-Lived Assets

 

The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, the recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values, or management's estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long-lived assets as of December 31, 2022, and 2021.

 

Fair Value Measurements

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.

 

Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.

 

Revenue Recognition

 

We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “Revenue from Contracts with Customers (Topic 606). Due to the nature of our contracts with customers, adopting the new accounting principles did not have a significant impact on our prior period results of operations, cash flows or financial position.

 

Our service and product revenues arise from contracts with customers. Service revenue includes Operations Divisions' consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, and (c) Cannabis sales division. The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.

 

We may also enter into contracts with customers that identify a single or few, distinct performance obligations but that also have non-distinct, underlying performance obligations. These contracts are typically fulfilled within one to six months. Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods and, accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.

 28 

 

 

 

 AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues:

 

  (1) Identify the contract with the Customer. Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.

 

  (2) Identify the performance obligations in the contract. We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.

 

  (3) Determination of the transaction price. Prices are typically fixed, and no price protections or variables are offered.

 

  (4) Allocation of the transaction price to the performance obligations in the contract. Transaction prices are typically allocated to the performance obligations outlined in the contract.

 

  (5) Recognize Revenue when (or as) the entity satisfies a performance obligation. We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.

 

Advances from Clients deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from Clients deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.

 

Product and Equipment Sales

 

Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, title has transferred, and collectability is reasonably assured. Generally, our suppliers’ drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for the customer or us under FASB ASC Topic 606. During the years ended December 31, 2022 and 2021, sales returns were $0.

 29 

 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Consulting Services

 

We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services. For hourly based fixed fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, in order to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients” account, and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer-based significant financing that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.

 

Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the years ended December 31, 2022 and 2021, we incurred no losses from fixed fee engagements that terminate prior to completion. We believe if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.

 

We primarily enter into arrangements for which fixed and determinable revenues are contingent and agreed upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.

 

Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis and the value of the separate elements can be established by VSOE or an estimated selling price.

 

While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.

 

Reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.

  

Cannabis Sales

 

Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. Sales discounts were not material during the years ended December 31, 2022, and 2021.

 

Loyalty Reward Program

 

The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based upon the total amount of a purchase, at the time of purchase. Management has determined that as there is no separate performance obligation to the reward program, i.e., the accumulation and redemption of points, and as such the Company recognizes the revenue at the time of purchase.

 

Costs of Revenues

 

The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

 

Advertising and Promotion Costs

 

Advertising and Promotion costs are included as a component of selling and marketing expense and are expensed as incurred. During the years ended December 31, 2022, and 2021, these expenses were $266,578 and $116,122, respectively.

 

Shipping and Handling Costs

 

For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.

 

Stock-Based Compensation

 

Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of the grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. During the years ended December 31, 2022, and 2021, stock-based compensation expense for restricted shares for Company employees was $78,342 and $42,206 , respectively. Compensation expenses for warrants are based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model and are expensed over the expected term of the awards. During the year ended December 31, 2022, and 2021, no warrants were issued as stock compensation.

 

Research and Development

 

As a component of our equipment and supplies offerings, from time-to-time we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include, but are not limited to: The Satchel™, Cultivation Cube™, So-Hum Living Soils™ and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the years ended December 31, 2022 and 2021, our research and development costs were de minimis.

 30 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Income Taxes

 

The Company’s corporate status changed from an S Corporation, which it had been since inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2022, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of December 31, 2022 and 2021 we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.

 

Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.

 

Net Loss Per Common Share

 

The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities since that would have an anti-dilutive effect on earnings.

 

Related Party Transactions

 

The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 31 

 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

 

Impact of the COVID-19 Pandemic

 

On March 11, 2020, the World Health Organization declared the current coronavirus (“COVID-19”) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state, and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact on many sectors of the economy, including retail commerce.

 

In response to state and local measures and for the protection of both employees, the Company made required changes to operations, which did not have a material impact on operations or the financial condition of the Company.

 

While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-19 cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these consolidated financial statements.

 

Recent Accounting Pronouncements

 

Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.

 

In December 2019, the FASB issued ASU 2019-12, “Simplifying the Accounting for Income Taxes”. The pronouncement simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740, “Income Taxes”. The pronouncement also improves consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. The Company has adopted the standard and there was not an impact on its consolidated financial statements.

 

In January 2020, the FASB issued ASU No. 2020-01, "Investments — Equity Securities: Clarifying the Interactions between Topic 321, Topic 323, and Topic 815" ("ASU No. 2020-01"). ASU No. 2020-01 clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with ASC 321, "Investments — Equity Securities" immediately before applying or upon discontinuing the equity method of accounting in ASC 323, "Investments—Equity Method and Joint Ventures." The provisions of ASU No. 2020-01 are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years with early adoption permitted, including early adoption in an interim period for public business entities for periods for which financial statements have not yet been issued. The Company has adopted thee standard and there was not an impact on its consolidated financial statements.

  

Note 3. Naturaleaf Asset Acquisition

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” (collectively, "Naturaleaf") in the medicinal cannabis industry in Colorado.

 32 

 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Naturaleaf agreed to sell or assign to the Company the following assets:

 

  1. Three Medical Marijuana (MMC) Store Licenses;

 

  2. One Marijuana Infused Product Licenses (MIPS); and,

 

  3. One Option Premises Cultivation License (OPC); and,

 

  4. Related real property assets, goodwill, and related business assets.

 

The aggregate consideration paid for the Assets was $2,912,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000, and (iv) the assumption of of $22,000 in current payables.

 

On April 29, 2022, the Company and the previous owners of Naturaleaf agreed to an amendment of the note. The Company paid $550,000 of the principal, combined with accrued interest of $110,000 in exchange for a new note with a principal balance of $550,000, interest per annum of 12% and a maturity date of April 29, 2023.

 

The asset acquisition was accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations. As the acquirer for accounting purposes, the Company has estimated the fair value of Medihemp LLC and Medical Cannabis Caregivers, Inc.’s (hereafter “Naturaleaf’s”) assets acquired and conformed the accounting policies of Naturaleaf to its own accounting policies. The Company expensed certain legal, auditing and licensing costs with the acquisition of $83,095.

 

As part of the acquisition, the owners of Naturaleaf retained the outstanding cash balance on the date of the acquisition and had agreed to the payment of all outstanding accounts payables and related party advances.

 

Preliminary Valuation

 

The Company has performed a valuation analysis of the fair market value of Naturaleaf’s assets. The following table summarizes the allocation of the preliminary purchase price as of the acquisition date:

 Schedule of purchase price as of the acquisition

         
Cash   $ --  
Inventory     72,172  
Property, plant and equipment     26,715  
Long Term Deposits     6,000  
Identifiable intangible assets     800,000  
Goodwill     1,985,113  
Accounts payable     --  
Total consideration   $ 2,890,000  

 

Goodwill from the acquisition primarily relates to the future economic benefits arising from the assets acquired, the assembled workforce acquired and synergies between the cultivation and retail operations and is consistent with the Company's stated intentions and strategy. Other assets include inventory and fixed assets.

 

The fair value of Naturaleaf’s identifiable intangible assets was $800,000 at April 30, 2021, consisting of $500,000 in licenses and $300,000 in brand names. During the year ended December 31, 2021, the Company recognized an amortization expense of $62,223.

 

Final Valuation

 

The Company finalized the fair market value assessment of Naturaleaf's assets during the year ended December 31, 2022. The following table summarizes the final allocation of the purchase price as of the acquisition date:

 

 Business Combination

      
Current Assets  $15,000 
Inventory   72,172 
Property, Plant and Equipment   26,715 
Other Assets   6,000 
Total Tangible Assets   119,887 
      
Tradenames and Trademarks   660,000 
Licenses   810,000 
Total Intangible Assets   1,470,000 
      
Goodwill   1,332,113 
Total Consideration  $2,912,000 

 

 33 

 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

 

 

The results of operations of Naturaleaf for the period from April 30, 2021 through December 31, 2022, are included in the Company's consolidated financial statements as of December 31, 2022.

 

Note 4. Accounts Receivable and Advance from Clients

 

Accounts receivable was comprised of the following:

 Schedule of Accounts receivable and advance from clients

       
       
   December 31,
2022		  December 31, 2021
Accounts Receivable – Trade  $469,111   $93,856 
Less: Allowance for Doubtful Accounts   (4,071)   (82,540)
Accounts Receivable, net  $465,040   $11,316 

 

The Company had allowances for bad debt expense during the years ended December 31, 2022 and 2021 of $5,438 and $54,435, respectively.

34 

 

 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

 

Our Advances from Clients had the following activity for 2022 and 2021:

Deposit Liabilities, Type 

    
December 31, 2020  $88,843 
  Additional deposits received   404,143 
  Less: Deposits recognized as revenue   (381,094)
December 31, 2021  $111,892 

 

    
   Amount
December 31, 2021  $111,892 
  Additional deposits received   691,769 
  Less: Deposits recognized as revenue   (522,663)
December 31, 2022  $280,705 

 

Note 5. Inventory

 

Inventory consisted of the following:

 Schedule of inventory

       
  December 31, 2022  December 31, 2021
Raw Materials  $38,464   $60,900 
Work In Process   206,306    136,266 
Finished Goods – Soil   66,557    58,594 
Finished Goods – Cannabis Retail   41,644    22,848 
Total Inventory  $352,971   $278,608 

 

Note 6. Property and Equipment, net

 

Property and equipment, net, was comprised of the following:

 Schedule of property and equipment

  December 31, 2022  December 31, 2021
Office equipment  $47,380   $39,574 
Software   13,204    13,204 
Furniture and Fixtures   2,328    2,328 
Machinery and Equipment   364,520    376,745 
Leasehold Improvements   ----    —   
Property and equipment, gross  $427,432   $431,851 
Less: Accumulated Depreciation   (113,650)   (56,019)
Property and equipment, net  $313,782   $375,832 

35 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Note 7. Intangible Assets

 

A significant amount of the Company’s current identified intangible assets were assumed upon consummation of the Naturaleaf acquisition on April 30, 2021. The Company has incurred capitalizable costs in connection with patent applications that it started work on. Identified intangible assets consisted of the following at the dates indicated below:

 Schedule of intangible assets

                                 
    December 31, 2022
    Gross carrying amount   Accumulated amortization   Carrying value   Estimated useful life
Licenses   $ 818,464     ($ 134,552 )   $ 683,912       15 years  
Brand   $ 660,000     ($ 120,670 )   $ 539,330       5 years  
Total intangible assets, net   $ 1,488,464     ($ 255,222 )   $ 1,223,242          

 

The weighted-average amortization period for intangible assets we acquired during the year ended December 31, 2022, was approximately 11.47 years.

 

Amortization expense for intangible assets was $186,000 and $62,223 for the years ended December 31, 2022 and 2021, respectively. Total estimated amortization expense for our intangible assets for the years 2023 through 2027 is as follows:

 Schedule of estimated amortization expense

             

   Year Ended
December 31, 2022
  2023     $ 186,000  
  2024     $ 186,000  
  2025     $ 186,000  
  2026     $ 145,997  
  2027     $ 54,000  
      $ 463,781  

 

Note 8. Accrued and Other Current Liabilities

 

Accrued and other current liabilities consisted of the following:

 Schedule of accrued and other current liabilities

       
  December 31, 2022  December 31, 2021
Accrued Interest  $39,130   $74,137 
Accrued Payroll   22,029    18,428 
Sales Tax Payable   3,931    592 
Other Accrued Expenses & Payables   168,258    68,559 
Accrued and other current liabilities  $233,348   $161,716 

 

36 

 

 

Note 9. Stock Payable

 

The following summarizes the changes in common stock payable:

 Schedule of stock payable

    
   Amount
December 31, 2021  $—   
  Payments received on shares not issued   74,342 
December 31, 2022  $74,342 

 

 

Note 10. Operating Lease Right-of-Use Asset/Operating Lease Liability

 

Our headquarters are located at 200 Union Street, Ste. 200, Lakewood, CO 80228. Our offices are not leased but granted pursuant to an accommodation that creates no tenancy, leasehold, or other real property interest. Our accommodation expires on August 31, 2023. Our monthly payment in exchange for the accommodation is $3,250.

 

The Company leases property under various operating leases. Property leases include retail and cultivation space with fixed rent payments and lease terms ranging from one to two years. The Company is obligated to pay the lessor for maintenance, real estate taxes, insurance and other operating expenses on certain property leases. These expenses are variable and are not included in the measurement of the lease asset or lease liability. These expenses are recognized as variable rent expense when incurred.

 

The Company’s lease portfolio consists of the following.

 Schedule of Other Operating Cost and Expense

  o 1004 S. Tejon Street, Colorado Springs, CO 80903; The Company assumed a lease originally entered into on February 12, 2016, which was the subject of a extension agreement dated April 5, 2022. The term of the lease was extended from May 1, 2022 until April 30, 2027. The Company's monthly rental payments from January 1, 2022 to May 1, 2022 was $3,700. From May 1, 2022 through the year ended December 31, 2022, monthly rent was $3,875. Remaining rental payments due for the extended period are:   May 1, 2022 to April 30, 2023 $3,875 May 1, 2023 to April 30, 2024 $4,050 May 1, 2024 to April 30, 2025 $4,225 May 1, 2025 to April 30, 2026 $4,400 May 1, 2026 to April 30, 2027 $4,575

 

May 1, 2022 to April 30, 2023 $3,875
May 1, 2023 to April 30, 2024 $4,050
May 1, 2024 to April 30, 2025 $4,225
May 1, 2025 to April 30, 2026 $4,400
May 1, 2026 to April 30, 2027 $4,575

 

  o 2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909 subject to a one-year term expiring June 30, 2023 with a monthly rent of $5,000.

  

  o 5870 Lehman Drive Suite 200, Colorado Springs, CO 80918 The Company and landlord  previously entered into a lease in 2017 which expired December 31, 2022. At December 31, 2022, the Company's monthly rent was $2,732. On April 26, 2022, the Company and landlord entered into an extension agreement which extended the tenancy from January 1, 2023 through January 1, 2027. Rental payments due for the extended period are:   January 1, 2023 $2,898 January 1, 2024 $2,985 January 1, 2025 $3,075 January 1, 2026 $3,167 January 1, 2027 $3,262

 

January 1, 2023 $2,898
January 1, 2024 $2,985
January 1, 2025 $3,075
January 1, 2026 $3,167
January 1, 2027 $3,262

  o 2611 Durango Drive, CO Springs, CO. The Company and landlord entered into a lease on March 10, 2021, which terminated on May 31, 2022. On June 23, 2021, the Company and landlord entered into an extension of the lease for a term of thirty-six months, beginning June 1, 2022 and terminating June 1, 2024. At December 31, 2022, monthly rent was $11,000. Rental payments due for the extended period are:       June 1, 2022 to June 1, 2023 $11,000 June 1, 2023 to June 1, 2024 $11,880 June 1, 2025 to June 1, 2025 $12,830  

 

 

June 1, 2022 to June 1, 2023 $11,000
June 1, 2023 to June 1, 2024 $11,880
June 1, 2025 to June 1, 2025 $12,830

 

37 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

On July 12, 2022, the Company entered into an accommodation for office space, effective September 1, 2022, located at 200 Union St., Suite 200, Lakewood, CO 80228. The accommodation creates no tenancy, leasehold or other real property interest concerning the Registrant. The Registrant's telephone number is unchanged. We determined under ASC 842, due to the nature of the accommodation that the membership agreement met the criteria of ASC 842-20-25-2, and as such, it was not necessary to capitalize the accomodation, and the membership fee will be recognized on a monthly straight-line basis.

 

On May 1, 2020, as part of the Naturaleaf Acquisition, the Company entered into leases for grow facilities and dispensaries. These leases were determined to be operating leases under ASC 842, and such leases were capitalized. It was determined that the Tejon lease, due to the short-term nature of the lease, met the criteria of ASC 842-20-25-2, and as such, it was not necessary to capitalize the lease, and rent would be recognized on a straight-line basis.

 

The Company records the lease asset and lease liability at the present value of lease payments over the lease term. The leases typically do not provide an implicit rate; therefore, the Company uses its estimated incremental borrowing rate at the time of lease commencement to discount the present value of lease payments. The Company’s discount rate for operating leases at December 31, 2022 was 12.5%. Leases often include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. Lease expense is recognized on a straight-line basis over the lease term to the extent that collection is considered probable. As a result, the Company has been recognizing rents as they become payable.

 

As of December 31, 2022, the aggregate remaining annual lease payments of operating leases liabilities are as follows:

 Schedule of operating leases liabilities

     
    Operating
Leases
2023   $ 604,020  
Total     604,020  
Less: amount representing interest       -
Present value of future minimum lease payments     604,020  
Less: current obligations under leases     181,661  
Long-term lease obligations   $ 422,359  

 

As of December 31, 2022, the aggregate remaining minimal annual lease payments under these operating leases were as follows: 

 Schedule of remaining minimal annual lease payments

             
  2023     $ 604,020  
  Total     $ 604,020  

 

Note 11. Loans Payable

 

PPP Loans

 

On March 27, 2020, the CARES Act was enacted to provide financial aid to family and businesses impacted by the COVID-19 pandemic. The Company participated in the CARES Act, and on August 6, 2020, the Company entered into a note payable with a bank under the Small Business Administration (“SBA”) Paycheck Protection Program (“PPP loan”) in the amount of $109,914. This loan payable matured on August 6, 2022, with a fixed interest rate of 1% per annum with interest deferred for six months. The PPP loan has an initial term of two years and is unsecured and guaranteed by the SBA. On March 1, 2021, the Company applied for and received forgiveness of the principal of $109,914 and interest of $632.01 on the PPP loan.

 

On April 23, 2021, the Company entered into a second note payable with a bank under the SBA PPP Loan in the amount of $130,186. The PPP Loan is subject to the same terms of forgiveness as above. On September 27, 2021, the SBA forgave the principal of $130,186 and any accrued interest.

 

Amendment to Naturaleaf Seller Note

 

On April 29, 2022, the Company and Medihemp, LLC, and its wholly owned subsidiary, SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., all collectively doing business as "Naturaleaf," (hereafter, "Naturaleaf") entered into an amendment to the previously disclosed material definitive agreement dated March 11, 2021.

 

The original material definitive agreement disclosed the Company's acquisition of assets from Naturaleaf, including, but not limited to: Naturaleaf's fixed assets, Medical Marijuana Center licenses, a Medical Cannabis’ Medical Marijuana Infused Product Manufacturer license, a Medical Marijuana Optional Premises Cultivation license, customer accounts, intellectual property, goodwill, and leases. As consideration for the purchase, the Company agreed to pay an aggregate purchase price of $2,200,000 in cash and 3,000,000 shares of Registrant's common stock.

 

The parties agreed to a payment schedule, requiring the Company to first pay an initial non-refundable payment of $20,000, credited against the purchase price. Thereafter, upon the party's completion of due diligence, and their receipt of contingent approval letters for the transfer of the Cannabis Licenses from the Colorado Marijuana Enforcement Division and the City of Colorado Springs (the "Closing"), the Company agreed to pay Naturaleaf $1,080,000 and issue Naturaleaf, or its designees, 3,000,000 shares of the Company's restricted common stock. The balance of the purchase price of $1,100,000 was payable based upon a promissory note issued by the Company, which included 10% interest. The note was due one year after Closing. On April 30, 2021, the Closing occurred, and the Company paid Naturaleaf $1,080,000 and issued 3,000,000 shares of restricted stock.

 

On April 29, 2022, the Company and the previous owners of Naturaleaf agreed to an amendment of the note. The Company paid $550,000 of the principal, combined with accrued interest of $110,000 in exhchange for a new note with a principal balance of $550,000, interest per annum of 12% and a maturity date of April 29, 2023.

 

Note 12. Related Party Transactions

 

On November 22, 2022, the Company issued a promissory note to Ellis Smith in exchange for $150,000. Interest on the note is 15% per annum. The note has a maturity date of May 21, 2023. If not paid within ten days of maturity, the note contains default interest of 18% per annum and a late charge penalty of 5% of the principal amount due.

 

Note 13. Stock Based Compensation

 

During the year ended December 31, 2022, the Company issued stock-based compensation for employees and service providers pursuant to its 2015 Equity Incentive Plan.

 

Restricted Shares

 

From time to time, the Company grants certain employees restricted shares of its common stock to provide further compensation in-lieu of wages and to align the employee’s interests with the interests of its stockholders. Because vesting is based on continued employment, these equity-based incentives are also intended to attract, retain and motivate personnel upon whose judgment, initiative and effort the Company’s success is largely dependent.

 

During the year ended December 31, 2022, the Company granted 2,000,000 restricted shares and recognized $78,342 in associated employee stock-based compensation expenses. The fair value of restricted stock unit is determined based on the quoted closing price of the Company’s common stock on the date granted. As of December 31, 2022, none of the shares were issued, and the entire amount is recorded as stock payable.

 

During the year ended December 31, 2022, the Company issued a total of 5,750,000 restricted shares to service providers and consultants for services rendered and recognized expenses of $219,940. The fair value of restricted stock is determined based on the quoted closing price of the Company’s common stock on the date granted.

 

 

38 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Net Loss Per Share

 

Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the reporting period. Diluted net loss per share is computed similarly to basic loss per share, except that it includes the potential dilution that could occur if dilutive securities are exercised.

 

Outstanding stock options and common stock warrants are considered anti-dilutive because we are in a net loss position. Accordingly, the number of weighted average shares outstanding for basic and fully diluted net loss per share are the same.

 

The following summarizes equity instruments that may, in the future, have a dilutive effect on earnings per share:

 Schedule of stock based compensation

         
    December 31,
2022		   December 31, 2021
Warrants     —        —  
Stock Payable                     —       275,000  
Total      —        275,000  

 

Warrants

 

During the year ended December 31, 2022, the Company did not issue or approve any warrants.

 

Note 14. Shareholders’ Equity

 

Preferred Stock

 

American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $0.01 par value. No shares of preferred stock were issued and outstanding at December 31, 2022, and 2021, respectively.

 

Common Stock

 

During the year ended December 31, 2022, the Company issued 2,500,000 registered shares of common stock in exchange for net proceeds of $117,628.50 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019, with White Lion Capital LLC. 

 

During the year ended December 31, 2022, the Company issued 1,000,000 restricted shares of common stock for consulting services. The Company recognized stock compensation of $50,000 related to the issuance based on the fair market value on the date of grant.

 

During the year ended December 31, 2022, the Company issued 4,750,000 restricted shares of common stock in exchange for marketing and investor relations services. The Company recognized stock compensation of $169,979 related to the issuance based on the fair market value on the date of grant.

 

During the year ended December 31, 2022, the Company issued 2,000,000 shares to employees for services rendered under contract. The Company recognized stock compensation of $46,226 related to the issuance based on the fair market value on the date of grant.

 

During the year ended December 31, 2021, the Company issued 8,050,000 registered shares of common stock in exchange for net proceeds of $1,241,043 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019 with White Lion Capital LLC.

 

During the year ended December 31, 2021, the Company issued 3,000,000 shares of its restricted common stock to the sellers of Naturaleaf, as part of the acquisition of assets of Naturaleaf. The shares had a value of $690,000 based on a closing market price on April 30, 2021 of $0.23 per share.

 

During the year ended December 31, 2021, warrants with a cashless exercise provision were exercised for 125,000 restricted shares, of which, a warrant for 100,000 shares was exercised by an officer/director of the Company.

 

Note 15. Commitments and Contingencies

 

Legal

 

In the ordinary course of its business, the Company becomes involved in various legal proceedings involving various matters. As of December 31, 2022, there are no pending legal proceedings involving the Company. The Company's expenses legal fees in the period they are incurred.

 

Employment Litigation

 

On November 15, 2019, a civil action was filed against the Company and Mr. Terry Buffalo, our former chief executive officer and director, and Mr. Ellis Smith, our current chief executive and financial officer and director, in Denver County District Court, Case Number 2019CV034380. The complaint sought a declaratory judgment and damages related to Plaintiff’s allegation that she was misclassified as an independent contractor while working for the Company. Plaintiff alleged she was owed unpaid overtime, liquidated damages, wages, statutory penalties, and other compensatory damages for her misclassification and alleged wrongful termination. Plaintiff’s suit against Mr. Buffalo and Mr. Smith alleged that each was the alter ego of the Company and is, therefore, jointly and severally liable. The Company filed a counterclaim against Plaintiff alleging misappropriation of trade secrets, breach of contract, and other claims relating to her theft of confidential and proprietary information. On January 24, 2022, a settlement agreement was entered into by all parties, and the action was dismissed.

 

The Settlement Agreement provides for a cash settlement of $350,000 to be paid over a 2-year period, and as a result, at December 31, 2022, the Company has recognized a total of liability of $350,000, of which $125,000 is classified as current.

 

39 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

 Note 16. Income Taxes

The following table displays a reconciliation from the U.S. statutory rate to the effective tax rate and the provision for (benefit from) income taxes for the years ended December 31, 2022, and 2021, respectively:

Schedule of income tax rate 

Schedule of income tax rate      
   For the Years Ended
   December 31,  December 31,
   2022  2021
       
Income Tax Provision (Benefit)  $428,083   $(623,358)
Non-deductible expenses including non-deductible pre-merger losses   187,711    163,495 
Change in valuation allowance   (615,794)   459,863 
Total Income Tax Benefit  $—     $—   

 

Deferred tax assets (liabilities) consisted of the following:

 Schedule of deferred tax assets

       
   December 31,  December 31,
   2022  2021
       
Total Deferred Tax Liabilities          
Lease Liability Expense  $—     $(24,457)
Total Deferred Tax Assets          
Net operating loss carryforwards   1,152,244    1,230,904 
           
Right of Use Asset   —      24,457 
Allowance for Doubtful Accounts   1,040    17,735 
Net Deferred Tax Assets   1,153,284    1,248,639 
Valuation Allowance   (1,153,284)   (1,248,639)
Total Deferred Tax Assets  $—     $—   

 

The Company determined that it is not more likely than not that its deferred tax asset would be realizable, accordingly, the Company recorded a valuation allowance for the full amount of its deferred tax asset, resulting in a zero carrying value of the Company’s deferred tax asset and no benefit from or provision for income taxes for the years ended December 31, 2022 and 2021. Federal and state operating loss carry forwards are $4,368,664 and $4,812,598 as of December 31, 2022 and 2021, respectively and begin to expire in 2035. The years 2019, 2020, 2021 remain subject to examination by the Company’s major tax jurisdictions. Utilization of the net operating loss carry forwards and credits may be subject to a substantial annual limitation due to ownership change limitations provided by Section 382 of the Internal Revenue Code of 1986, as amended, and similar state provisions. The Company is subject to Section 280(e ) since it sells cannabis with THC.

40 

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

 

Note 17. Subsequent Events

 

In accordance with ASC 855-10, the Company has analyzed its operations after consolidated financial statements were available to be issued and determined that there were no other significant subsequent events or transactions that would require recognition or disclosure in the consolidated financial statements for the year ended December 31, 2022, other than as follows.

  

During the three months ended March 31, 2023, the Company issued to its officers and directors 2,175,000 restricted shares.

 

41 

 

 

 

SUPPLEMENTARY DATA

 

The Company is a smaller reporting Company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information required under this item.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

  

On June 24, 2022, the Company dismissed Macias Gini & O’Connell (“MGO”) as its independent registered public accounting firm to audit the Company's financial statements. MGO’s reports on the Company's financial statements for the past two years, and any subsequent interim period through the date of dismissal, did not contain an adverse opinion or a disclaimer of opinion, or was qualified or modified as to uncertainty, audit scope, or matter of accounting principles or practices, financial statement disclosure or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of MGO, would have caused MGO to make reference to such disagreement in its report. During the two most recent fiscal years, and any subsequent interim period through the date of dismissal, were no disagreements with MGO or certain other reportable events.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

 

We carried out an evaluation under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2022, the end of the period covered by this Report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level due to the material weaknesses discussed below.

 

Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, our principal executive officer and principal financial officer and effected by the Board, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes those policies and procedures that:

 

  o pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets.

 

  o provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures of are being made only in accordance with authorizations of our management and directors; and,

 

  o provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.

 

Because of our inherent limitations, our internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Management identified the following material weaknesses:

 

  o we do not have an Audit Committee – While not being legally obligated to have an Audit Committee, it is the management’s view that such a committee, including a financial expert board member, is an utmost important entity level control of the Company’s financial statements. Currently, the Board of Directors acts in the capacity of the Audit Committee and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.

 

  o we have not performed a risk assessment and mapped our processes to control objectives.

 

  o we have not implemented comprehensive entity-level internal controls.

 

  o we have not implemented adequate system and manual controls; and

 

  o we do not have sufficient segregation of duties.

 

Our management assessed the effectiveness of internal control over financial reporting as of December 31, 2022. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organization of the Treadway Commission (“COSO”) in Internal Control – Integrated Framework (2013). Based on management’s assessment, management concluded that the above material weaknesses have not been remediated and, accordingly, our internal control over financial reporting is not effective as of December 31, 2022.

 

Remediation of Material Weaknesses

 

We have designed and plan to implement, or in some cases have already implemented, the specific remediation initiatives described below:

 

42 

 

 

  o We intend to allocate resources to perform a risk assessment and map processes to control objectives and, where necessary, implement and document internal controls in accordance with COSO.

 

  o Our entity-level controls are, generally, informal and we intend to evaluate current processes, supplement where necessary, and document requirements.

 

  o While we have implemented procedures to identify, evaluate and record significant transactions, we need to formally document these procedures and evidence the performance of the related controls.

 

  o We plan to evaluate system and manual controls, identify specific weaknesses, and implement a comprehensive system of internal controls.

 

Management understands that in order to remediate the material weaknesses, additional segregation of duties, changes in personnel and technologies are necessary. We will not consider these material weaknesses fully remediated until management has tested those internal controls and found them to be operating effectively.

 

This Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to such attestation pursuant to rules of the Securities and Exchange Commission that permits us to provide only management’s report in this Annual Report.

 

This Report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to such attestation pursuant to rules of the Securities and Exchange Commission that permits us to provide only management’s report in this Annual Report.

 

Changes in Internal Control over Financial Reporting

 

We implemented no changes to our internal control over financial reporting during the year ended December 31, 2021.

 

  

ITEM 9B. OTHER INFORMATION

 

 

PART III.

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Our Board of Directors

 

The following table sets forth information regarding our current directors and each director as of December 31, 2022.

 

Name   Principal Occupation   Age   Director Since
Ellis Smith   Director     45       2014  
Tad Mailander   Director     67       2017  

  

Ellis Smith from June 2014 to the present; Ellis Smith has served as our Chief Development Officer and as a director since September 2014. In March 2013, Mr. Smith co-founded ACC, and from March 2013 to May 2014, Mr. Smith served as a Managing Director of ACC. From September 2010 to July 2013, Mr. Smith co-owned Colorado Kind Care LLC d/b/a The Village Green Society, a Colorado based Medical Marijuana Center, where he was responsible for managing the operations and protocols supporting the growth and production of medical marijuana. From 2008 to 2010, Mr. Smith founded and operated The Happy Camper Organics Inc., a medical marijuana company focused on the growth of wholesale cannabis for sale to medical marijuana businesses. From 2005 to 2010, Mr. Smith founded and operated Bluebird Productions, a video production company. Mr. Smith has been published and recognized for

43 

 

his horticultural experience and organic gardening in the cannabis industry, and he is known for assisting in identifying the Hemp Russet Mite and working with SKUNK magazine to educate the industry. Our Board believes Mr. Smith’s qualifications to serve as an executive of the Company and as a member of our Board include his past success in founding and operating businesses, his unique experience in horticultural and organic gardening, and his recognized qualifications in the emerging medical cannabis markets.

  

Tad Mailander is an attorney licensed to practice before all of the Courts in the State of California. Mr. Mailander has been in practice since 1991 and is a member of the State Bar of California, the bars of the United States District Court for the Southern District of California, and the United States Court of Appeal for the Ninth Circuit. Mr. Mailander is an independent director.

 

Our Executive Officers

 

We designate persons serving in the following positions as our named executive officers: our chief executive officer, chief financial officer, chief development officer, and chief operating officer. The following table sets forth information regarding our executive officers as of December 31, 2022.

 

Name   Principal Occupation   Age   Officer Since
Ellis Smith   Chief Executive Officer, Chief Financial Officer     46       2018  
Tyler A. Schloesser   Chief Operations Officer     32       2019  

 

Ellis Smith, Chief Executive Officer, Chief Financial Officer. Mr. Smith’s biographical summary is included under “Our Board of Directors.” Mr. Smith was appointed Chief Executive Officer and Chief Financial Officer December 31, 2021.

 

Tyler A. Schloesser, Chief Operations Officer. Mr. Schloesser attended the University of Colorado at Boulder receiving a double major degree in Psychology and Philosophy. After graduation, Mr. Schloesser worked in the banking industry with Wells Fargo, U.S. Bank and Credit Union of Colorado. Mr. Schloesser received professional certificates from Dartmouth College in Retail & Omnichannel Management (2021); UC Berkeley in Blockchain Fundamentals (2021), and Columbia University in Corporate Finance (2022); Mr. Schloesser’s functions with the Registrant include developing and maintaining policies, procedures, processes and risk mitigation best practices as well as manage and perform day-to-day internal operational tasks required by the Registrant.

  

Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Exchange Act requires our executive officers and directors and persons who beneficially own more than 10% of our common stock to file initial reports of beneficial ownership and reports of changes in beneficial ownership with the SEC. Such persons are required by SEC regulations to furnish us with copies of all Section 16(a) forms filed by such persons.

 

Based solely on our review of such forms furnished to us and written representations from certain reporting persons, we believe all filing requirements applicable to our executive officers, directors, and greater than 10% stockholders during the fiscal year ended December 31, 2022, were satisfied.

 

ITEM 11. EXECUTIVE COMPENSATION

Summary Compensation Table

 

The following table sets forth information concerning the compensation of our principal executive officer, our principal financial officer and each of our other executive officers during 2022.

 

44 

 

 

Name and Principal Position   Year   Salary   Bonus  ($)   Bonus Stock Awards (in $)   Bonus Stock Awards  (in Shares)(4)   All Other Compensation ($)   Total ($)
Ellis Smith, CEO, CFO     2022       130,000               40,600       500,000       —         170,600  
      2021       90,000       —         11,510       75,000               101,510  
      2020       85,000       —         9,304       130,000       —         109,669  
Tyler A. Schloesser, COO     2022       100,000               20,300       250,000       —         120,300  
      2021       90,000       —         3,836       25,000       —         83,836  
      2020       72,000       —         3,632       50,000       —         75,632  
Jon Workman, VP Sales     2022       78,000               8,120       100,000       —         86,120  
      2021       78,000       —         3,836       25,000       —         86,386  
      2020       72,000       —         3,632       50,000                 —       75,632  

 

 

Retirement Benefits

We do not currently provide our named executive officers with supplemental or other retirement benefits.

Equity Awards at December 31, 2022

As of December 31, 2022, we granted the following stock-based compensation awards pursuant to contracts, board of directors compensation, and our 2015 Equity Incentive Plan (“Plan”), as amended. The Plan is intended to promote the best interest of the Company and its stockholders by assisting the Company in the recruitment and retentions of person with ability and initiative and providing an incentive to such person to contribute to the growth of the Company’s business. Eligible person under the Plan include employees, directors and consultants of the Company or any affiliated of the Company. Unless earlier terminated, the Plan will remain in force unless a new Plan has been adopted by the Board of the Company.

Compensation of Directors & Executive Officers

 

The Board of Directors granted the following compensation for directors as at the fiscal year ended December 31, 2022:

On February 9, 2022, the Company issued 25,000 shares to Ellis Smith under contract.

On February 9, 2022, the Company issued 25,000 shares to the Terry Buffalo Revocable Living Trust under contract.

Effective December 19, 2022, issued January 11, 2023, the Company issued 500,000 shares to Ellis Smith under contract.

 

Effective December 19, 2022, issued January 11, 2023, the Company issued 100,000 shares to Jon Workman under contract.

 

Effective December 19, 2022, issued January 11, 2023, the Company issued 250,000 shares to Tyler A. Schloesser under contract.

 

Effective December 19, 2022, issued January 11, 2023, the Company issued 500,000 shares to Tad Mailander as director compensation.

  

45 

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The following table sets forth information known to us regarding the beneficial ownership of our common stock as of December 31, 2022 by (1) each stockholder who is known by us to beneficially own more than 5% of our common stock, (2) each of our directors, (3) each of our executive officers named in the Summary Compensation Table above, and (4) all of our directors and executive officers as a group.

 

    Number of    
    Shares    
    Beneficially    
Beneficial Owner(1)   Owned(2)   Percent(3)
Named Executive Officers and Directors:                
Ellis Smith     13,346,543       14.48 %
Tad Mailander     1,250,000       1.35 %
Tyler A. Schloesser     1,000,000       1.08 %
Jon Workman     450,000       0.48 %
All executive officers and directors as a group     16,046,543       17.41 %

 

  (1) Except as otherwise indicated, the persons named in this table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them, subject to community property laws where applicable and to the information contained in the footnotes to this table.

 

  (2) Under SEC rules, a person is deemed to be the beneficial owner of shares that can be acquired by such person within 60 days upon the exercise of warrants or the settlement of other equity awards.

 

  (3) Calculated based on 92,152,938 shares of common stock outstanding as of December 31, 2022, plus any additional shares of common stock that a stockholder has the right to acquire within 60 days after December 31, 2022.

 

Equity Compensation Plan Information

 

  (1) Historically, the Company has granted restricted shares that are subject to forfeiture.

 

  (2) Historically, the Company has granted restricted shares that are subject to forfeiture. Restricted shares subject to forfeiture have a weighted average exercise price of $0.00.

 

  (3) The Company equity compensation grants to date have been approved on a grant-by-grant basis, as opposed to under an umbrella equity compensation plan establishing a total number of grants available.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS, AND DIRECTOR INDEPENDENCE

On November 22, 2022, the Company issued a promissory note to Ellis Smith in exchange for $150,000. Interest on the note is 15% per annum. The note has a maturity date of May 21, 2023. If not paid within ten days of maturity, the note contains default interest of 18% per annum and a late charge penalty of 5% of the principal amount due. The Company used the funds for operating capital.

 

46 

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 

The following table sets forth the aggregate fees billed to us for the fiscal year ended December 31, 2022, by Macias Gini & O’Connell through their date of termination on June 24, 2022:

 

    Year Ended   Year Ended
    December 31,   December 31,
    2022   2021
Audit fees (1)     157,590       91,662  
Audit-related fees (2)     ―       ―  
Tax fees (3)     ―       ―  
All other fees (4)     ―       ―  

 

The following table sets forth the aggregate fees billed to us for the fiscal year ended December 31, 2022, by Hudgens CPA, PLLC from the date of engagement on June 24, 2022:

 

    Year Ended   Year Ended
    December 31,   December 31,
    2022   2021
Audit fees (1)     $15,000       ―  
Audit-related fees (2)     ―       ―  
Tax fees (3)     ―       ―  
All other fees (4)     ―       ―  

 

  (1)   Audit fees consist of fees billed for professional services rendered for the audit of our annual financial statements, the review of the interim financial statements included in quarterly reports and services that are normally provided by Macias Gini & O’Connell in connection with statutory and regulatory filings or engagements, consultations in connection with acquisitions and issuances of auditor consents and comfort letters in connection with SEC registration statements and related SEC and non-SEC securities offerings.

 

  (2)   Audit fees consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements and are not reported under “Audit fees”.

 

  (3)   Tax fees consist of fees billed for professional services rendered for tax compliance, tax advice and tax planning (domestic and international). These services include assistance regarding federal, state, and international tax compliance, acquisitions and international tax planning.

 

  (4)   All other fees consist of fees for products and services other than the services reported above.

 

 

PART IV

 

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

(a)(1) Financial Statements

 

The following consolidated financial statements of American Cannabis Company, Inc. are included in “Item 8. Financial Statements and Supplementary Data.”

 

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets

Consolidated Statements of Operations

Consolidated Statements of Changes in Stockholders’ Equity

Consolidated Statements of Cash Flows

Notes to Consolidated Statements

47 

 

 

(a)(2) Financial Statement Schedules

 

(a)(3) Exhibits

 

 

(a)(3) Exhibits

Exhibit No Exhibit Title Filed Herewith Form Filing Date
2 Plan of Acquisition, Reorganization, Arrangement, Liquidation or Recession   14A 5/16/2000
2.1 Plan of Acquisition, Reorganization, Arrangement, Liquidation or Recession   14c 4/16/2013
2.2 Plan of Acquisition, Reorganization, Arrangement, Liquidation or Recession   14c 9/09/2014
3(i) Articles of Incorporation   SB-2 10/12/1995
3(i)(a) Amendment to Articles of Incorporation   14A 5/16/2000
3(i)(b) Amendment to Articles of Incorporation   14c 4/16/2013
3(i)(c) Amendment to Articles of Incorporation   14c 9/09/2014
3(i)(c) Amendment to Articles of Incorporation   8-K 10/3/2014
3(i)(c) Amendment to Articles of Incorporation   8-K 4/21/20
3(ii) By Laws  

SB-2

8-K 

10/12/1995

6/5/2017 

10 Material Contracts  

14c

8-K 

9/09/2014

10/15/2019 

16 Letter RE Change in Certifying Public Accountant  

8-K

8-K

8-K

8-K 

8-K

02/17/2015

11/5/2015

6/12/2017

8/23/2018

1/7/2020 

17 Disclosures on Departures of Directors  

8-K

14c

8-K

8-K 

10/03/2014

9/09/2014

1/25/2018

6//2017 

31.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a) X    
31.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a) X    
32.1 Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. X    
32.2 Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. X    

  

 

48 

 

 

 

* In accordance with Rule 406T of Regulation S-T, the information in these exhibits is furnished and deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Exchange Act of 1934, and otherwise is not subject to liability under these sections.

 

 

  SIGNATURES  

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

         
Date:  April 17, 2023   AMERICAN CANNABIS COMPANY, INC.
   
By:		  


/s/ Ellis Smith

 

Ellis Smith
Chief Executive Officer

 

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Terry Buffalo, with full power of substitution and re-substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file, any and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their and his or her substitute or substitutes, may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

 

Signature Title Date
     
/s/ Ellis Smith Chief Executive Officer, Chief Financial Officer, and Director April 17, 2023
Ellis Smith    
     
/s/ Tad Mailander Director April 17, 2023
Tad Mailander    

 

 49 

 

 EX-31.1 2 ex31_1.htm I, ELLIS SMITH, CERTIFY THAT:

Exhibit 31.1

 

I, Ellis Smith, certify that:

 

1.            I have reviewed this annual report on Form 10-K for fiscal year 2022 of American Cannabis Company, Inc.

 

2.            Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.            Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.            The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

(a)                    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)                    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(c)                    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.            The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)                    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)                    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

By: /s/ Ellis Smith

Ellis Smith

Chief Executive Officer

 

Date: April 17, 2023

 EX-31.2 3 ex31_2.htm I, ELLIS SMITH, CERTIFY THAT:

 

Exhibit 31.2

 

I, Ellis Smith, certify that:

 

1.            I have reviewed this annual report on Form 10-K for fiscal year 2022 of American Cannabis Company, Inc.

 

2.            Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.            Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.            The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

(a)                    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)                    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(c)                    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.            The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)                    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)                    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

By: /s/ Ellis Smith

Ellis Smith

Chief Financial Officer

 

Date: April 17, 2023

 

 EX-32.1 4 ex32_1.htm CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual report of American Cannabis Company, Inc. (the “Company”) on Form 10-K for fiscal year 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

By: /s/ Ellis Smith

Ellis Smith

Chief Executive Officer

 

 

Date: April 17, 2023

 

By: /s/ Ellis Smith

Ellis Smith

Chief Financial Officer

 

Date: April 17, 2023

 

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

 GRAPHIC 5 image_001.jpg GRAPHIC begin 644 image_001.jpg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end EX-101.SCH 6 ammj-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Description of Business. link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Naturaleaf Asset Acquisition link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Accounts Receivable and Advance from Clients link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Property and Equipment, net link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Intangible Assets link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Accrued and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Stock Payable link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Loans Payable link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Stock Based Compensation link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Shareholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Naturaleaf Asset Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Accounts Receivable and Advance from Clients (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Property and Equipment, net (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Accrued and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Stock Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Stock Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Naturaleaf Asset Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Naturaleaf Asset Acquisition (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Naturaleaf Asset Acquisition (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Accounts Receivable and Advance from Clients (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Accounts Receivable and Advance from Clients (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Accounts Receivable and Advance from Clients (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Property and Equipment, net (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Intangible Assets (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Intangible Assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Accrued and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Stock Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Schedule of remaining minimal annual lease payments (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Stock Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Income Taxes (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ammj-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ammj-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ammj-20221231_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Segments [Axis] Other Segments [Member] Long-Lived Tangible Asset [Axis] Office Equipment [Member] Software Development [Member] Furniture and Fixtures [Member] Machinery and Equipment [Member] Leasehold Improvements [Member] Finite-Lived Intangible Assets by Major Class [Axis] License [Member] Brand [Member] Award Date [Axis] May 2022 To April 2023 [Member] May 2023 To April 2024 [Member] May 2024 To April 2025 [Member] May 2025 To April 2026 [Member] May 2026 To April 2027 [Member] January 2023 [Member] January 2024 [Member] January 2025 [Member] January 2026 [Member] January 2027 [Member] June 2022 To June 2023 [Member] June 2023 To June 2024 [Member] June 2024 To June 2025 [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Auditor Name Auditor Firm ID Auditor Location Statement of Financial Position [Abstract] ASSETS Current Assets Cash and Equivalents Accounts Receivable, Net Deposits Inventory Prepaid Expenses and Other Current Assets Total Current Assets Property and Equipment - Net Other Assets Intangible Assets Goodwill Right of Use Assets - Operating Leases, net Long Term Deposits Total Other Assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS' EQUITY Current Liabilities Accounts Payable Advances from Clients Accrued and Other Current Liabilities Stock payable Right of Use Liabilities, all current Litigation Settlement, current Note payable, current Total Current Liabilities LONG TERM LIABILITIES Litigation Settlement Right of Use Liabilities, LT LTD Note Payable Total Long Term Liabilities TOTAL LIABILITIES Shareholders' Equity Preferred Stock, $0.01 par value, 5,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2022 and 2021 Common stock, $0.00001 par value; 500,000,000 shares authorized; 92,152,938 and 81,902,938 shares issued and outstanding at December 31, 2022 and 2021, respectively Additional paid-in capital Accumulated deficit Total Shareholders' Equity TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Outstanding Income Statement [Abstract] Revenues Consulting Services Product & Equipment Cannabis Products Total Revenues Cost of Revenues Cost of Consulting Services Cost of Products and Equipment Cost of Cannabis Products Total Cost of Revenues Gross Profit Operating Expenses General and Administrative Selling and Marketing Bad Debt Expense Litigation Settlement Expense Stock Based Compensation Expense Total Operating Expenses Loss from Operations Other Income (Expense) Interest (expense) Debt Forgiveness Other income Total Other (Expense) Income Net Loss Income Tax Expense NET LOSS Basic and diluted net loss per common share Basic and diluted weighted average common shares outstanding Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net Loss Adjustments to reconcile net loss to net cash used in operating activities: Allowance for Bad Debt Expenses Depreciation and amortization Stock-based compensation to employees Litigation Settlement Expense Operating lease expense Debt Forgiveness Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other current assets Accounts Payable Advances from Clients Litigation payable Accrued and other current liabilities Operating Lease Liability Net Cash Used In Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property and equipment Acquisition of Assets Intangible Assets Net Cash Used in Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from note payable Payment of note payable LTD Note Payable Proceeds from sale of common stock Net Cash (Used in) Provided by Financing Activities NET (DECREASE) INCREASE IN CASH CASH AT BEGINNING OF PERIOD CASH AT END OF PERIOD SUPPLEMENTAL CASH FLOW INFORMATION: Cash paid for income taxes Cash paid for interest Initial recognition of leases Stock issued for Receivables Stock issued for Acquisition Statement [Table] Statement [Line Items] Balance, December 31, 2021 Shares, Outstanding, Beginning Balance Stock-issued for asset acquisition Stock-issued for asset acquisition Shares Stock issued for cashless exercise of warrants Stock issued for cashless exercise of warrants Shares Stock issued for cash Stock issued for cash shares Net Loss Stock-based compensation Stock-based compentation Stock issued for services Stock issued for services shares Stock issued for consultant Stock issued for consultant Balance, December 31, 2022 Shares, Outstanding, Ending Balance Accounting Policies [Abstract] Description of Business. Basis of Presentation and Summary of Significant Accounting Policies Business Combination and Asset Acquisition [Abstract] Naturaleaf Asset Acquisition Receivables [Abstract] Accounts Receivable and Advance from Clients Inventory Disclosure [Abstract] Inventory Property, Plant and Equipment [Abstract] Property and Equipment, net Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets Payables and Accruals [Abstract] Accrued and Other Current Liabilities Stock Payable Stock Payable Operating Lease Right-of-use Assetoperating Lease Liability Operating Lease Right-of-Use Asset/Operating Lease Liability Debt Disclosure [Abstract] Loans Payable Related Party Transactions [Abstract] Related Party Transactions Equity [Abstract] Stock Based Compensation Shareholders’ Equity Commitments and Contingencies Disclosure [Abstract] Income Taxes Subsequent Events [Abstract] Subsequent Events Basis of Accounting Principal of Consolidation Going Concern Use of Estimates in Financial Reporting Segment Information Cash and Cash Equivalents Accounts Receivable, net Deposits Inventory Prepaid Expenses and Other Current Assets Significant Clients and Customers Property and Equipment, ne Goodwill Intangible Assets, net Accounting for the Impairment of Long-Lived Assets Fair Value Measurements Revenue Recognition Product and Equipment Sales Consulting Services Cannabis Sales Loyalty Reward Program Costs of Revenues Advertising and Promotion Costs Shipping and Handling Costs Stock-Based Compensation Research and Development Income Taxes Net Loss Per Common Share Related Party Transactions Impact of the COVID-19 Pandemic Recent Accounting Pronouncements Schedule of Segment Reporting Information, by Segment Schedule of purchase price as of the acquisition Business Combination Deposit Liabilities, Type Deposit Liabilities, Type Schedule of inventory Schedule of property and equipment Schedule of intangible assets Schedule of estimated amortization expense Schedule of accrued and other current liabilities Schedule of stock payable Schedule of Other Operating Cost and Expense Schedule of operating leases liabilities Schedule of remaining minimal annual lease payments Schedule of stock based compensation Schedule of income tax rate Schedule of deferred tax assets Revenues Cost of Goods Sold  Gross Profit Depreciation Expense Stock-based Compensation Payroll and Related expenses General and Admin Expenses Total Expense Net Loss from Operations Accounts Receivable, Allowance for Credit Loss [custom:BadDebtExpense] Amortization of Acquisition Costs Revenue Recognition, Sales Returns, Reserve for Sales Returns Advertising Expense Employee Benefits and Share-Based Compensation Cash Inventory Property, plant and equipment Long Term Deposits Identifiable intangible assets Goodwill Accounts payable Total consideration Current Assets Inventory Property, Plant and Equipment Other Assets Total Tangible Assets Tradenames and Trademarks Licenses Total Intangible Assets Goodwill Total Consideration Legal Fees Amortization Accounts Receivable – Trade Less: Allowance for Doubtful Accounts Accounts Receivable, net December 31, 2021   Additional deposits received   Less: Deposits recognized as revenue December 31, 2022 allowances for bad debt expense Raw Materials Work In Process Finished Goods – Soil Finished Goods – Cannabis Retail Total Inventory Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Gross Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment [custom:PropertyPlantAndEquipmentNet1-0] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets, Gross Finite-Lived Intangible Assets, Accumulated Amortization Finite-Lived Intangible Assets, Net Estimated Useful Life [custom:FiniteLivedIntangibleAssetsNet1-0]             Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Other Depreciation and Amortization Accrued Interest Accrued Payroll Sales Tax Payable Other Accrued Expenses & Payables Accrued and other current liabilities StockPayableAmounts Additional Expensed Incurred, Amount StockPayableAmounts Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Rental expense Rental expense 2023 Total Less: amount representing interest Present value of future minimum lease payments Less: current obligations under leases Long-term lease obligations Schedule Of Remaining Minimal Annual Lease Payments 2023 Total Warrants Stock Payable Total Income Tax Provision (Benefit) Non-deductible expenses including non-deductible pre-merger losses Change in valuation allowance Total Income Tax Benefit Total Deferred Tax Liabilities Lease Liability Expense Total Deferred Tax Assets Net operating loss carryforwards Right of Use Asset Allowance for Doubtful Accounts Net Deferred Tax Assets Valuation Allowance Total Deferred Tax Assets Subsequent Event [Table] Subsequent Event [Line Items] Stock Issued During Period, Shares, Restricted Stock Award, Gross Assets, Current Other Assets [Default Label] Assets Liabilities, Current Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Revenues [Default Label] Cost of Revenue Interest Expense DebtForgiveness Nonoperating Income (Expense) NetLoss Net Income (Loss) Attributable to Parent Litigation Settlement, Expense DebtInstrumentDecreaseForgivenes Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable AdvancesFromClients Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment PaymentForAcquisitionOfAssets PaymentsToAcquireIntangibleAsset Net Cash Provided by (Used in) Investing Activities Payments to Acquire Notes Receivable Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Shares, Outstanding Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Stock Issued During Period, Shares, Other Inventory Disclosure [Text Block] Intangible Assets Disclosure [Text Block] Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] StockPayableTextBlock Deposit Contracts, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] Receivables and Portions of Securitizations that can be Prepaid at Potential Loss, Policy [Policy Text Block] Goodwill and Intangible Assets, Policy [Policy Text Block] ConsultingServicesPolicyTextBlock Income Tax, Policy [Policy Text Block] RelatedPartyTransactionsPolicyTextBlock Deposit Liabilities, Type [Table Text Block] Inventory, Gross Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets Intangible Assets, Net (Excluding Goodwill) Accounts Receivable, Allowance for Credit Loss, Current Accounts and Financing Receivable, after Allowance for Credit Loss DepositsRecognizedAsRevenue Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Finite-Lived Intangible Asset, Expected Amortization, Year Two Finite-Lived Intangible Asset, Expected Amortization, Year Three Finite-Lived Intangible Asset, Expected Amortization, Year Four Finite-Lived Intangible Asset, Expected Amortization, Year Five Finite-Lived Intangible Asset, Expected Amortization, after Year Five Accounts Payable and Other Accrued Liabilities StockPayableAmounts LessAmountRepresentingInterest Less: current obligations under leases Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid Convertible Notes Payable DilutiveSecuritiesAmount NondeductibleExpensesIncludingNondeductiblePremergerLosses Deferred Tax Liabilities, Leasing Arrangements Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net EX-101.PRE 10 ammj-20221231_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2022
Apr. 17, 2023
Cover [Abstract]    
Document Type 10-K  
Amendment Flag false  
Document Annual Report true  
Document Transition Report false  
Document Period End Date Dec. 31, 2022  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 000-26108  
Entity Registrant Name AMERICAN CANNABIS COMPANY, INC  
Entity Central Index Key 0000945617  
Entity Tax Identification Number 90-1116625  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 200 Union Street, Ste.  
Entity Address, Address Line Two 200  
Entity Address, City or Town Lakewood  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80228  
City Area Code 303  
Local Phone Number 974-4770  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Public Float $ 5,076,892  
Entity Common Stock, Shares Outstanding   92,152,938
Auditor Name Macias Gini & O’Connell LLP  
Auditor Firm ID 324  
Auditor Location Irvine, CA  

XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and Equivalents $ 117,547 $ 670,423
Accounts Receivable, Net 469,111 11,316
Deposits 9,595 2,895
Inventory 352,971 278,608
Prepaid Expenses and Other Current Assets 73,933 51,353
Total Current Assets 1,023,157 1,014,595
Property and Equipment - Net 427,669 375,832
Other Assets    
Intangible Assets 1,223,242 745,937
Goodwill 1,332,113 1,985,113
Right of Use Assets - Operating Leases, net 604,020 95,722
Long Term Deposits 6,000 6,000
Total Other Assets 3,165,375 2,832,772
TOTAL ASSETS 4,616,201 4,223,199
Current Liabilities    
Accounts Payable 679,163 242,679
Advances from Clients 280,705 111,892
Accrued and Other Current Liabilities 233,348 161,718
Stock payable 74,343 42,207
Right of Use Liabilities, all current 181,661 95,722
Litigation Settlement, current 100,000 175,000
Note payable, current 550,000 1,100,000
Total Current Liabilities 2,099,220 1,929,218
LONG TERM LIABILITIES    
Litigation Settlement 75,000 175,000
Right of Use Liabilities, LT 422,359
LTD Note Payable 150,000
Total Long Term Liabilities 612,960 175,000
TOTAL LIABILITIES 2,746,579 2,104,218
Shareholders' Equity    
Preferred Stock, $0.01 par value, 5,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2022 and 2021
Common stock, $0.00001 par value; 500,000,000 shares authorized; 92,152,938 and 81,902,938 shares issued and outstanding at December 31, 2022 and 2021, respectively 922 819
Additional paid-in capital 11,949,409 11,565,679
Accumulated deficit (10,080,709) (9,447,517)
Total Shareholders' Equity 1,869,622 2,118,981
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 4,616,201 $ 4,223,199
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Preferred Stock, Par or Stated Value Per Share   $ 0.01
Preferred Stock, Shares Authorized   5,000,000
Preferred Stock, Shares Issued   0
Common Stock, Par or Stated Value Per Share   $ 0.00001
Common Stock, Shares Authorized 500,000,000  
Common Stock, Shares, Outstanding 92,152,938 81,902,938
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenues    
Consulting Services $ 475,837 $ 381,094
Product & Equipment 17,539,377 1,037,962
Cannabis Products 793,331 1,006,148
Total Revenues 18,808,545 2,425,204
Cost of Revenues    
Cost of Consulting Services 61,246 36,179
Cost of Products and Equipment 15,230,648 758,940
Cost of Cannabis Products 979,437 573,937
Total Cost of Revenues 16,271,331 1,369,056
Gross Profit 2,537,214 1,056,148
Operating Expenses    
General and Administrative 2,833,140 2,050,272
Selling and Marketing 225,950 199,968
Bad Debt Expense 5,438 54,435
Litigation Settlement Expense 350,000
Stock Based Compensation Expense 78,342 42,206
Total Operating Expenses 3,142,870 2,696,881
Loss from Operations (605,656) (1,640,733)
Other Income (Expense)    
Interest (expense) (78,086) (75,374)
Debt Forgiveness 240,975
Other income 50,550 35,883
Total Other (Expense) Income (27,536) 201,484
Net Loss (633,192) (1,439,249)
Income Tax Expense
NET LOSS $ (633,192) $ (1,439,249)
Basic and diluted net loss per common share $ (0.01) $ (0.02)
Basic and diluted weighted average common shares outstanding 85,727,938 78,387,733
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (633,192) $ (1,439,249)
Adjustments to reconcile net loss to net cash used in operating activities:    
Allowance for Bad Debt Expenses 64,344 54,345
Depreciation and amortization 227,533 95,562
Stock-based compensation to employees 266,207 42,207
Litigation Settlement Expense 350,000
Operating lease expense 192,432 (95,722)
Debt Forgiveness (240,975)
Changes in operating assets and liabilities:    
Accounts receivable (522,139) (40,795)
Inventory (74,363) (144,034)
Prepaid expenses and other current assets (29,282) (1,051)
Accounts Payable 436,484 229,524
Advances from Clients 168,813 23,409
Litigation payable (175,000)
Accrued and other current liabilities 71,630 113,349
Operating Lease Liability (192,432) 95,722
Net Cash Used In Operating Activities (198,965) (957,978)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (103,675) (357,801)
Acquisition of Assets (1,100,000)
Intangible Assets (8,159)
Net Cash Used in Investing Activities (103,675) (1,465,960)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from note payable 130,186
Payment of note payable (550,000)
LTD Note Payable 150,000
Proceeds from sale of common stock 149,764 1,241,043
Net Cash (Used in) Provided by Financing Activities (250,236) 1,371,229
NET (DECREASE) INCREASE IN CASH (552,875) (1,052,709)
CASH AT BEGINNING OF PERIOD 670,423 1,723,132
CASH AT END OF PERIOD 117,547 670,423
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid for income taxes
Cash paid for interest
Initial recognition of leases 700,730
Stock issued for Receivables 690,000
Stock issued for Acquisition $ 1,100,000
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance, December 31, 2021 at Dec. 31, 2020 $ 707 $ 9,634,748 $ (8,008,268) $ 1,627,187
Shares, Outstanding, Beginning Balance at Dec. 31, 2020 70,727,938      
Stock-issued for asset acquisition $ 30 689,970 690,000
Stock-issued for asset acquisition Shares 3,000,000      
Stock issued for cashless exercise of warrants $ 1 (1)
Stock issued for cashless exercise of warrants Shares 125,000      
Stock issued for cash $ 81 1,240,962 1,241,043
Stock issued for cash shares 8,050,000      
Net Loss (1,439,249) (1,439,249)
Balance, December 31, 2022 at Dec. 31, 2021 $ 819 11,565,679 (9,447,517) 2,118,981
Shares, Outstanding, Ending Balance at Dec. 31, 2021 81,902,938      
Stock issued for cash $ 25 117,603 117,628
Stock issued for cash shares 2,500,000      
Net Loss (633,192) (633,192)
Stock-based compensation $ 20 46,206 46,226
Stock-based compentation 2,000,000      
Stock issued for services $ 48 169,931 169,979
Stock issued for services shares 4,750,000      
Stock issued for consultant $ 10 49,990 50,000
Stock issued for consultant 1,000,000      
Balance, December 31, 2022 at Dec. 31, 2022 $ 922 $ 11,949,409 $ (10,080,709) $ 1,869,622
Shares, Outstanding, Ending Balance at Dec. 31, 2022 92,152,938      
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Description of Business.
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Description of Business.

Note 1. Description of Business.

 

American Cannabis Company, Inc. and its wholly owned subsidiary Company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and sell both exclusive and non-exclusive customer products commonly used in the industry.

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.

 

Naturaleaf agreed to sell or assign to the Company the following assets:

 

  1. Three Medical Marijuana (MMC) Store Licenses;

 

  2. One Marijuana Infused Product Licenses (MIPS); and

 

  3. One Option Premises Cultivation License (OPC); and

 

  4. Related real property assets, goodwill, and related business assets.

 

As a result, the Company has expanded its business model to include the cultivation and retail sale of cannabis in the medicinal cannabis industry.

 
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies

Note 2. Basis of Presentation and Summary of Significant Accounting Policies

 

Basis of Accounting

 

The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.

 

Principal of Consolidation

 

The consolidated financial statements for the years ended December 31, 2022 and 2021, include the accounts of American Cannabis Company, Inc. and its wholly owned subsidiary, Hollister & Blacksmith, Inc., doing business as American Cannabis Company, Inc. Intercompany accounts and transactions have been eliminated.

 

 

 

Going Concern

 

Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements - Going Concern ("ASC 205-40") requires management to assess the Company’s ability to continue as a going concern for one year after the date the financial statements are issued. Under ASC 205-40, management has the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet future financial obligations as they become due within one year after the date that the financial statements are issued. As required by this standard, management’s evaluation shall initially not take into consideration the potential mitigating effects of management’s plans that have not been fully implemented as of the date the financial statements are issued.

 

Our assessment included the preparation of a detailed cash forecast that included all projected cash inflows and outflows. During 2022, we secured additional cash financings through the sales and issuances of our common stock through. However, we continue to focus on growing our revenues. Accordingly, operating expenditures may exceed the revenue we expect to receive for the foreseeable future. We also have a history of operating losses, negative operating cash flows, and negative working capital, and expect these trends to continue into the foreseeable future.

 

As of the date of this Annual Report on Form 10-K, while we believe we have adequate capital resources to complete our near-term operations, there is no guarantee that such capital resources will be sufficient until such time we reach profitability. We may access capital markets to fund strategic acquisitions or ongoing operations on terms we believe are favorable. The timing and amount of capital that may be raised are dependent on market conditions and the terms and conditions upon which investors would require to provide such capital. We may utilize debt or sell newly issued equity securities through public or private transactions.

  

There can be no assurance that we can obtain additional funding on satisfactory terms or at all. In addition, no assurance can be given that any such financing, if obtained, will be adequate to meet our capital needs and support our growth. If additional funding cannot be obtained on a timely basis and on satisfactory terms, our operations would be materially negatively impacted; however, we have successfully accessed capital markets in the past, and we are confident in our ability to access capital markets again if needed.

 

The Company has an accumulated deficit of $10,080,709 and recurring losses and expects continuing future losses. In addition, the Company has a working capital deficit of $1,076,063. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s primary source of operating funds in 2022 and 2021 has been funds generated from proceeds from the sale of common stock and operations. The Company has experienced net losses from operations since its inception. The Company has an accumulated deficit at December 31, 2022, and requires additional financing to fund future operations.

 

The Company’s existence is dependent upon management’s ability to develop profitable operations and to obtain additional funding sources. There can be no assurance that the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

 

The accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. 

 

 

Use of Estimates in Financial Reporting

 

The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in preparing the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.

 

Segment Information

 

Accounting Standards Codification subtopic Segment Reporting 280-10 ("ASC 280-10") establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information for those segments to be presented in interim financial reports issued to stockholders. ASC 280-10 also establishes standards for related disclosures about products and services and geographic areas. Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions on how to allocate resources and assess performance. The following table represents the Company’s Naturaleaf business.

 

 Schedule of Segment Reporting Information, by Segment

              
   For the Years ended
   Dec 31, 2022  Dec 31, 2021
       
Revenues  $793,330   $1,006,148 
           

Cost of Goods Sold 

   979,437    553,336 
           
Gross Profit   (186,107)   452,812 
           
Expense          
Depreciation Expense   46,111    19,811 
Stock-based Compensation   —      —   
Selling and Marketing   44,758    66,205 
Payroll and Related expenses   256,255    222,496 
General and Admin Expenses   538,528    231,341 
Total Expense   885,652    539,853 
           
Net Loss from Operations  $(1,071,759)  $(87,041)
           

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of December 31, 2022, and 2021, the Company had cash balances in excess of FDIC-insured limits of $250,000.

 

 

 

Accounts Receivable, net

 

Accounts receivable are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods.

 

This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. At December 31, 2022, and 2021, the Company’s allowance for doubtful accounts was $4,071 and $82,540, respectively. The Company recorded bad debt expense during the years ended December 31, 2022, and 2021, of $5,438 and $54,435, respectively.

 

Deposits

 

Deposits are comprised of advance payments made to third parties, for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale.

 

Inventory

 

Inventory is comprised of products and equipment owned by the Company to be sold to end-customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in first-out and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of December 31, 2022 and 2021, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third party vendors for retail sales at dispensaries is determined using the first in first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production related depreciation and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At December 31, 2022, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary

 

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

 

 

 

Significant Clients and Customers

 

For the year ended December 31, 2022, eight customers accounted for 87.33% of the Company's total revenues from its consulting, soil, and products revenue lines for the period. At December 31, 2021, nine customers accounted for 50.1% of the Company’s total revenues from its consulting and soil and product revenue lines for the period.

 

At December 31, 2022, three customers accounted for 84.76% of accounts receivable, net, consisting of customers for our products, soil, and consulting services product streams. At December 31, 2021, two customers accounted for 77.3% of accounts receivable, net, consisting of customers of our consulting services and soil, and products revenue streams.

 

Property and Equipment, net

 

Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in-progress construction are capitalized as incurred, and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of December 31, 2022, and 2021.

 

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed. The Company accounts for goodwill under ASC Topic 350, Intangibles-Goodwill and Other. The Company tests goodwill for impairment annually or more frequently whenever events or circumstances indicate impairment may exist. Goodwill is stated at cost less accumulated impairment losses. The Company completes its goodwill impairment test annually in the fourth quarter. The Company evaluated its Naturaleaf Acquisition that closed on April 30, 2021, and recognized $1,332,113 in goodwill connected with the acquisition during the year ended December 31, 2022.

The Company does not have any other indefinite-lived intangible assets. 

In accordance with FASB ASC 350, “Intangibles – Goodwill and Other,” we perform goodwill impairment testing at least annually, unless indicators of impairment exist in interim periods. The impairment test for goodwill uses a two-step approach. Step one compares the estimated fair value of a reporting unit with goodwill to its carrying value. If the carrying value exceeds the estimated fair value, step two must be performed. Step two compares the carrying value of the reporting unit to the fair value of all of the assets and liabilities of the reporting unit (including any unrecognized intangibles) as if the reporting unit was acquired in a business combination. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of its goodwill, an impairment loss is recognized in an amount equal to the excess.

 

Intangible Assets, net

 

Definite life intangible assets at December 31, 2022, include licenses, trademarks, goodwill and brand names recognized as part of the Naturaleaf Acquisition. Intangible assets are recorded at cost. Licenses, trademarks and brand names represent the estimated fair value of these items at the date of acquisition, April 30, 2021. Intangible assets are amortized on a straight-line basis over their estimated useful life. Licenses are assigned a life of 15 years, and tradenames are assigned a life of 5 years. During the year ended December 31, 2022, the Company recognized an amortization expense of $186,000.

 

 

 

Accounting for the Impairment of Long-Lived Assets

 

The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, the recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values, or management's estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long-lived assets as of December 31, 2022, and 2021.

 

Fair Value Measurements

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.

 

Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.

 

Revenue Recognition

 

We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “Revenue from Contracts with Customers (Topic 606). Due to the nature of our contracts with customers, adopting the new accounting principles did not have a significant impact on our prior period results of operations, cash flows or financial position.

 

Our service and product revenues arise from contracts with customers. Service revenue includes Operations Divisions' consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, and (c) Cannabis sales division. The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.

 

We may also enter into contracts with customers that identify a single or few, distinct performance obligations but that also have non-distinct, underlying performance obligations. These contracts are typically fulfilled within one to six months. Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods and, accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.

 

We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues:

 

  (1) Identify the contract with the Customer. Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.

 

  (2) Identify the performance obligations in the contract. We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.

 

  (3) Determination of the transaction price. Prices are typically fixed, and no price protections or variables are offered.

 

  (4) Allocation of the transaction price to the performance obligations in the contract. Transaction prices are typically allocated to the performance obligations outlined in the contract.

 

  (5) Recognize Revenue when (or as) the entity satisfies a performance obligation. We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.

 

Advances from Clients deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from Clients deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.

 

Product and Equipment Sales

 

Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, title has transferred, and collectability is reasonably assured. Generally, our suppliers’ drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for the customer or us under FASB ASC Topic 606. During the years ended December 31, 2022 and 2021, sales returns were $0.

 

Consulting Services

 

We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services. For hourly based fixed fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, in order to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients” account, and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer-based significant financing that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.

 

Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the years ended December 31, 2022 and 2021, we incurred no losses from fixed fee engagements that terminate prior to completion. We believe if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.

 

We primarily enter into arrangements for which fixed and determinable revenues are contingent and agreed upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.

 

Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis and the value of the separate elements can be established by VSOE or an estimated selling price.

 

While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.

 

Reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.

  

Cannabis Sales

 

Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. Sales discounts were not material during the years ended December 31, 2022, and 2021.

 

Loyalty Reward Program

 

The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based upon the total amount of a purchase, at the time of purchase. Management has determined that as there is no separate performance obligation to the reward program, i.e., the accumulation and redemption of points, and as such the Company recognizes the revenue at the time of purchase.

 

Costs of Revenues

 

The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

 

Advertising and Promotion Costs

 

Advertising and Promotion costs are included as a component of selling and marketing expense and are expensed as incurred. During the years ended December 31, 2022, and 2021, these expenses were $266,578 and $116,122, respectively.

 

Shipping and Handling Costs

 

For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.

 

Stock-Based Compensation

 

Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of the grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. During the years ended December 31, 2022, and 2021, stock-based compensation expense for restricted shares for Company employees was $78,342 and $42,206 , respectively. Compensation expenses for warrants are based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model and are expensed over the expected term of the awards. During the year ended December 31, 2022, and 2021, no warrants were issued as stock compensation.

 

Research and Development

 

As a component of our equipment and supplies offerings, from time-to-time we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include, but are not limited to: The Satchel™, Cultivation Cube™, So-Hum Living Soils™ and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the years ended December 31, 2022 and 2021, our research and development costs were de minimis.

 

Income Taxes

 

The Company’s corporate status changed from an S Corporation, which it had been since inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2022, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of December 31, 2022 and 2021 we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.

 

Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.

 

Net Loss Per Common Share

 

The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities since that would have an anti-dilutive effect on earnings.

 

Related Party Transactions

 

The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

Impact of the COVID-19 Pandemic

 

On March 11, 2020, the World Health Organization declared the current coronavirus (“COVID-19”) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state, and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact on many sectors of the economy, including retail commerce.

 

In response to state and local measures and for the protection of both employees, the Company made required changes to operations, which did not have a material impact on operations or the financial condition of the Company.

 

While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-19 cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these consolidated financial statements.

 

Recent Accounting Pronouncements

 

Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.

 

In December 2019, the FASB issued ASU 2019-12, “Simplifying the Accounting for Income Taxes”. The pronouncement simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740, “Income Taxes”. The pronouncement also improves consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. The Company has adopted the standard and there was not an impact on its consolidated financial statements.

 

In January 2020, the FASB issued ASU No. 2020-01, "Investments — Equity Securities: Clarifying the Interactions between Topic 321, Topic 323, and Topic 815" ("ASU No. 2020-01"). ASU No. 2020-01 clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with ASC 321, "Investments — Equity Securities" immediately before applying or upon discontinuing the equity method of accounting in ASC 323, "Investments—Equity Method and Joint Ventures." The provisions of ASU No. 2020-01 are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years with early adoption permitted, including early adoption in an interim period for public business entities for periods for which financial statements have not yet been issued. The Company has adopted thee standard and there was not an impact on its consolidated financial statements.

  
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Naturaleaf Asset Acquisition
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Naturaleaf Asset Acquisition

Note 3. Naturaleaf Asset Acquisition

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” (collectively, "Naturaleaf") in the medicinal cannabis industry in Colorado.

 

Naturaleaf agreed to sell or assign to the Company the following assets:

 

  1. Three Medical Marijuana (MMC) Store Licenses;

 

  2. One Marijuana Infused Product Licenses (MIPS); and,

 

  3. One Option Premises Cultivation License (OPC); and,

 

  4. Related real property assets, goodwill, and related business assets.

 

The aggregate consideration paid for the Assets was $2,912,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000, and (iv) the assumption of of $22,000 in current payables.

 

On April 29, 2022, the Company and the previous owners of Naturaleaf agreed to an amendment of the note. The Company paid $550,000 of the principal, combined with accrued interest of $110,000 in exchange for a new note with a principal balance of $550,000, interest per annum of 12% and a maturity date of April 29, 2023.

 

The asset acquisition was accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations. As the acquirer for accounting purposes, the Company has estimated the fair value of Medihemp LLC and Medical Cannabis Caregivers, Inc.’s (hereafter “Naturaleaf’s”) assets acquired and conformed the accounting policies of Naturaleaf to its own accounting policies. The Company expensed certain legal, auditing and licensing costs with the acquisition of $83,095.

 

As part of the acquisition, the owners of Naturaleaf retained the outstanding cash balance on the date of the acquisition and had agreed to the payment of all outstanding accounts payables and related party advances.

 

Preliminary Valuation

 

The Company has performed a valuation analysis of the fair market value of Naturaleaf’s assets. The following table summarizes the allocation of the preliminary purchase price as of the acquisition date:

 Schedule of purchase price as of the acquisition

         
Cash   $ --  
Inventory     72,172  
Property, plant and equipment     26,715  
Long Term Deposits     6,000  
Identifiable intangible assets     800,000  
Goodwill     1,985,113  
Accounts payable     --  
Total consideration   $ 2,890,000  

 

Goodwill from the acquisition primarily relates to the future economic benefits arising from the assets acquired, the assembled workforce acquired and synergies between the cultivation and retail operations and is consistent with the Company's stated intentions and strategy. Other assets include inventory and fixed assets.

 

The fair value of Naturaleaf’s identifiable intangible assets was $800,000 at April 30, 2021, consisting of $500,000 in licenses and $300,000 in brand names. During the year ended December 31, 2021, the Company recognized an amortization expense of $62,223.

 

Final Valuation

 

The Company finalized the fair market value assessment of Naturaleaf's assets during the year ended December 31, 2022. The following table summarizes the final allocation of the purchase price as of the acquisition date:

 

 Business Combination

      
Current Assets  $15,000 
Inventory   72,172 
Property, Plant and Equipment   26,715 
Other Assets   6,000 
Total Tangible Assets   119,887 
      
Tradenames and Trademarks   660,000 
Licenses   810,000 
Total Intangible Assets   1,470,000 
      
Goodwill   1,332,113 
Total Consideration  $2,912,000 

 

 

 

 

The results of operations of Naturaleaf for the period from April 30, 2021 through December 31, 2022, are included in the Company's consolidated financial statements as of December 31, 2022.

 
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Receivable and Advance from Clients
 12 Months Ended
Dec. 31, 2022
Receivables [Abstract]  
Accounts Receivable and Advance from Clients

Note 4. Accounts Receivable and Advance from Clients

 

Accounts receivable was comprised of the following:

 Schedule of Accounts receivable and advance from clients

       
       
   December 31,
2022		  December 31, 2021
Accounts Receivable – Trade  $469,111   $93,856 
Less: Allowance for Doubtful Accounts   (4,071)   (82,540)
Accounts Receivable, net  $465,040   $11,316 

 

The Company had allowances for bad debt expense during the years ended December 31, 2022 and 2021 of $5,438 and $54,435, respectively.

 

 

 

 

Our Advances from Clients had the following activity for 2022 and 2021:

Deposit Liabilities, Type 

    
December 31, 2020  $88,843 
  Additional deposits received   404,143 
  Less: Deposits recognized as revenue   (381,094)
December 31, 2021  $111,892 

 

    
   Amount
December 31, 2021  $111,892 
  Additional deposits received   691,769 
  Less: Deposits recognized as revenue   (522,663)
December 31, 2022  $280,705 

 
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Inventory
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Inventory

Note 5. Inventory

 

Inventory consisted of the following:

 Schedule of inventory

       
  December 31, 2022  December 31, 2021
Raw Materials  $38,464   $60,900 
Work In Process   206,306    136,266 
Finished Goods – Soil   66,557    58,594 
Finished Goods – Cannabis Retail   41,644    22,848 
Total Inventory  $352,971   $278,608 

 
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment, net
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Property and Equipment, net

Note 6. Property and Equipment, net

 

Property and equipment, net, was comprised of the following:

 Schedule of property and equipment

  December 31, 2022  December 31, 2021
Office equipment  $47,380   $39,574 
Software   13,204    13,204 
Furniture and Fixtures   2,328    2,328 
Machinery and Equipment   364,520    376,745 
Leasehold Improvements   ----    —   
Property and equipment, gross  $427,432   $431,851 
Less: Accumulated Depreciation   (113,650)   (56,019)
Property and equipment, net  $313,782   $375,832 

 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible Assets
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets

Note 7. Intangible Assets

 

A significant amount of the Company’s current identified intangible assets were assumed upon consummation of the Naturaleaf acquisition on April 30, 2021. The Company has incurred capitalizable costs in connection with patent applications that it started work on. Identified intangible assets consisted of the following at the dates indicated below:

 Schedule of intangible assets

                                 
    December 31, 2022
    Gross carrying amount   Accumulated amortization   Carrying value   Estimated useful life
Licenses   $ 818,464     ($ 134,552 )   $ 683,912       15 years  
Brand   $ 660,000     ($ 120,670 )   $ 539,330       5 years  
Total intangible assets, net   $ 1,488,464     ($ 255,222 )   $ 1,223,242          

 

The weighted-average amortization period for intangible assets we acquired during the year ended December 31, 2022, was approximately 11.47 years.

 

Amortization expense for intangible assets was $186,000 and $62,223 for the years ended December 31, 2022 and 2021, respectively. Total estimated amortization expense for our intangible assets for the years 2023 through 2027 is as follows:

 Schedule of estimated amortization expense

             

   Year Ended
December 31, 2022
  2023     $ 186,000  
  2024     $ 186,000  
  2025     $ 186,000  
  2026     $ 145,997  
  2027     $ 54,000  
      $ 463,781  

 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Accrued and Other Current Liabilities
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Accrued and Other Current Liabilities

Note 8. Accrued and Other Current Liabilities

 

Accrued and other current liabilities consisted of the following:

 Schedule of accrued and other current liabilities

       
  December 31, 2022  December 31, 2021
Accrued Interest  $39,130   $74,137 
Accrued Payroll   22,029    18,428 
Sales Tax Payable   3,931    592 
Other Accrued Expenses & Payables   168,258    68,559 
Accrued and other current liabilities  $233,348   $161,716 

 
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Payable
 12 Months Ended
Dec. 31, 2022
Stock Payable  
Stock Payable

Note 9. Stock Payable

 

The following summarizes the changes in common stock payable:

 Schedule of stock payable

    
   Amount
December 31, 2021  $—   
  Payments received on shares not issued   74,342 
December 31, 2022  $74,342 

 

 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Operating Lease Right-of-Use Asset/Operating Lease Liability
 12 Months Ended
Dec. 31, 2022
Operating Lease Right-of-use Assetoperating Lease Liability  
Operating Lease Right-of-Use Asset/Operating Lease Liability

Note 10. Operating Lease Right-of-Use Asset/Operating Lease Liability

 

Our headquarters are located at 200 Union Street, Ste. 200, Lakewood, CO 80228. Our offices are not leased but granted pursuant to an accommodation that creates no tenancy, leasehold, or other real property interest. Our accommodation expires on August 31, 2023. Our monthly payment in exchange for the accommodation is $3,250.

 

The Company leases property under various operating leases. Property leases include retail and cultivation space with fixed rent payments and lease terms ranging from one to two years. The Company is obligated to pay the lessor for maintenance, real estate taxes, insurance and other operating expenses on certain property leases. These expenses are variable and are not included in the measurement of the lease asset or lease liability. These expenses are recognized as variable rent expense when incurred.

 

The Company’s lease portfolio consists of the following.

 Schedule of Other Operating Cost and Expense

  o 1004 S. Tejon Street, Colorado Springs, CO 80903; The Company assumed a lease originally entered into on February 12, 2016, which was the subject of a extension agreement dated April 5, 2022. The term of the lease was extended from May 1, 2022 until April 30, 2027. The Company's monthly rental payments from January 1, 2022 to May 1, 2022 was $3,700. From May 1, 2022 through the year ended December 31, 2022, monthly rent was $3,875. Remaining rental payments due for the extended period are:   May 1, 2022 to April 30, 2023 $3,875 May 1, 2023 to April 30, 2024 $4,050 May 1, 2024 to April 30, 2025 $4,225 May 1, 2025 to April 30, 2026 $4,400 May 1, 2026 to April 30, 2027 $4,575

 

May 1, 2022 to April 30, 2023 $3,875
May 1, 2023 to April 30, 2024 $4,050
May 1, 2024 to April 30, 2025 $4,225
May 1, 2025 to April 30, 2026 $4,400
May 1, 2026 to April 30, 2027 $4,575

 

  o 2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909 subject to a one-year term expiring June 30, 2023 with a monthly rent of $5,000.

  

  o 5870 Lehman Drive Suite 200, Colorado Springs, CO 80918 The Company and landlord  previously entered into a lease in 2017 which expired December 31, 2022. At December 31, 2022, the Company's monthly rent was $2,732. On April 26, 2022, the Company and landlord entered into an extension agreement which extended the tenancy from January 1, 2023 through January 1, 2027. Rental payments due for the extended period are:   January 1, 2023 $2,898 January 1, 2024 $2,985 January 1, 2025 $3,075 January 1, 2026 $3,167 January 1, 2027 $3,262

 

January 1, 2023 $2,898
January 1, 2024 $2,985
January 1, 2025 $3,075
January 1, 2026 $3,167
January 1, 2027 $3,262

  o 2611 Durango Drive, CO Springs, CO. The Company and landlord entered into a lease on March 10, 2021, which terminated on May 31, 2022. On June 23, 2021, the Company and landlord entered into an extension of the lease for a term of thirty-six months, beginning June 1, 2022 and terminating June 1, 2024. At December 31, 2022, monthly rent was $11,000. Rental payments due for the extended period are:       June 1, 2022 to June 1, 2023 $11,000 June 1, 2023 to June 1, 2024 $11,880 June 1, 2025 to June 1, 2025 $12,830  

 

 

June 1, 2022 to June 1, 2023 $11,000
June 1, 2023 to June 1, 2024 $11,880
June 1, 2025 to June 1, 2025 $12,830

 

 

On July 12, 2022, the Company entered into an accommodation for office space, effective September 1, 2022, located at 200 Union St., Suite 200, Lakewood, CO 80228. The accommodation creates no tenancy, leasehold or other real property interest concerning the Registrant. The Registrant's telephone number is unchanged. We determined under ASC 842, due to the nature of the accommodation that the membership agreement met the criteria of ASC 842-20-25-2, and as such, it was not necessary to capitalize the accomodation, and the membership fee will be recognized on a monthly straight-line basis.

 

On May 1, 2020, as part of the Naturaleaf Acquisition, the Company entered into leases for grow facilities and dispensaries. These leases were determined to be operating leases under ASC 842, and such leases were capitalized. It was determined that the Tejon lease, due to the short-term nature of the lease, met the criteria of ASC 842-20-25-2, and as such, it was not necessary to capitalize the lease, and rent would be recognized on a straight-line basis.

 

The Company records the lease asset and lease liability at the present value of lease payments over the lease term. The leases typically do not provide an implicit rate; therefore, the Company uses its estimated incremental borrowing rate at the time of lease commencement to discount the present value of lease payments. The Company’s discount rate for operating leases at December 31, 2022 was 12.5%. Leases often include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. Lease expense is recognized on a straight-line basis over the lease term to the extent that collection is considered probable. As a result, the Company has been recognizing rents as they become payable.

 

As of December 31, 2022, the aggregate remaining annual lease payments of operating leases liabilities are as follows:

 Schedule of operating leases liabilities

     
    Operating
Leases
2023   $ 604,020  
Total     604,020  
Less: amount representing interest       -
Present value of future minimum lease payments     604,020  
Less: current obligations under leases     181,661  
Long-term lease obligations   $ 422,359  

 

As of December 31, 2022, the aggregate remaining minimal annual lease payments under these operating leases were as follows: 

 Schedule of remaining minimal annual lease payments

             
  2023     $ 604,020  
  Total     $ 604,020  

 
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Loans Payable
 12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Loans Payable

Note 11. Loans Payable

 

PPP Loans

 

On March 27, 2020, the CARES Act was enacted to provide financial aid to family and businesses impacted by the COVID-19 pandemic. The Company participated in the CARES Act, and on August 6, 2020, the Company entered into a note payable with a bank under the Small Business Administration (“SBA”) Paycheck Protection Program (“PPP loan”) in the amount of $109,914. This loan payable matured on August 6, 2022, with a fixed interest rate of 1% per annum with interest deferred for six months. The PPP loan has an initial term of two years and is unsecured and guaranteed by the SBA. On March 1, 2021, the Company applied for and received forgiveness of the principal of $109,914 and interest of $632.01 on the PPP loan.

 

On April 23, 2021, the Company entered into a second note payable with a bank under the SBA PPP Loan in the amount of $130,186. The PPP Loan is subject to the same terms of forgiveness as above. On September 27, 2021, the SBA forgave the principal of $130,186 and any accrued interest.

 

Amendment to Naturaleaf Seller Note

 

On April 29, 2022, the Company and Medihemp, LLC, and its wholly owned subsidiary, SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., all collectively doing business as "Naturaleaf," (hereafter, "Naturaleaf") entered into an amendment to the previously disclosed material definitive agreement dated March 11, 2021.

 

The original material definitive agreement disclosed the Company's acquisition of assets from Naturaleaf, including, but not limited to: Naturaleaf's fixed assets, Medical Marijuana Center licenses, a Medical Cannabis’ Medical Marijuana Infused Product Manufacturer license, a Medical Marijuana Optional Premises Cultivation license, customer accounts, intellectual property, goodwill, and leases. As consideration for the purchase, the Company agreed to pay an aggregate purchase price of $2,200,000 in cash and 3,000,000 shares of Registrant's common stock.

 

The parties agreed to a payment schedule, requiring the Company to first pay an initial non-refundable payment of $20,000, credited against the purchase price. Thereafter, upon the party's completion of due diligence, and their receipt of contingent approval letters for the transfer of the Cannabis Licenses from the Colorado Marijuana Enforcement Division and the City of Colorado Springs (the "Closing"), the Company agreed to pay Naturaleaf $1,080,000 and issue Naturaleaf, or its designees, 3,000,000 shares of the Company's restricted common stock. The balance of the purchase price of $1,100,000 was payable based upon a promissory note issued by the Company, which included 10% interest. The note was due one year after Closing. On April 30, 2021, the Closing occurred, and the Company paid Naturaleaf $1,080,000 and issued 3,000,000 shares of restricted stock.

 

On April 29, 2022, the Company and the previous owners of Naturaleaf agreed to an amendment of the note. The Company paid $550,000 of the principal, combined with accrued interest of $110,000 in exhchange for a new note with a principal balance of $550,000, interest per annum of 12% and a maturity date of April 29, 2023.

 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions
 12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
Related Party Transactions

Note 12. Related Party Transactions

 

On November 22, 2022, the Company issued a promissory note to Ellis Smith in exchange for $150,000. Interest on the note is 15% per annum. The note has a maturity date of May 21, 2023. If not paid within ten days of maturity, the note contains default interest of 18% per annum and a late charge penalty of 5% of the principal amount due.

 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Based Compensation
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Stock Based Compensation

Note 13. Stock Based Compensation

 

During the year ended December 31, 2022, the Company issued stock-based compensation for employees and service providers pursuant to its 2015 Equity Incentive Plan.

 

Restricted Shares

 

From time to time, the Company grants certain employees restricted shares of its common stock to provide further compensation in-lieu of wages and to align the employee’s interests with the interests of its stockholders. Because vesting is based on continued employment, these equity-based incentives are also intended to attract, retain and motivate personnel upon whose judgment, initiative and effort the Company’s success is largely dependent.

 

During the year ended December 31, 2022, the Company granted 2,000,000 restricted shares and recognized $78,342 in associated employee stock-based compensation expenses. The fair value of restricted stock unit is determined based on the quoted closing price of the Company’s common stock on the date granted. As of December 31, 2022, none of the shares were issued, and the entire amount is recorded as stock payable.

 

During the year ended December 31, 2022, the Company issued a total of 5,750,000 restricted shares to service providers and consultants for services rendered and recognized expenses of $219,940. The fair value of restricted stock is determined based on the quoted closing price of the Company’s common stock on the date granted.

 

 

Net Loss Per Share

 

Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the reporting period. Diluted net loss per share is computed similarly to basic loss per share, except that it includes the potential dilution that could occur if dilutive securities are exercised.

 

Outstanding stock options and common stock warrants are considered anti-dilutive because we are in a net loss position. Accordingly, the number of weighted average shares outstanding for basic and fully diluted net loss per share are the same.

 

The following summarizes equity instruments that may, in the future, have a dilutive effect on earnings per share:

 Schedule of stock based compensation

         
    December 31,
2022		   December 31, 2021
Warrants     —        —  
Stock Payable                     —       275,000  
Total      —        275,000  

 

Warrants

 

During the year ended December 31, 2022, the Company did not issue or approve any warrants.

 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Shareholders’ Equity
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Shareholders’ Equity

Note 14. Shareholders’ Equity

 

Preferred Stock

 

American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $0.01 par value. No shares of preferred stock were issued and outstanding at December 31, 2022, and 2021, respectively.

 

Common Stock

 

During the year ended December 31, 2022, the Company issued 2,500,000 registered shares of common stock in exchange for net proceeds of $117,628.50 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019, with White Lion Capital LLC. 

 

During the year ended December 31, 2022, the Company issued 1,000,000 restricted shares of common stock for consulting services. The Company recognized stock compensation of $50,000 related to the issuance based on the fair market value on the date of grant.

 

During the year ended December 31, 2022, the Company issued 4,750,000 restricted shares of common stock in exchange for marketing and investor relations services. The Company recognized stock compensation of $169,979 related to the issuance based on the fair market value on the date of grant.

 

During the year ended December 31, 2022, the Company issued 2,000,000 shares to employees for services rendered under contract. The Company recognized stock compensation of $46,226 related to the issuance based on the fair market value on the date of grant.

 

During the year ended December 31, 2021, the Company issued 8,050,000 registered shares of common stock in exchange for net proceeds of $1,241,043 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019 with White Lion Capital LLC.

 

During the year ended December 31, 2021, the Company issued 3,000,000 shares of its restricted common stock to the sellers of Naturaleaf, as part of the acquisition of assets of Naturaleaf. The shares had a value of $690,000 based on a closing market price on April 30, 2021 of $0.23 per share.

 

During the year ended December 31, 2021, warrants with a cashless exercise provision were exercised for 125,000 restricted shares, of which, a warrant for 100,000 shares was exercised by an officer/director of the Company.

 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Income Taxes

Note 15. Commitments and Contingencies

 

Legal

 

In the ordinary course of its business, the Company becomes involved in various legal proceedings involving various matters. As of December 31, 2022, there are no pending legal proceedings involving the Company. The Company's expenses legal fees in the period they are incurred.

 

Employment Litigation

 

On November 15, 2019, a civil action was filed against the Company and Mr. Terry Buffalo, our former chief executive officer and director, and Mr. Ellis Smith, our current chief executive and financial officer and director, in Denver County District Court, Case Number 2019CV034380. The complaint sought a declaratory judgment and damages related to Plaintiff’s allegation that she was misclassified as an independent contractor while working for the Company. Plaintiff alleged she was owed unpaid overtime, liquidated damages, wages, statutory penalties, and other compensatory damages for her misclassification and alleged wrongful termination. Plaintiff’s suit against Mr. Buffalo and Mr. Smith alleged that each was the alter ego of the Company and is, therefore, jointly and severally liable. The Company filed a counterclaim against Plaintiff alleging misappropriation of trade secrets, breach of contract, and other claims relating to her theft of confidential and proprietary information. On January 24, 2022, a settlement agreement was entered into by all parties, and the action was dismissed.

 

The Settlement Agreement provides for a cash settlement of $350,000 to be paid over a 2-year period, and as a result, at December 31, 2022, the Company has recognized a total of liability of $350,000, of which $125,000 is classified as current.

 

 

 Note 16. Income Taxes

The following table displays a reconciliation from the U.S. statutory rate to the effective tax rate and the provision for (benefit from) income taxes for the years ended December 31, 2022, and 2021, respectively:

Schedule of income tax rate 

Schedule of income tax rate      
   For the Years Ended
   December 31,  December 31,
   2022  2021
       
Income Tax Provision (Benefit)  $428,083   $(623,358)
Non-deductible expenses including non-deductible pre-merger losses   187,711    163,495 
Change in valuation allowance   (615,794)   459,863 
Total Income Tax Benefit  $—     $—   

 

Deferred tax assets (liabilities) consisted of the following:

 Schedule of deferred tax assets

       
   December 31,  December 31,
   2022  2021
       
Total Deferred Tax Liabilities          
Lease Liability Expense  $—     $(24,457)
Total Deferred Tax Assets          
Net operating loss carryforwards   1,152,244    1,230,904 
           
Right of Use Asset   —      24,457 
Allowance for Doubtful Accounts   1,040    17,735 
Net Deferred Tax Assets   1,153,284    1,248,639 
Valuation Allowance   (1,153,284)   (1,248,639)
Total Deferred Tax Assets  $—     $—   

 

The Company determined that it is not more likely than not that its deferred tax asset would be realizable, accordingly, the Company recorded a valuation allowance for the full amount of its deferred tax asset, resulting in a zero carrying value of the Company’s deferred tax asset and no benefit from or provision for income taxes for the years ended December 31, 2022 and 2021. Federal and state operating loss carry forwards are $4,368,664 and $4,812,598 as of December 31, 2022 and 2021, respectively and begin to expire in 2035. The years 2019, 2020, 2021 remain subject to examination by the Company’s major tax jurisdictions. Utilization of the net operating loss carry forwards and credits may be subject to a substantial annual limitation due to ownership change limitations provided by Section 382 of the Internal Revenue Code of 1986, as amended, and similar state provisions. The Company is subject to Section 280(e ) since it sells cannabis with THC.

 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
 12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events

Note 17. Subsequent Events

 

In accordance with ASC 855-10, the Company has analyzed its operations after consolidated financial statements were available to be issued and determined that there were no other significant subsequent events or transactions that would require recognition or disclosure in the consolidated financial statements for the year ended December 31, 2022, other than as follows.

  

During the three months ended March 31, 2023, the Company issued to its officers and directors 2,175,000 restricted shares.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of Accounting

Basis of Accounting

 

The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.

 
Principal of Consolidation

Principal of Consolidation

 

The consolidated financial statements for the years ended December 31, 2022 and 2021, include the accounts of American Cannabis Company, Inc. and its wholly owned subsidiary, Hollister & Blacksmith, Inc., doing business as American Cannabis Company, Inc. Intercompany accounts and transactions have been eliminated.

 

 

 
Going Concern

Going Concern

 

Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements - Going Concern ("ASC 205-40") requires management to assess the Company’s ability to continue as a going concern for one year after the date the financial statements are issued. Under ASC 205-40, management has the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet future financial obligations as they become due within one year after the date that the financial statements are issued. As required by this standard, management’s evaluation shall initially not take into consideration the potential mitigating effects of management’s plans that have not been fully implemented as of the date the financial statements are issued.

 

Our assessment included the preparation of a detailed cash forecast that included all projected cash inflows and outflows. During 2022, we secured additional cash financings through the sales and issuances of our common stock through. However, we continue to focus on growing our revenues. Accordingly, operating expenditures may exceed the revenue we expect to receive for the foreseeable future. We also have a history of operating losses, negative operating cash flows, and negative working capital, and expect these trends to continue into the foreseeable future.

 

As of the date of this Annual Report on Form 10-K, while we believe we have adequate capital resources to complete our near-term operations, there is no guarantee that such capital resources will be sufficient until such time we reach profitability. We may access capital markets to fund strategic acquisitions or ongoing operations on terms we believe are favorable. The timing and amount of capital that may be raised are dependent on market conditions and the terms and conditions upon which investors would require to provide such capital. We may utilize debt or sell newly issued equity securities through public or private transactions.

  

There can be no assurance that we can obtain additional funding on satisfactory terms or at all. In addition, no assurance can be given that any such financing, if obtained, will be adequate to meet our capital needs and support our growth. If additional funding cannot be obtained on a timely basis and on satisfactory terms, our operations would be materially negatively impacted; however, we have successfully accessed capital markets in the past, and we are confident in our ability to access capital markets again if needed.

 

The Company has an accumulated deficit of $10,080,709 and recurring losses and expects continuing future losses. In addition, the Company has a working capital deficit of $1,076,063. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s primary source of operating funds in 2022 and 2021 has been funds generated from proceeds from the sale of common stock and operations. The Company has experienced net losses from operations since its inception. The Company has an accumulated deficit at December 31, 2022, and requires additional financing to fund future operations.

 

The Company’s existence is dependent upon management’s ability to develop profitable operations and to obtain additional funding sources. There can be no assurance that the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

 

The accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. 

 

 
Use of Estimates in Financial Reporting

Use of Estimates in Financial Reporting

 

The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in preparing the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.

 
Segment Information

Segment Information

 

Accounting Standards Codification subtopic Segment Reporting 280-10 ("ASC 280-10") establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information for those segments to be presented in interim financial reports issued to stockholders. ASC 280-10 also establishes standards for related disclosures about products and services and geographic areas. Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions on how to allocate resources and assess performance. The following table represents the Company’s Naturaleaf business.

 

 Schedule of Segment Reporting Information, by Segment

              
   For the Years ended
   Dec 31, 2022  Dec 31, 2021
       
Revenues  $793,330   $1,006,148 
           

Cost of Goods Sold 

   979,437    553,336 
           
Gross Profit   (186,107)   452,812 
           
Expense          
Depreciation Expense   46,111    19,811 
Stock-based Compensation   —      —   
Selling and Marketing   44,758    66,205 
Payroll and Related expenses   256,255    222,496 
General and Admin Expenses   538,528    231,341 
Total Expense   885,652    539,853 
           
Net Loss from Operations  $(1,071,759)  $(87,041)
           

 
Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of December 31, 2022, and 2021, the Company had cash balances in excess of FDIC-insured limits of $250,000.

 

 

 
Accounts Receivable, net

Accounts Receivable, net

 

Accounts receivable are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods.

 

This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. At December 31, 2022, and 2021, the Company’s allowance for doubtful accounts was $4,071 and $82,540, respectively. The Company recorded bad debt expense during the years ended December 31, 2022, and 2021, of $5,438 and $54,435, respectively.

 
Deposits

Deposits

 

Deposits are comprised of advance payments made to third parties, for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale.

 
Inventory

Inventory

 

Inventory is comprised of products and equipment owned by the Company to be sold to end-customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in first-out and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of December 31, 2022 and 2021, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third party vendors for retail sales at dispensaries is determined using the first in first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production related depreciation and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At December 31, 2022, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary

 
Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

 

 

 
Significant Clients and Customers

Significant Clients and Customers

 

For the year ended December 31, 2022, eight customers accounted for 87.33% of the Company's total revenues from its consulting, soil, and products revenue lines for the period. At December 31, 2021, nine customers accounted for 50.1% of the Company’s total revenues from its consulting and soil and product revenue lines for the period.

 

At December 31, 2022, three customers accounted for 84.76% of accounts receivable, net, consisting of customers for our products, soil, and consulting services product streams. At December 31, 2021, two customers accounted for 77.3% of accounts receivable, net, consisting of customers of our consulting services and soil, and products revenue streams.

 
Property and Equipment, ne

Property and Equipment, net

 

Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in-progress construction are capitalized as incurred, and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of December 31, 2022, and 2021.

 
Goodwill

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed. The Company accounts for goodwill under ASC Topic 350, Intangibles-Goodwill and Other. The Company tests goodwill for impairment annually or more frequently whenever events or circumstances indicate impairment may exist. Goodwill is stated at cost less accumulated impairment losses. The Company completes its goodwill impairment test annually in the fourth quarter. The Company evaluated its Naturaleaf Acquisition that closed on April 30, 2021, and recognized $1,332,113 in goodwill connected with the acquisition during the year ended December 31, 2022.

The Company does not have any other indefinite-lived intangible assets. 

In accordance with FASB ASC 350, “Intangibles – Goodwill and Other,” we perform goodwill impairment testing at least annually, unless indicators of impairment exist in interim periods. The impairment test for goodwill uses a two-step approach. Step one compares the estimated fair value of a reporting unit with goodwill to its carrying value. If the carrying value exceeds the estimated fair value, step two must be performed. Step two compares the carrying value of the reporting unit to the fair value of all of the assets and liabilities of the reporting unit (including any unrecognized intangibles) as if the reporting unit was acquired in a business combination. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of its goodwill, an impairment loss is recognized in an amount equal to the excess.

 
Intangible Assets, net

Intangible Assets, net

 

Definite life intangible assets at December 31, 2022, include licenses, trademarks, goodwill and brand names recognized as part of the Naturaleaf Acquisition. Intangible assets are recorded at cost. Licenses, trademarks and brand names represent the estimated fair value of these items at the date of acquisition, April 30, 2021. Intangible assets are amortized on a straight-line basis over their estimated useful life. Licenses are assigned a life of 15 years, and tradenames are assigned a life of 5 years. During the year ended December 31, 2022, the Company recognized an amortization expense of $186,000.

 

 

 
Accounting for the Impairment of Long-Lived Assets

Accounting for the Impairment of Long-Lived Assets

 

The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, the recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values, or management's estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long-lived assets as of December 31, 2022, and 2021.

 
Fair Value Measurements

Fair Value Measurements

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.

 

Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.

 
Revenue Recognition

Revenue Recognition

 

We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “Revenue from Contracts with Customers (Topic 606). Due to the nature of our contracts with customers, adopting the new accounting principles did not have a significant impact on our prior period results of operations, cash flows or financial position.

 

Our service and product revenues arise from contracts with customers. Service revenue includes Operations Divisions' consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, and (c) Cannabis sales division. The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.

 

We may also enter into contracts with customers that identify a single or few, distinct performance obligations but that also have non-distinct, underlying performance obligations. These contracts are typically fulfilled within one to six months. Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods and, accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.

 

We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues:

 

  (1) Identify the contract with the Customer. Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.

 

  (2) Identify the performance obligations in the contract. We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.

 

  (3) Determination of the transaction price. Prices are typically fixed, and no price protections or variables are offered.

 

  (4) Allocation of the transaction price to the performance obligations in the contract. Transaction prices are typically allocated to the performance obligations outlined in the contract.

 

  (5) Recognize Revenue when (or as) the entity satisfies a performance obligation. We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.

 

Advances from Clients deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from Clients deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.

 
Product and Equipment Sales

Product and Equipment Sales

 

Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, title has transferred, and collectability is reasonably assured. Generally, our suppliers’ drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for the customer or us under FASB ASC Topic 606. During the years ended December 31, 2022 and 2021, sales returns were $0.

 
Consulting Services

Consulting Services

 

We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services. For hourly based fixed fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, in order to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients” account, and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer-based significant financing that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.

 

Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the years ended December 31, 2022 and 2021, we incurred no losses from fixed fee engagements that terminate prior to completion. We believe if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.

 

We primarily enter into arrangements for which fixed and determinable revenues are contingent and agreed upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.

 

Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis and the value of the separate elements can be established by VSOE or an estimated selling price.

 

While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.

 

Reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.

  
Cannabis Sales

Cannabis Sales

 

Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. Sales discounts were not material during the years ended December 31, 2022, and 2021.

 
Loyalty Reward Program

Loyalty Reward Program

 

The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based upon the total amount of a purchase, at the time of purchase. Management has determined that as there is no separate performance obligation to the reward program, i.e., the accumulation and redemption of points, and as such the Company recognizes the revenue at the time of purchase.

 
Costs of Revenues

Costs of Revenues

 

The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

 
Advertising and Promotion Costs

Advertising and Promotion Costs

 

Advertising and Promotion costs are included as a component of selling and marketing expense and are expensed as incurred. During the years ended December 31, 2022, and 2021, these expenses were $266,578 and $116,122, respectively.

 
Shipping and Handling Costs

Shipping and Handling Costs

 

For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.

 
Stock-Based Compensation

Stock-Based Compensation

 

Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of the grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. During the years ended December 31, 2022, and 2021, stock-based compensation expense for restricted shares for Company employees was $78,342 and $42,206 , respectively. Compensation expenses for warrants are based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model and are expensed over the expected term of the awards. During the year ended December 31, 2022, and 2021, no warrants were issued as stock compensation.

 
Research and Development

Research and Development

 

As a component of our equipment and supplies offerings, from time-to-time we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include, but are not limited to: The Satchel™, Cultivation Cube™, So-Hum Living Soils™ and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the years ended December 31, 2022 and 2021, our research and development costs were de minimis.

 
Income Taxes

Income Taxes

 

The Company’s corporate status changed from an S Corporation, which it had been since inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2022, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of December 31, 2022 and 2021 we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.

 

Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“IRC”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.

 
Net Loss Per Common Share

Net Loss Per Common Share

 

The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities since that would have an anti-dilutive effect on earnings.

 
Related Party Transactions

Related Party Transactions

 

The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 
Impact of the COVID-19 Pandemic

Impact of the COVID-19 Pandemic

 

On March 11, 2020, the World Health Organization declared the current coronavirus (“COVID-19”) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state, and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact on many sectors of the economy, including retail commerce.

 

In response to state and local measures and for the protection of both employees, the Company made required changes to operations, which did not have a material impact on operations or the financial condition of the Company.

 

While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-19 cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these consolidated financial statements.

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.

 

In December 2019, the FASB issued ASU 2019-12, “Simplifying the Accounting for Income Taxes”. The pronouncement simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740, “Income Taxes”. The pronouncement also improves consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. The Company has adopted the standard and there was not an impact on its consolidated financial statements.

 

In January 2020, the FASB issued ASU No. 2020-01, "Investments — Equity Securities: Clarifying the Interactions between Topic 321, Topic 323, and Topic 815" ("ASU No. 2020-01"). ASU No. 2020-01 clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with ASC 321, "Investments — Equity Securities" immediately before applying or upon discontinuing the equity method of accounting in ASC 323, "Investments—Equity Method and Joint Ventures." The provisions of ASU No. 2020-01 are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years with early adoption permitted, including early adoption in an interim period for public business entities for periods for which financial statements have not yet been issued. The Company has adopted thee standard and there was not an impact on its consolidated financial statements.

  
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of Segment Reporting Information, by Segment

 Schedule of Segment Reporting Information, by Segment

              
   For the Years ended
   Dec 31, 2022  Dec 31, 2021
       
Revenues  $793,330   $1,006,148 
           

Cost of Goods Sold 

   979,437    553,336 
           
Gross Profit   (186,107)   452,812 
           
Expense          
Depreciation Expense   46,111    19,811 
Stock-based Compensation   —      —   
Selling and Marketing   44,758    66,205 
Payroll and Related expenses   256,255    222,496 
General and Admin Expenses   538,528    231,341 
Total Expense   885,652    539,853 
           
Net Loss from Operations  $(1,071,759)  $(87,041)
           
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Naturaleaf Asset Acquisition (Tables)
 12 Months Ended
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of purchase price as of the acquisition

 Schedule of purchase price as of the acquisition

         
Cash   $ --  
Inventory     72,172  
Property, plant and equipment     26,715  
Long Term Deposits     6,000  
Identifiable intangible assets     800,000  
Goodwill     1,985,113  
Accounts payable     --  
Total consideration   $ 2,890,000  
Business Combination

 Business Combination

      
Current Assets  $15,000 
Inventory   72,172 
Property, Plant and Equipment   26,715 
Other Assets   6,000 
Total Tangible Assets   119,887 
      
Tradenames and Trademarks   660,000 
Licenses   810,000 
Total Intangible Assets   1,470,000 
      
Goodwill   1,332,113 
Total Consideration  $2,912,000 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Receivable and Advance from Clients (Tables)
 12 Months Ended
Dec. 31, 2022
Receivables [Abstract]  
Deposit Liabilities, Type

 Schedule of Accounts receivable and advance from clients

       
       
   December 31,
2022		  December 31, 2021
Accounts Receivable – Trade  $469,111   $93,856 
Less: Allowance for Doubtful Accounts   (4,071)   (82,540)
Accounts Receivable, net  $465,040   $11,316 

 

The Company had allowances for bad debt expense during the years ended December 31, 2022 and 2021 of $5,438 and $54,435, respectively.

 

 

 

 

Our Advances from Clients had the following activity for 2022 and 2021:

Deposit Liabilities, Type 

    
December 31, 2020  $88,843 
  Additional deposits received   404,143 
  Less: Deposits recognized as revenue   (381,094)
December 31, 2021  $111,892 

 

    
   Amount
December 31, 2021  $111,892 
  Additional deposits received   691,769 
  Less: Deposits recognized as revenue   (522,663)
December 31, 2022  $280,705 
Deposit Liabilities, Type

Deposit Liabilities, Type 

    
December 31, 2020  $88,843 
  Additional deposits received   404,143 
  Less: Deposits recognized as revenue   (381,094)
December 31, 2021  $111,892 

 

    
   Amount
December 31, 2021  $111,892 
  Additional deposits received   691,769 
  Less: Deposits recognized as revenue   (522,663)
December 31, 2022  $280,705 
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Inventory (Tables)
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Schedule of inventory

 Schedule of inventory

       
  December 31, 2022  December 31, 2021
Raw Materials  $38,464   $60,900 
Work In Process   206,306    136,266 
Finished Goods – Soil   66,557    58,594 
Finished Goods – Cannabis Retail   41,644    22,848 
Total Inventory  $352,971   $278,608 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment, net (Tables)
 12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment

 Schedule of property and equipment

  December 31, 2022  December 31, 2021
Office equipment  $47,380   $39,574 
Software   13,204    13,204 
Furniture and Fixtures   2,328    2,328 
Machinery and Equipment   364,520    376,745 
Leasehold Improvements   ----    —   
Property and equipment, gross  $427,432   $431,851 
Less: Accumulated Depreciation   (113,650)   (56,019)
Property and equipment, net  $313,782   $375,832 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of intangible assets

 Schedule of intangible assets

                                 
    December 31, 2022
    Gross carrying amount   Accumulated amortization   Carrying value   Estimated useful life
Licenses   $ 818,464     ($ 134,552 )   $ 683,912       15 years  
Brand   $ 660,000     ($ 120,670 )   $ 539,330       5 years  
Total intangible assets, net   $ 1,488,464     ($ 255,222 )   $ 1,223,242          
Schedule of estimated amortization expense

 Schedule of estimated amortization expense

             

   Year Ended
December 31, 2022
  2023     $ 186,000  
  2024     $ 186,000  
  2025     $ 186,000  
  2026     $ 145,997  
  2027     $ 54,000  
      $ 463,781  
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Accrued and Other Current Liabilities (Tables)
 12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Schedule of accrued and other current liabilities

 Schedule of accrued and other current liabilities

       
  December 31, 2022  December 31, 2021
Accrued Interest  $39,130   $74,137 
Accrued Payroll   22,029    18,428 
Sales Tax Payable   3,931    592 
Other Accrued Expenses & Payables   168,258    68,559 
Accrued and other current liabilities  $233,348   $161,716 
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Payable (Tables)
 12 Months Ended
Dec. 31, 2022
Stock Payable  
Schedule of stock payable

 Schedule of stock payable

    
   Amount
December 31, 2021  $—   
  Payments received on shares not issued   74,342 
December 31, 2022  $74,342 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables)
 12 Months Ended
Dec. 31, 2022
Operating Lease Right-of-use Assetoperating Lease Liability  
Schedule of Other Operating Cost and Expense

 Schedule of Other Operating Cost and Expense

  o 1004 S. Tejon Street, Colorado Springs, CO 80903; The Company assumed a lease originally entered into on February 12, 2016, which was the subject of a extension agreement dated April 5, 2022. The term of the lease was extended from May 1, 2022 until April 30, 2027. The Company's monthly rental payments from January 1, 2022 to May 1, 2022 was $3,700. From May 1, 2022 through the year ended December 31, 2022, monthly rent was $3,875. Remaining rental payments due for the extended period are:   May 1, 2022 to April 30, 2023 $3,875 May 1, 2023 to April 30, 2024 $4,050 May 1, 2024 to April 30, 2025 $4,225 May 1, 2025 to April 30, 2026 $4,400 May 1, 2026 to April 30, 2027 $4,575

 

May 1, 2022 to April 30, 2023 $3,875
May 1, 2023 to April 30, 2024 $4,050
May 1, 2024 to April 30, 2025 $4,225
May 1, 2025 to April 30, 2026 $4,400
May 1, 2026 to April 30, 2027 $4,575

 

  o 2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909 subject to a one-year term expiring June 30, 2023 with a monthly rent of $5,000.

  

  o 5870 Lehman Drive Suite 200, Colorado Springs, CO 80918 The Company and landlord  previously entered into a lease in 2017 which expired December 31, 2022. At December 31, 2022, the Company's monthly rent was $2,732. On April 26, 2022, the Company and landlord entered into an extension agreement which extended the tenancy from January 1, 2023 through January 1, 2027. Rental payments due for the extended period are:   January 1, 2023 $2,898 January 1, 2024 $2,985 January 1, 2025 $3,075 January 1, 2026 $3,167 January 1, 2027 $3,262

 

January 1, 2023 $2,898
January 1, 2024 $2,985
January 1, 2025 $3,075
January 1, 2026 $3,167
January 1, 2027 $3,262

  o 2611 Durango Drive, CO Springs, CO. The Company and landlord entered into a lease on March 10, 2021, which terminated on May 31, 2022. On June 23, 2021, the Company and landlord entered into an extension of the lease for a term of thirty-six months, beginning June 1, 2022 and terminating June 1, 2024. At December 31, 2022, monthly rent was $11,000. Rental payments due for the extended period are:       June 1, 2022 to June 1, 2023 $11,000 June 1, 2023 to June 1, 2024 $11,880 June 1, 2025 to June 1, 2025 $12,830  

 

 

June 1, 2022 to June 1, 2023 $11,000
June 1, 2023 to June 1, 2024 $11,880
June 1, 2025 to June 1, 2025 $12,830
Schedule of operating leases liabilities

 Schedule of operating leases liabilities

     
    Operating
Leases
2023   $ 604,020  
Total     604,020  
Less: amount representing interest       -
Present value of future minimum lease payments     604,020  
Less: current obligations under leases     181,661  
Long-term lease obligations   $ 422,359  
Schedule of remaining minimal annual lease payments

 Schedule of remaining minimal annual lease payments

             
  2023     $ 604,020  
  Total     $ 604,020  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of stock based compensation

 Schedule of stock based compensation

         
    December 31,
2022		   December 31, 2021
Warrants     —        —  
Stock Payable                     —       275,000  
Total      —        275,000  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Schedule of income tax rate

Schedule of income tax rate 

Schedule of income tax rate      
   For the Years Ended
   December 31,  December 31,
   2022  2021
       
Income Tax Provision (Benefit)  $428,083   $(623,358)
Non-deductible expenses including non-deductible pre-merger losses   187,711    163,495 
Change in valuation allowance   (615,794)   459,863 
Total Income Tax Benefit  $—     $—   
Schedule of deferred tax assets

 Schedule of deferred tax assets

       
   December 31,  December 31,
   2022  2021
       
Total Deferred Tax Liabilities          
Lease Liability Expense  $—     $(24,457)
Total Deferred Tax Assets          
Net operating loss carryforwards   1,152,244    1,230,904 
           
Right of Use Asset   —      24,457 
Allowance for Doubtful Accounts   1,040    17,735 
Net Deferred Tax Assets   1,153,284    1,248,639 
Valuation Allowance   (1,153,284)   (1,248,639)
Total Deferred Tax Assets  $—     $—   
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenues $ 18,808,545 $ 2,425,204
Gross Profit 2,537,214 1,056,148
Selling and Marketing 225,950 199,968
Total Expense 3,142,870 2,696,881
Net Loss from Operations (605,656) (1,640,733)
Other Segments [Member]    
Revenues 793,330 1,006,148
Cost of Goods Sold  979,437 553,336
Gross Profit (186,107) 452,812
Depreciation Expense 46,111 19,811
Stock-based Compensation
Selling and Marketing 44,758 66,205
Payroll and Related expenses 256,255 222,496
General and Admin Expenses 538,528 231,341
Total Expense 885,652 539,853
Net Loss from Operations $ (1,071,759) $ (87,041)
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Accounting Policies [Abstract]    
Accounts Receivable, Allowance for Credit Loss $ 4,071 $ 82,540
[custom:BadDebtExpense] 5,438 54,435
Amortization of Acquisition Costs 186,000  
Revenue Recognition, Sales Returns, Reserve for Sales Returns   0
Advertising Expense 266,578 116,122
Employee Benefits and Share-Based Compensation $ 78,342 $ 42,206
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Naturaleaf Asset Acquisition (Details)
Dec. 31, 2022
USD ($)
Business Combination and Asset Acquisition [Abstract]  
Cash
Inventory 72,172
Property, plant and equipment 26,715
Long Term Deposits 6,000
Identifiable intangible assets 800,000
Goodwill 1,985,113
Accounts payable
Total consideration $ 2,890,000
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Naturaleaf Asset Acquisition (Details 1)
Dec. 31, 2022
USD ($)
Business Combination and Asset Acquisition [Abstract]  
Current Assets $ 15,000
Inventory 72,172
Property, Plant and Equipment 26,715
Other Assets 6,000
Total Tangible Assets 119,887
Tradenames and Trademarks 660,000
Licenses 810,000
Total Intangible Assets 1,470,000
Goodwill 1,332,113
Total Consideration $ 2,912,000
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Naturaleaf Asset Acquisition (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]    
Legal Fees $ 83,095  
Amortization   $ 62,223
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Receivable and Advance from Clients (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Receivables [Abstract]    
Accounts Receivable – Trade $ 469,111 $ 93,856
Less: Allowance for Doubtful Accounts (4,071) (82,540)
Accounts Receivable, net $ 465,040 $ 11,316
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Receivable and Advance from Clients (Details 1) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Receivables [Abstract]    
December 31, 2021 $ 111,892 $ 88,843
  Additional deposits received 691,769 404,143
  Less: Deposits recognized as revenue (522,663) (381,094)
December 31, 2022 $ 280,705 $ 111,892
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Accounts Receivable and Advance from Clients (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Receivables [Abstract]    
allowances for bad debt expense $ 5,438 $ 54,435
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Inventory (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Inventory Disclosure [Abstract]    
Raw Materials $ 38,464 $ 60,900
Work In Process 206,306 136,266
Finished Goods – Soil 66,557 58,594
Finished Goods – Cannabis Retail 41,644 22,848
Total Inventory $ 352,971 $ 278,608
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Property and Equipment, net (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross $ 427,432 $ 431,851
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment (113,650) (56,019)
[custom:PropertyPlantAndEquipmentNet1-0] 313,782 375,832
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross 47,380 39,574
Software Development [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross 13,204 13,204
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross 2,328 2,328
Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross $ 364,520 376,745
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross  
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible Assets (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross $ 1,488,464    
Finite-Lived Intangible Assets, Accumulated Amortization 255,222    
Finite-Lived Intangible Assets, Net 1,223,242 $ 745,937  
[custom:FiniteLivedIntangibleAssetsNet1-0] 1,223,242    
License [Member]      
Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross     $ 818,464
Finite-Lived Intangible Assets, Accumulated Amortization 134,552    
Finite-Lived Intangible Assets, Net $ 683,912    
Estimated Useful Life 15 years    
Brand [Member]      
Finite-Lived Intangible Assets [Line Items]      
Finite-Lived Intangible Assets, Gross $ 660,000    
Finite-Lived Intangible Assets, Accumulated Amortization 120,670    
Finite-Lived Intangible Assets, Net $ 539,330    
Estimated Useful Life 5 years    
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible Assets (Details 1)
Dec. 31, 2022
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
  $ 186,000
  186,000
  186,000
  145,997
  54,000
  $ 463,781
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible Assets (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]    
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life 11 years 5 months 19 days  
Other Depreciation and Amortization $ 186,000 $ 62,223
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Accrued and Other Current Liabilities (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Accrued Interest $ 39,130 $ 74,137
Accrued Payroll 22,029 18,428
Sales Tax Payable 3,931 592
Other Accrued Expenses & Payables 168,258 68,559
Accrued and other current liabilities $ 233,348 $ 161,716
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Payable (Details)
 12 Months Ended
Dec. 31, 2022
USD ($)
Stock Payable  
StockPayableAmounts
Additional Expensed Incurred, Amount 74,342
StockPayableAmounts $ 74,342
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)
 12 Months Ended
Dec. 31, 2022
USD ($)
May 2022 To April 2023 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense $ 3,875
Rental expense 3,875
May 2023 To April 2024 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense 4,050
Rental expense 4,050
May 2024 To April 2025 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense 4,225
Rental expense 4,225
May 2025 To April 2026 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense 4,400
Rental expense 4,400
May 2026 To April 2027 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense 4,575
Rental expense 4,575
January 2023 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense 2,898
Rental expense 2,898
January 2024 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense 2,985
Rental expense 2,985
January 2025 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense 3,075
Rental expense 3,075
January 2026 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense 3,167
Rental expense 3,167
January 2027 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense 3,262
Rental expense 3,262
June 2022 To June 2023 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense 11,000
Rental expense 11,000
June 2023 To June 2024 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense 11,880
Rental expense 11,880
June 2024 To June 2025 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Rental expense 12,830
Rental expense $ 12,830
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)
Dec. 31, 2022
USD ($)
Operating Lease Right-of-use Assetoperating Lease Liability  
2023 $ 604,020
Total 604,020
Less: amount representing interest
Present value of future minimum lease payments 604,020
Less: current obligations under leases 181,661
Long-term lease obligations $ 422,359
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of remaining minimal annual lease payments (Details)
Dec. 31, 2022
USD ($)
Operating Lease Right-of-use Assetoperating Lease Liability  
2023 $ 604,020
Total $ 604,020
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Based Compensation (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Warrants
Stock Payable 275,000
Total $ 275,000
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]    
Income Tax Provision (Benefit) $ 428,083 $ (623,358)
Non-deductible expenses including non-deductible pre-merger losses 187,711 163,495
Change in valuation allowance (615,794) 459,863
Total Income Tax Benefit
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes (Details 1) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Total Deferred Tax Liabilities    
Lease Liability Expense $ (24,457)
Net operating loss carryforwards 1,152,244 1,230,904
Right of Use Asset 24,457
Allowance for Doubtful Accounts 1,040 17,735
Net Deferred Tax Assets 1,153,284 1,248,639
Valuation Allowance (1,153,284) (1,248,639)
Total Deferred Tax Assets
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events (Details Narrative)
 3 Months Ended
Mar. 31, 2023
shares
Subsequent Event [Member]  
Subsequent Event [Line Items]  
Stock Issued During Period, Shares, Restricted Stock Award, Gross 2,175,000
XML 67 acc_10k_htm.xml IDEA: XBRL DOCUMENT 0000945617 2022-01-01 2022-12-31 0000945617 2022-12-31 0000945617 2023-04-17 0000945617 2021-12-31 0000945617 2021-01-01 2021-12-31 0000945617 2020-12-31 0000945617 us-gaap:CommonStockMember 2020-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000945617 us-gaap:RetainedEarningsMember 2020-12-31 0000945617 us-gaap:CommonStockMember 2021-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000945617 us-gaap:RetainedEarningsMember 2021-12-31 0000945617 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000945617 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000945617 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000945617 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000945617 us-gaap:CommonStockMember 2022-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000945617 us-gaap:RetainedEarningsMember 2022-12-31 0000945617 us-gaap:AllOtherSegmentsMember 2022-01-01 2022-12-31 0000945617 us-gaap:AllOtherSegmentsMember 2021-01-01 2021-12-31 0000945617 us-gaap:OfficeEquipmentMember 2022-12-31 0000945617 us-gaap:OfficeEquipmentMember 2021-12-31 0000945617 us-gaap:SoftwareDevelopmentMember 2022-12-31 0000945617 us-gaap:SoftwareDevelopmentMember 2021-12-31 0000945617 us-gaap:FurnitureAndFixturesMember 2022-12-31 0000945617 us-gaap:FurnitureAndFixturesMember 2021-12-31 0000945617 us-gaap:MachineryAndEquipmentMember 2022-12-31 0000945617 us-gaap:MachineryAndEquipmentMember 2021-12-31 0000945617 us-gaap:LeaseholdImprovementsMember 2021-12-31 0000945617 us-gaap:LicenseMember 2020-12-31 0000945617 us-gaap:LicenseMember 2022-12-31 0000945617 us-gaap:LicenseMember 2022-01-01 2022-12-31 0000945617 ammj:BrandMember 2022-12-31 0000945617 ammj:BrandMember 2022-01-01 2022-12-31 0000945617 ammj:May2022ToApril2023Member 2022-01-01 2022-12-31 0000945617 ammj:May2023ToApril2024Member 2022-01-01 2022-12-31 0000945617 ammj:May2024ToApril2025Member 2022-01-01 2022-12-31 0000945617 ammj:May2025ToApril2026Member 2022-01-01 2022-12-31 0000945617 ammj:May2026ToApril2027Member 2022-01-01 2022-12-31 0000945617 ammj:January2023Member 2022-01-01 2022-12-31 0000945617 ammj:January2024Member 2022-01-01 2022-12-31 0000945617 ammj:January2025Member 2022-01-01 2022-12-31 0000945617 ammj:January2026Member 2022-01-01 2022-12-31 0000945617 ammj:January2027Member 2022-01-01 2022-12-31 0000945617 ammj:June2022ToJune2023Member 2022-01-01 2022-12-31 0000945617 ammj:June2023ToJune2024Member 2022-01-01 2022-12-31 0000945617 ammj:June2024ToJune2025Member 2022-01-01 2022-12-31 0000945617 us-gaap:SubsequentEventMember 2023-01-01 2023-03-31 iso4217:USD shares iso4217:USD shares pure 0000945617 false FY 2022 --12-31 10-K true 2022-12-31 false 000-26108 AMERICAN CANNABIS COMPANY, INC DE 90-1116625 200 Union Street, Ste. 200 Lakewood CO 80228 303 974-4770 No No Yes Yes Non-accelerated Filer true false false 5076892 92152938 Macias Gini & O’Connell LLP 324 Irvine, CA 117547 670423 469111 11316 9595 2895 352971 278608 73933 51353 1023157 1014595 427669 375832 1223242 745937 1332113 1985113 604020 95722 6000 6000 3165375 2832772 4616201 4223199 679163 242679 280705 111892 233348 161718 74343 42207 181661 95722 100000 175000 550000 1100000 2099220 1929218 75000 175000 422359 150000 612960 175000 2746579 2104218 0.01 5000000 0 0.00001 500000000 92152938 81902938 922 819 11949409 11565679 -10080709 -9447517 1869622 2118981 4616201 4223199 475837 381094 17539377 1037962 793331 1006148 18808545 2425204 61246 36179 15230648 758940 979437 573937 16271331 1369056 2537214 1056148 2833140 2050272 225950 199968 5438 54435 350000 78342 42206 3142870 2696881 -605656 -1640733 78086 75374 -240975 50550 35883 -27536 201484 -633192 -1439249 -633192 -1439249 -0.01 -0.02 85727938 78387733 -633192 -1439249 64344 54345 227533 95562 266207 42207 350000 192432 -95722 240975 522139 40795 74363 144034 29282 1051 436484 229524 -168813 -23409 -175000 71630 113349 -192432 95722 -198965 -957978 103675 357801 1100000 8159 -103675 -1465960 130186 550000 150000 149764 1241043 -250236 1371229 -552875 -1052709 670423 1723132 117547 670423 700730 690000 1100000 70727938 707 9634748 -8008268 1627187 3000000 30 689970 690000 125000 1 -1 8050000 81 1240962 1241043 -1439249 -1439249 81902938 819 11565679 -9447517 2118981 81902938 819 11565679 -9447517 2118981 2000000 20 46206 46226 4750000 48 169931 169979 2500000 25 117603 117628 1000000 10 49990 50000 -633192 -633192 92152938 922 11949409 -10080709 1869622 <p id="xdx_807_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zL8azTn57g4j" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1. <span id="xdx_820_zqL4jlNd2iee">Description of Business.</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">American Cannabis Company, Inc. and its wholly owned subsidiary Company, Hollister &amp; Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and sell both exclusive and non-exclusive customer products commonly used in the industry.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Naturaleaf agreed to sell or assign to the Company the following assets:</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Medical Marijuana (MMC) Store Licenses;</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Marijuana Infused Product Licenses (MIPS); and</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Option Premises Cultivation License (OPC); and</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related real property assets, goodwill, and related business assets.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result, the Company has expanded its business model to include the cultivation and retail sale of cannabis in the medicinal cannabis industry.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80A_eus-gaap--SignificantAccountingPoliciesTextBlock_zPBVJlteoDTi" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2. <span id="xdx_82A_z1EvYmvKyWNf">Basis of Presentation and Summary of Significant Accounting Policies</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zgdcuzX0jY1j" style="margin: 0"><span id="xdx_867_zMLZVw6ijqn5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basis of Accounting</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_z2wd35wBAif6" style="margin: 0"><span id="xdx_865_z6um7tUalrTg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Principal of Consolidation</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements for the years ended December 31, 2022 and 2021, include the accounts of American Cannabis Company, Inc. and its wholly owned subsidiary, Hollister &amp; Blacksmith, Inc., doing business as American Cannabis Company, Inc. Intercompany accounts and transactions have been eliminated.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zCz22PNVZzYa" style="margin: 0"><span id="xdx_863_zbC2wzULsBJ5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going Concern</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Standards Codification (“ASC”) Topic 205-40, <i>Presentation of Financial Statements - Going Concern</i> ("ASC 205-40") requires management to assess the Company’s ability to continue as a going concern for one year after the date the financial statements are issued. Under ASC 205-40, management has the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet future financial obligations as they become due within one year after the date that the financial statements are issued. As required by this standard, management’s evaluation shall initially not take into consideration the potential mitigating effects of management’s plans that have not been fully implemented as of the date the financial statements are issued.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our assessment included the preparation of a detailed cash forecast that included all projected cash inflows and outflows. During 2022, we secured additional cash financings through the sales and issuances of our common stock through. However, we continue to focus on growing our revenues. Accordingly, operating expenditures may exceed the revenue we expect to receive for the foreseeable future. We also have a history of operating losses, negative operating cash flows, and negative working capital, and expect these trends to continue into the foreseeable future.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the date of this Annual Report on Form 10-K, while we believe we have adequate capital resources to complete our near-term operations, there is no guarantee that such capital resources will be sufficient until such time we reach profitability. We may access capital markets to fund strategic acquisitions or ongoing operations on terms we believe are favorable. The timing and amount of capital that may be raised are dependent on market conditions and the terms and conditions upon which investors would require to provide such capital. We may utilize debt or sell newly issued equity securities through public or private transactions.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There can be no assurance that we can obtain additional funding on satisfactory terms or at all. In addition, no assurance can be given that any such financing, if obtained, will be adequate to meet our capital needs and support our growth. If additional funding cannot be obtained on a timely basis and on satisfactory terms, our operations would be materially negatively impacted; however, we have successfully accessed capital markets in the past, and we are confident in our ability to access capital markets again if needed.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has an accumulated deficit of $10,080,709 and recurring losses and expects continuing future losses. In addition, the Company has a working capital deficit of $1,076,063. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s primary source of operating funds in 2022 and 2021 has been funds generated from proceeds from the sale of common stock and operations. The Company has experienced net losses from operations since its inception. The Company has an accumulated deficit at December 31, 2022, and requires additional financing to fund future operations.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s existence is dependent upon management’s ability to develop profitable operations and to obtain additional funding sources. There can be no assurance that the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying statements do not include any adjustments that might result should the Company be unable to continue as a going concern.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. </span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_zT6JjXMyCZr9" style="margin: 0"><span id="xdx_868_z5b1rqJk6C13" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates in Financial Reporting</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in preparing the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_845_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zCkVWFfvWHd3" style="margin: 0"><span id="xdx_86D_z2p0n00EbXC8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Segment Information</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Standards Codification subtopic Segment Reporting 280-10 ("ASC 280-10") establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information for those segments to be presented in interim financial reports issued to stockholders. ASC 280-10 also establishes standards for related disclosures about products and services and geographic areas. Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions on how to allocate resources and assess performance. The following table represents the Company’s Naturaleaf business.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zDxvejxvYpqe" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zt8wlMhhTBha" style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">Schedule of Segment Reporting Information, by Segment</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30A_134_zop1vYK2P7hd" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_492_20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zJVDPiSfRtF5" style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zg8HUozDJlE7" style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="7" style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Years ended</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dec 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dec 31, 2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--Revenues_zd8ZGXOwNa7d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; color: #333333; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">793,330</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,006,148</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--CostOfGoodsAndServicesSold_zZcqTQSt1P2f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of Goods Sold </span></p></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">979,437</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">553,336</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--GrossProfit_zlSsoWnnyqR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross Profit</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(186,107</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">452,812</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; color: #333333; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--DepreciationAndAmortization_zobpe0PlmU16" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation Expense</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,111</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,811</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_zioyYIo9gaCb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based Compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0490">—</span>  </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0491">—</span>  </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--SellingAndMarketingExpense_z2OjJyzccVc8" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and Marketing</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,758</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,205</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--IncreaseDecreaseInEmployeeRelatedLiabilities_z543XdALA6U7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payroll and Related expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">256,255</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">222,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AdministrativeFeesExpense_zlDmiM4N5B3b" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and Admin Expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">538,528</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">231,341</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--OperatingExpenses_zhp6pNfcGjn1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Expense</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">885,652</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">539,853</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_zpS3IRhcw7ji" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Loss from Operations</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,071,759</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(87,041</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0; text-align: justify"/> <p id="xdx_8A2_zmfocSqtQ2pk" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zFD7vM8SBZoh" style="margin: 0"><span id="xdx_863_zMdYaPrOTG83" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash and Cash Equivalents</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of December 31, 2022, and 2021, the Company had cash balances in excess of FDIC-insured limits of $250,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ReceivablesPolicyTextBlock_zR7QF0QBs53d" style="margin: 0"><span id="xdx_86A_zvxgEVzVjWmj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts Receivable, net</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. At December 31, 2022, and 2021, the Company’s allowance for doubtful accounts was $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20221231_zXj8slyV7k2f">4,071 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20211231_zdD6aEdOfj1h" style="background-color: white">82,540</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. The Company recorded bad debt expense during the years ended December 31, 2022, and 2021, of <span id="xdx_903_ecustom--BadDebtExpense_c20220101__20221231_zrVbKaKoMAee">$5,438 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_908_ecustom--BadDebtExpense_c20210101__20211231_zL5xRz1jDgM2">54,435</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--DepositContractsPolicy_z9RENJ4pTV3c" style="margin: 0"><span id="xdx_86A_z3C4ZoRCzNHc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deposits</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits are comprised of advance payments made to third parties, for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--InventoryPolicyTextBlock_zYGPXgMGBlf5" style="margin: 0"><span id="xdx_863_zxcP2eq2d95f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Inventory</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is comprised of products and equipment owned by the Company to be sold to end-customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in first-out and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of December 31, 2022 and 2021, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third party vendors for retail sales at dispensaries is determined using the first in first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production related depreciation and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At December 31, 2022, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock_zVFKhyAKuXa5" style="margin: 0"><span id="xdx_861_z9QcgAUztcw6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Prepaid Expenses and Other Current Assets</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_z4N43YQGO6Kb" style="margin: 0"><span id="xdx_86A_zJe1yzjo3uTe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant Clients and Customers</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022, eight customers accounted for 87.33% of the Company's total revenues from its consulting, soil, and products revenue lines for the period. At December 31, 2021, nine customers accounted for 50.1% of the Company’s total revenues from its consulting and soil and product revenue lines for the period.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, three customers accounted for 84.76% of accounts receivable, net, consisting of customers for our products, soil, and consulting services product streams. At December 31, 2021, two customers accounted for 77.3% of accounts receivable, net, consisting of customers of our consulting services and soil, and products revenue streams.</span></p> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zZB8jLRwivi1" style="margin: 0"><span id="xdx_86D_zVRLeuUfYDjd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Property and Equipment, ne</i></span><i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">t</span></i></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in-progress construction are capitalized as incurred, and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of December 31, 2022, and 2021.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_840_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z343R4vKkrv2" style="margin: 0"><span id="xdx_864_ztmVS18y4wlj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Goodwill</i></span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed. The Company accounts for goodwill under <i>ASC Topic 350, Intangibles-Goodwill and Other</i>. The Company tests goodwill for impairment annually or more frequently whenever events or circumstances indicate impairment may exist. Goodwill is stated at cost less accumulated impairment losses. The Company completes its goodwill impairment test annually in the fourth quarter. The Company evaluated its Naturaleaf Acquisition that closed on April 30, 2021, and recognized $1,332,113 in goodwill connected with the acquisition during the year ended December 31, 2022.</span></p> <p style="margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not have any other indefinite-lived intangible assets. </span></p> <p style="margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with FASB ASC 350, “Intangibles – Goodwill and Other,” we perform goodwill impairment testing at least annually, unless indicators of impairment exist in interim periods. The impairment test for goodwill uses a two-step approach. Step one compares the estimated fair value of a reporting unit with goodwill to its carrying value. If the carrying value exceeds the estimated fair value, step two must be performed. Step two compares the carrying value of the reporting unit to the fair value of all of the assets and liabilities of the reporting unit (including any unrecognized intangibles) as if the reporting unit was acquired in a business combination. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of its goodwill, an impairment loss is recognized in an amount equal to the excess.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zNkKWllQDkd3" style="margin: 0"><span id="xdx_860_zEPz4TZFFHSi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Intangible Assets, net</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definite life intangible assets at December 31, 2022, include licenses, trademarks, goodwill and brand names recognized as part of the Naturaleaf Acquisition. Intangible assets are recorded at cost. Licenses, trademarks and brand names represent the estimated fair value of these items at the date of acquisition, April 30, 2021. Intangible assets are amortized on a straight-line basis over their estimated useful life. Licenses are assigned a life of 15 years, and tradenames are assigned a life of 5 years. During the year ended December 31, 2022, the Company recognized an amortization expense of $<span id="xdx_90B_eus-gaap--AmortizationOfAcquisitionCosts_c20220101__20221231_z95eLTpZpAi">186,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zC1mViqb4134" style="margin: 0"><span id="xdx_86B_znHM0c05FWq5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounting for the Impairment of Long-Lived Assets</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, the recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values, or management's estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long-lived assets as of December 31, 2022, and 2021.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zZw0DLwKeWJj" style="margin: 0"><span id="xdx_863_zx8q4WuvSClb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair Value Measurements</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zdIkQYGuurK7" style="margin: 0"><span id="xdx_866_zsgJNJHU2Ffa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue Recognition</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “<i>Revenue from Contracts with Customers (Topic 606). </i>Due to the nature of our contracts with customers, adopting the new accounting principles did not have a significant impact on our prior period results of operations, cash flows or financial position.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our service and product revenues arise from contracts with customers. Service revenue includes Operations Divisions' consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, and (c) Cannabis sales division. The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may also enter into contracts with customers that identify a single or few, distinct performance obligations but that also have non-distinct, underlying performance obligations. These contracts are typically fulfilled within one to six months. Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods and, accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues:</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(1)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identify the contract with the Customer. </i>Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(2)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identify the performance obligations in the contract. </i>We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(3)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determination of the transaction price. </i>Prices are typically fixed, and no price protections or variables are offered.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(4)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Allocation of the transaction price to the performance obligations in the contract</i>. Transaction prices are typically allocated to the performance obligations outlined in the contract.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(5)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognize Revenue when (or as) the entity satisfies a performance obligation. </i>We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances from Clients deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from Clients deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84F_ecustom--ProductAndEquipmentSalesPolicyTextBlock_z6EWtdWXZXb3" style="margin: 0"><span id="xdx_86B_zzJnrcR8HZl1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Product and Equipment Sales</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, title has transferred, and collectability is reasonably assured. Generally, our suppliers’ drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for the customer or us under FASB ASC Topic 606. During the years ended December 31, 2022 and 2021, sales returns were $<span id="xdx_90D_eus-gaap--RevenueRecognitionSalesReturnsReserveForSalesReturns_c20210101__20211231_z3BEmw9UN3fc">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--ConsultingServicesPolicyTextBlock_zm52uwZFTC5b" style="margin: 0"><span id="xdx_861_zOLzkar6Al1c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consulting Services</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services. For hourly based fixed fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, in order to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients” account, and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer-based significant financing that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the years ended December 31, 2022 and 2021, we incurred no losses from fixed fee engagements that terminate prior to completion. We believe if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We primarily enter into arrangements for which fixed and determinable revenues are contingent and agreed upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis and the value of the separate elements can be established by VSOE or an estimated selling price.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p id="xdx_847_ecustom--CannabisSalesPolicyTextBlock_zw71MSJgHGQb" style="margin: 0"><span id="xdx_86A_zafPDsiLU6yl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cannabis Sales</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. Sales discounts were not material during the years ended December 31, 2022, and 2021.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84C_ecustom--LoyaltyRewardProgramPolicyTextBlock_zQFftbxdOG7a" style="margin: 0; text-align: justify"><span id="xdx_86E_zuzEbSZCmTB9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loyalty Reward Program</i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based upon the total amount of a purchase, at the time of purchase. Management has determined that as there is no separate performance obligation to the reward program, i.e., the accumulation and redemption of points, and as such the Company recognizes the revenue at the time of purchase.</span></p> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--CostOfSalesPolicyTextBlock_zQRNoCeIEnWf" style="margin: 0"><span id="xdx_863_zWY5pHYrnyp" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Costs of Revenues</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--AdvertisingCostsPolicyTextBlock_zE8lnzF3vNB3" style="margin: 0"><span id="xdx_869_zHFP06Ca6mQ3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Advertising and Promotion Costs</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising and Promotion costs are included as a component of selling and marketing expense and are expensed as incurred. During the years ended December 31, 2022, and 2021, these expenses were $<span id="xdx_900_eus-gaap--AdvertisingExpense_c20220101__20221231_zzgGnmR0ozQ9">266,578 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_905_eus-gaap--AdvertisingExpense_c20210101__20211231_zzxhe9bY26T5">116,122</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_z8GtwtPtit21" style="margin: 0"><span id="xdx_861_zur7cTyn6Una" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shipping and Handling Costs</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_ztV4i3s2Ygl3" style="margin: 0"><span id="xdx_86F_zCupY9V3t4t1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock-Based Compensation</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of the grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. During the years ended December 31, 2022, and 2021, stock-based compensation expense for restricted shares for Company employees was $<span id="xdx_905_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20220101__20221231_zNmkhr6ZE1J8">78,342 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90D_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20210101__20211231_z7s2QoQXYfI6">42,206 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. Compensation expenses for warrants are based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model and are expensed over the expected term of the awards. During the year ended December 31, 2022, and 2021, no warrants were issued as stock compensation.</span></p> <p style="margin: 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84D_eus-gaap--ResearchAndDevelopmentExpensePolicy_zn4hIvCtXGbh" style="margin: 0"><span id="xdx_863_zLia8MJUD3d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research and Development</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a component of our equipment and supplies offerings, from time-to-time we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include, but are not limited to: The Satchel™, Cultivation Cube™, So-Hum Living Soils™ and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the years ended December 31, 2022 and 2021, our research and development costs were de minimis.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zOpbw8EE8Qc1" style="margin: 0"><span id="xdx_86F_zetT8HlPpvOj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income Taxes</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s corporate status changed from an S Corporation, which it had been since inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2022, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of December 31, 2022 and 2021 we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“<b>IRC</b>”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_z2ST0v6rAar3" style="margin: 0"><span id="xdx_86E_z1vAq3yjlJXg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net Loss Per Common Share</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities since that would have an anti-dilutive effect on earnings.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84F_ecustom--RelatedPartyTransactionsPolicyTextBlock_zxuuQy4mUFkj" style="margin: 0"><span id="xdx_86D_zmYHHP8WNRd4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Related Party Transactions</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows FASB ASC subtopic 850-10, <i>Related Party Disclosures,</i> for the identification of related parties and disclosure of related party transactions.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--ImpactOfCovid19PandemicPolicyTextBlock_z5QKj93xJcbe" style="margin: 0"><span id="xdx_864_z5Q8asPeXFbb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Impact of the COVID-19 Pandemic</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 11, 2020<i>, </i>the World Health Organization declared the current coronavirus (“COVID-<i>19”</i>) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-<i>19</i> within the United States, federal, state, and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact on many sectors of the economy, including retail commerce.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In response to state and local measures and for the protection of both employees, the Company made required changes to operations, which did not have a material impact on operations or the financial condition of the Company.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-<i>19</i> cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z553iu4too5i" style="margin: 0"><span id="xdx_867_ziUQGQYKMsU9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recent Accounting Pronouncements</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2019, the FASB issued ASU 2019-12<i>, “Simplifying the Accounting for Income Taxes</i>”. The pronouncement simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740, “Income Taxes”. The pronouncement also improves consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. The Company has adopted the standard and there was not an impact on its consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2020, the FASB issued ASU No. 2020-01, "<i>Investments — Equity Securities: Clarifying the Interactions between Topic 321, Topic 323, and Topic 815</i>" ("ASU No. 2020-01"). ASU No. 2020-01 clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with ASC 321, "<i>Investments — Equity Securities"</i> immediately before applying or upon discontinuing the equity method of accounting in ASC 323, "<i>Investments—Equity Method and Joint Ventures</i>." The provisions of ASU No. 2020-01 are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years with early adoption permitted, including early adoption in an interim period for public business entities for periods for which financial statements have not yet been issued. The Company has adopted thee standard and there was not an impact on its consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b> </b></span></p> <p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zgdcuzX0jY1j" style="margin: 0"><span id="xdx_867_zMLZVw6ijqn5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basis of Accounting</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--ConsolidationPolicyTextBlock_z2wd35wBAif6" style="margin: 0"><span id="xdx_865_z6um7tUalrTg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Principal of Consolidation</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements for the years ended December 31, 2022 and 2021, include the accounts of American Cannabis Company, Inc. and its wholly owned subsidiary, Hollister &amp; Blacksmith, Inc., doing business as American Cannabis Company, Inc. Intercompany accounts and transactions have been eliminated.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zCz22PNVZzYa" style="margin: 0"><span id="xdx_863_zbC2wzULsBJ5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going Concern</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Standards Codification (“ASC”) Topic 205-40, <i>Presentation of Financial Statements - Going Concern</i> ("ASC 205-40") requires management to assess the Company’s ability to continue as a going concern for one year after the date the financial statements are issued. Under ASC 205-40, management has the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet future financial obligations as they become due within one year after the date that the financial statements are issued. As required by this standard, management’s evaluation shall initially not take into consideration the potential mitigating effects of management’s plans that have not been fully implemented as of the date the financial statements are issued.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our assessment included the preparation of a detailed cash forecast that included all projected cash inflows and outflows. During 2022, we secured additional cash financings through the sales and issuances of our common stock through. However, we continue to focus on growing our revenues. Accordingly, operating expenditures may exceed the revenue we expect to receive for the foreseeable future. We also have a history of operating losses, negative operating cash flows, and negative working capital, and expect these trends to continue into the foreseeable future.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the date of this Annual Report on Form 10-K, while we believe we have adequate capital resources to complete our near-term operations, there is no guarantee that such capital resources will be sufficient until such time we reach profitability. We may access capital markets to fund strategic acquisitions or ongoing operations on terms we believe are favorable. The timing and amount of capital that may be raised are dependent on market conditions and the terms and conditions upon which investors would require to provide such capital. We may utilize debt or sell newly issued equity securities through public or private transactions.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There can be no assurance that we can obtain additional funding on satisfactory terms or at all. In addition, no assurance can be given that any such financing, if obtained, will be adequate to meet our capital needs and support our growth. If additional funding cannot be obtained on a timely basis and on satisfactory terms, our operations would be materially negatively impacted; however, we have successfully accessed capital markets in the past, and we are confident in our ability to access capital markets again if needed.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has an accumulated deficit of $10,080,709 and recurring losses and expects continuing future losses. In addition, the Company has a working capital deficit of $1,076,063. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s primary source of operating funds in 2022 and 2021 has been funds generated from proceeds from the sale of common stock and operations. The Company has experienced net losses from operations since its inception. The Company has an accumulated deficit at December 31, 2022, and requires additional financing to fund future operations.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s existence is dependent upon management’s ability to develop profitable operations and to obtain additional funding sources. There can be no assurance that the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying statements do not include any adjustments that might result should the Company be unable to continue as a going concern.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. </span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--UseOfEstimates_zT6JjXMyCZr9" style="margin: 0"><span id="xdx_868_z5b1rqJk6C13" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates in Financial Reporting</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in preparing the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_845_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zCkVWFfvWHd3" style="margin: 0"><span id="xdx_86D_z2p0n00EbXC8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Segment Information</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Standards Codification subtopic Segment Reporting 280-10 ("ASC 280-10") establishes standards for reporting information regarding operating segments in annual financial statements and requires selected information for those segments to be presented in interim financial reports issued to stockholders. ASC 280-10 also establishes standards for related disclosures about products and services and geographic areas. Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions on how to allocate resources and assess performance. The following table represents the Company’s Naturaleaf business.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zDxvejxvYpqe" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zt8wlMhhTBha" style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">Schedule of Segment Reporting Information, by Segment</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30A_134_zop1vYK2P7hd" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_492_20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zJVDPiSfRtF5" style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zg8HUozDJlE7" style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="7" style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Years ended</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dec 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dec 31, 2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--Revenues_zd8ZGXOwNa7d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; color: #333333; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">793,330</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,006,148</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--CostOfGoodsAndServicesSold_zZcqTQSt1P2f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of Goods Sold </span></p></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">979,437</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">553,336</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--GrossProfit_zlSsoWnnyqR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross Profit</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(186,107</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">452,812</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; color: #333333; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--DepreciationAndAmortization_zobpe0PlmU16" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation Expense</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,111</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,811</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_zioyYIo9gaCb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based Compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0490">—</span>  </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0491">—</span>  </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--SellingAndMarketingExpense_z2OjJyzccVc8" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and Marketing</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,758</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,205</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--IncreaseDecreaseInEmployeeRelatedLiabilities_z543XdALA6U7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payroll and Related expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">256,255</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">222,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AdministrativeFeesExpense_zlDmiM4N5B3b" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and Admin Expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">538,528</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">231,341</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--OperatingExpenses_zhp6pNfcGjn1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Expense</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">885,652</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">539,853</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_zpS3IRhcw7ji" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Loss from Operations</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,071,759</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(87,041</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0; text-align: justify"/> <p id="xdx_8A2_zmfocSqtQ2pk" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zDxvejxvYpqe" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zt8wlMhhTBha" style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">Schedule of Segment Reporting Information, by Segment</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30A_134_zop1vYK2P7hd" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_492_20220101__20221231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zJVDPiSfRtF5" style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20210101__20211231__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zg8HUozDJlE7" style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="7" style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Years ended</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dec 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dec 31, 2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--Revenues_zd8ZGXOwNa7d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; color: #333333; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">793,330</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,006,148</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--CostOfGoodsAndServicesSold_zZcqTQSt1P2f" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of Goods Sold </span></p></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">979,437</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">553,336</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--GrossProfit_zlSsoWnnyqR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross Profit</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(186,107</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">452,812</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-decoration: underline; color: #333333; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--DepreciationAndAmortization_zobpe0PlmU16" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation Expense</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,111</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,811</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_zioyYIo9gaCb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based Compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0490">—</span>  </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0491">—</span>  </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--SellingAndMarketingExpense_z2OjJyzccVc8" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and Marketing</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,758</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,205</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--IncreaseDecreaseInEmployeeRelatedLiabilities_z543XdALA6U7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payroll and Related expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">256,255</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">222,496</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AdministrativeFeesExpense_zlDmiM4N5B3b" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and Admin Expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">538,528</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">231,341</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--OperatingExpenses_zhp6pNfcGjn1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Expense</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">885,652</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">539,853</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_zpS3IRhcw7ji" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Loss from Operations</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,071,759</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; color: #333333; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; color: #333333; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(87,041</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; color: #333333; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0; text-align: justify"/> 793330 1006148 979437 553336 -186107 452812 46111 19811 44758 66205 256255 222496 538528 231341 885652 539853 -1071759 -87041 <p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zFD7vM8SBZoh" style="margin: 0"><span id="xdx_863_zMdYaPrOTG83" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash and Cash Equivalents</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of December 31, 2022, and 2021, the Company had cash balances in excess of FDIC-insured limits of $250,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ReceivablesPolicyTextBlock_zR7QF0QBs53d" style="margin: 0"><span id="xdx_86A_zvxgEVzVjWmj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts Receivable, net</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. At December 31, 2022, and 2021, the Company’s allowance for doubtful accounts was $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20221231_zXj8slyV7k2f">4,071 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20211231_zdD6aEdOfj1h" style="background-color: white">82,540</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. The Company recorded bad debt expense during the years ended December 31, 2022, and 2021, of <span id="xdx_903_ecustom--BadDebtExpense_c20220101__20221231_zrVbKaKoMAee">$5,438 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_908_ecustom--BadDebtExpense_c20210101__20211231_zL5xRz1jDgM2">54,435</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 4071 82540 5438 54435 <p id="xdx_84D_eus-gaap--DepositContractsPolicy_z9RENJ4pTV3c" style="margin: 0"><span id="xdx_86A_z3C4ZoRCzNHc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deposits</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits are comprised of advance payments made to third parties, for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--InventoryPolicyTextBlock_zYGPXgMGBlf5" style="margin: 0"><span id="xdx_863_zxcP2eq2d95f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Inventory</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is comprised of products and equipment owned by the Company to be sold to end-customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in first-out and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of December 31, 2022 and 2021, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third party vendors for retail sales at dispensaries is determined using the first in first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production related depreciation and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At December 31, 2022, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock_zVFKhyAKuXa5" style="margin: 0"><span id="xdx_861_z9QcgAUztcw6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Prepaid Expenses and Other Current Assets</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_z4N43YQGO6Kb" style="margin: 0"><span id="xdx_86A_zJe1yzjo3uTe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant Clients and Customers</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022, eight customers accounted for 87.33% of the Company's total revenues from its consulting, soil, and products revenue lines for the period. At December 31, 2021, nine customers accounted for 50.1% of the Company’s total revenues from its consulting and soil and product revenue lines for the period.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, three customers accounted for 84.76% of accounts receivable, net, consisting of customers for our products, soil, and consulting services product streams. At December 31, 2021, two customers accounted for 77.3% of accounts receivable, net, consisting of customers of our consulting services and soil, and products revenue streams.</span></p> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zZB8jLRwivi1" style="margin: 0"><span id="xdx_86D_zVRLeuUfYDjd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Property and Equipment, ne</i></span><i><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">t</span></i></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in-progress construction are capitalized as incurred, and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of December 31, 2022, and 2021.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_840_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z343R4vKkrv2" style="margin: 0"><span id="xdx_864_ztmVS18y4wlj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Goodwill</i></span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed. The Company accounts for goodwill under <i>ASC Topic 350, Intangibles-Goodwill and Other</i>. The Company tests goodwill for impairment annually or more frequently whenever events or circumstances indicate impairment may exist. Goodwill is stated at cost less accumulated impairment losses. The Company completes its goodwill impairment test annually in the fourth quarter. The Company evaluated its Naturaleaf Acquisition that closed on April 30, 2021, and recognized $1,332,113 in goodwill connected with the acquisition during the year ended December 31, 2022.</span></p> <p style="margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not have any other indefinite-lived intangible assets. </span></p> <p style="margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with FASB ASC 350, “Intangibles – Goodwill and Other,” we perform goodwill impairment testing at least annually, unless indicators of impairment exist in interim periods. The impairment test for goodwill uses a two-step approach. Step one compares the estimated fair value of a reporting unit with goodwill to its carrying value. If the carrying value exceeds the estimated fair value, step two must be performed. Step two compares the carrying value of the reporting unit to the fair value of all of the assets and liabilities of the reporting unit (including any unrecognized intangibles) as if the reporting unit was acquired in a business combination. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of its goodwill, an impairment loss is recognized in an amount equal to the excess.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zNkKWllQDkd3" style="margin: 0"><span id="xdx_860_zEPz4TZFFHSi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Intangible Assets, net</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definite life intangible assets at December 31, 2022, include licenses, trademarks, goodwill and brand names recognized as part of the Naturaleaf Acquisition. Intangible assets are recorded at cost. Licenses, trademarks and brand names represent the estimated fair value of these items at the date of acquisition, April 30, 2021. Intangible assets are amortized on a straight-line basis over their estimated useful life. Licenses are assigned a life of 15 years, and tradenames are assigned a life of 5 years. During the year ended December 31, 2022, the Company recognized an amortization expense of $<span id="xdx_90B_eus-gaap--AmortizationOfAcquisitionCosts_c20220101__20221231_z95eLTpZpAi">186,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 186000 <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zC1mViqb4134" style="margin: 0"><span id="xdx_86B_znHM0c05FWq5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounting for the Impairment of Long-Lived Assets</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, the recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values, or management's estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long-lived assets as of December 31, 2022, and 2021.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zZw0DLwKeWJj" style="margin: 0"><span id="xdx_863_zx8q4WuvSClb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair Value Measurements</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--RevenueRecognitionPolicyTextBlock_zdIkQYGuurK7" style="margin: 0"><span id="xdx_866_zsgJNJHU2Ffa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue Recognition</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “<i>Revenue from Contracts with Customers (Topic 606). </i>Due to the nature of our contracts with customers, adopting the new accounting principles did not have a significant impact on our prior period results of operations, cash flows or financial position.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our service and product revenues arise from contracts with customers. Service revenue includes Operations Divisions' consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, and (c) Cannabis sales division. The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may also enter into contracts with customers that identify a single or few, distinct performance obligations but that also have non-distinct, underlying performance obligations. These contracts are typically fulfilled within one to six months. Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods and, accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize revenue in accordance with ASC 606 using the following 5 steps to identify revenues:</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(1)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identify the contract with the Customer. </i>Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(2)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identify the performance obligations in the contract. </i>We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(3)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determination of the transaction price. </i>Prices are typically fixed, and no price protections or variables are offered.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(4)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Allocation of the transaction price to the performance obligations in the contract</i>. Transaction prices are typically allocated to the performance obligations outlined in the contract.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(5)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognize Revenue when (or as) the entity satisfies a performance obligation. </i>We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances from Clients deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future, or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from Clients deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84F_ecustom--ProductAndEquipmentSalesPolicyTextBlock_z6EWtdWXZXb3" style="margin: 0"><span id="xdx_86B_zzJnrcR8HZl1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Product and Equipment Sales</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, title has transferred, and collectability is reasonably assured. Generally, our suppliers’ drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for the customer or us under FASB ASC Topic 606. During the years ended December 31, 2022 and 2021, sales returns were $<span id="xdx_90D_eus-gaap--RevenueRecognitionSalesReturnsReserveForSalesReturns_c20210101__20211231_z3BEmw9UN3fc">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 <p id="xdx_84C_ecustom--ConsultingServicesPolicyTextBlock_zm52uwZFTC5b" style="margin: 0"><span id="xdx_861_zOLzkar6Al1c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consulting Services</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services. For hourly based fixed fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, in order to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients” account, and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer-based significant financing that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the years ended December 31, 2022 and 2021, we incurred no losses from fixed fee engagements that terminate prior to completion. We believe if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We primarily enter into arrangements for which fixed and determinable revenues are contingent and agreed upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis and the value of the separate elements can be established by VSOE or an estimated selling price.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p id="xdx_847_ecustom--CannabisSalesPolicyTextBlock_zw71MSJgHGQb" style="margin: 0"><span id="xdx_86A_zafPDsiLU6yl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cannabis Sales</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time period permitted under the Company’s credit policy. Sales discounts were not material during the years ended December 31, 2022, and 2021.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84C_ecustom--LoyaltyRewardProgramPolicyTextBlock_zQFftbxdOG7a" style="margin: 0; text-align: justify"><span id="xdx_86E_zuzEbSZCmTB9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loyalty Reward Program</i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based upon the total amount of a purchase, at the time of purchase. Management has determined that as there is no separate performance obligation to the reward program, i.e., the accumulation and redemption of points, and as such the Company recognizes the revenue at the time of purchase.</span></p> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--CostOfSalesPolicyTextBlock_zQRNoCeIEnWf" style="margin: 0"><span id="xdx_863_zWY5pHYrnyp" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Costs of Revenues</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--AdvertisingCostsPolicyTextBlock_zE8lnzF3vNB3" style="margin: 0"><span id="xdx_869_zHFP06Ca6mQ3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Advertising and Promotion Costs</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising and Promotion costs are included as a component of selling and marketing expense and are expensed as incurred. During the years ended December 31, 2022, and 2021, these expenses were $<span id="xdx_900_eus-gaap--AdvertisingExpense_c20220101__20221231_zzgGnmR0ozQ9">266,578 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_905_eus-gaap--AdvertisingExpense_c20210101__20211231_zzxhe9bY26T5">116,122</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 266578 116122 <p id="xdx_84F_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_z8GtwtPtit21" style="margin: 0"><span id="xdx_861_zur7cTyn6Una" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shipping and Handling Costs</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_ztV4i3s2Ygl3" style="margin: 0"><span id="xdx_86F_zCupY9V3t4t1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock-Based Compensation</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of the grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. During the years ended December 31, 2022, and 2021, stock-based compensation expense for restricted shares for Company employees was $<span id="xdx_905_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20220101__20221231_zNmkhr6ZE1J8">78,342 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90D_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20210101__20211231_z7s2QoQXYfI6">42,206 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. Compensation expenses for warrants are based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model and are expensed over the expected term of the awards. During the year ended December 31, 2022, and 2021, no warrants were issued as stock compensation.</span></p> <p style="margin: 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> 78342 42206 <p id="xdx_84D_eus-gaap--ResearchAndDevelopmentExpensePolicy_zn4hIvCtXGbh" style="margin: 0"><span id="xdx_863_zLia8MJUD3d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research and Development</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a component of our equipment and supplies offerings, from time-to-time we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include, but are not limited to: The Satchel™, Cultivation Cube™, So-Hum Living Soils™ and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the years ended December 31, 2022 and 2021, our research and development costs were de minimis.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zOpbw8EE8Qc1" style="margin: 0"><span id="xdx_86F_zetT8HlPpvOj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income Taxes</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s corporate status changed from an S Corporation, which it had been since inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2022, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of December 31, 2022 and 2021 we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“<b>IRC</b>”) Section 280E under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--EarningsPerSharePolicyTextBlock_z2ST0v6rAar3" style="margin: 0"><span id="xdx_86E_z1vAq3yjlJXg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net Loss Per Common Share</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities since that would have an anti-dilutive effect on earnings.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84F_ecustom--RelatedPartyTransactionsPolicyTextBlock_zxuuQy4mUFkj" style="margin: 0"><span id="xdx_86D_zmYHHP8WNRd4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Related Party Transactions</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows FASB ASC subtopic 850-10, <i>Related Party Disclosures,</i> for the identification of related parties and disclosure of related party transactions.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--ImpactOfCovid19PandemicPolicyTextBlock_z5QKj93xJcbe" style="margin: 0"><span id="xdx_864_z5Q8asPeXFbb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Impact of the COVID-19 Pandemic</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 11, 2020<i>, </i>the World Health Organization declared the current coronavirus (“COVID-<i>19”</i>) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-<i>19</i> within the United States, federal, state, and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact on many sectors of the economy, including retail commerce.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In response to state and local measures and for the protection of both employees, the Company made required changes to operations, which did not have a material impact on operations or the financial condition of the Company.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-<i>19</i> cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z553iu4too5i" style="margin: 0"><span id="xdx_867_ziUQGQYKMsU9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recent Accounting Pronouncements</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2019, the FASB issued ASU 2019-12<i>, “Simplifying the Accounting for Income Taxes</i>”. The pronouncement simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740, “Income Taxes”. The pronouncement also improves consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This standard is effective for fiscal years beginning after December 15, 2020, with early adoption permitted. The Company has adopted the standard and there was not an impact on its consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2020, the FASB issued ASU No. 2020-01, "<i>Investments — Equity Securities: Clarifying the Interactions between Topic 321, Topic 323, and Topic 815</i>" ("ASU No. 2020-01"). ASU No. 2020-01 clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with ASC 321, "<i>Investments — Equity Securities"</i> immediately before applying or upon discontinuing the equity method of accounting in ASC 323, "<i>Investments—Equity Method and Joint Ventures</i>." The provisions of ASU No. 2020-01 are effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years with early adoption permitted, including early adoption in an interim period for public business entities for periods for which financial statements have not yet been issued. The Company has adopted thee standard and there was not an impact on its consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b> </b></span></p> <p id="xdx_800_eus-gaap--AssetAcquisitionTextBlock_zMf32RuaSNA6" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3. <span id="xdx_82A_zgEkAN5NnFm5">Naturaleaf Asset Acquisition</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” (collectively, "Naturaleaf") in the medicinal cannabis industry in Colorado.</span></p> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Naturaleaf agreed to sell or assign to the Company the following assets:</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Medical Marijuana (MMC) Store Licenses;</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Marijuana Infused Product Licenses (MIPS); and,</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Option Premises Cultivation License (OPC); and,</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related real property assets, goodwill, and related business assets.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate consideration paid for the Assets was $2,912,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000, and (iv) the assumption of of $22,000 in current payables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 29, 2022, the Company and the previous owners of Naturaleaf agreed to an amendment of the note. The Company paid $550,000 of the principal, combined with accrued interest of $110,000 in exchange for a new note with a principal balance of $550,000, interest per annum of 12% and a maturity date of April 29, 2023.</span></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"/> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The asset acquisition was accounted for under the acquisition method of accounting in accordance with ASC Topic 805, <i>Business Combinations</i>. As the acquirer for accounting purposes, the Company has estimated the fair value of Medihemp LLC and Medical Cannabis Caregivers, Inc.’s (hereafter “Naturaleaf’s”) assets acquired and conformed the accounting policies of Naturaleaf to its own accounting policies. The Company expensed certain legal, auditing and licensing costs with the acquisition of $<span id="xdx_90A_eus-gaap--LegalFees_c20220101__20221231_zHsfxka7YPFc">83,095</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the acquisition, the owners of Naturaleaf retained the outstanding cash balance on the date of the acquisition and had agreed to the payment of all outstanding accounts payables and related party advances.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preliminary Valuation</i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has performed a valuation analysis of the fair market value of Naturaleaf’s assets. The following table summarizes the allocation of the preliminary purchase price as of the acquisition date:</span></p> <p id="xdx_891_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zgY4XqjWC429" style="margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zReHnvOxd5n9">Schedule of purchase price as of the acquisition</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_303_134_zC9KzJ46vPSg" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Naturaleaf Asset Acquisition (Details)"> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_496_20221231_zsnmuE9rkB46" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--Cash_iI_zQGGUKcC7g45" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0613">--</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--InventoryGross_iI_zavevIgzR9Bd" style="vertical-align: bottom; background-color: white"> <td style="width: 77%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,172</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zuwxkI34C3O" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant and equipment</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,715</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_iI_z2qn4BSykUr7" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long Term Deposits</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_znFrc9JYUZY8" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identifiable intangible assets</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">800,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_znpAsWN2M8yc" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,985,113</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zyiFgAZf3eb4" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0625">--</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_zBvBXmEOrBu4" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total consideration</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2,890,000</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AD_zAPQice8z4x" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill from the acquisition primarily relates to the future economic benefits arising from the assets acquired, the assembled workforce acquired and synergies between the cultivation and retail operations and is consistent with the Company's stated intentions and strategy. Other assets include inventory and fixed assets.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of Naturaleaf’s identifiable intangible assets was $800,000 at April 30, 2021, consisting of $500,000 in licenses and $300,000 in brand names. During the year ended December 31, 2021, the Company recognized an amortization expense of $<span id="xdx_908_eus-gaap--AdjustmentForAmortization_c20210101__20211231_zsVzrA9Lsnvk">62,223</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Final Valuation</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt/106% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company finalized the fair market value assessment of Naturaleaf's assets during the year ended December 31, 2022. The following table summarizes the final allocation of the purchase price as of the acquisition date:</span></p> <p style="font: 10pt/106% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"/> <p id="xdx_894_eus-gaap--BusinessCombinationSegmentAllocationTableTextBlock_zD4GCHrXgMRe" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zDPsUuF6Z796" style="font-style: normal; font-weight: normal; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">Business Combination</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30A_134_zsJ3gENUmDK1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Naturaleaf Asset Acquisition (Details 1)"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_49E_20221231_z7iHfnmlx0Qa" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_zHXdTiZsCW4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Assets</span></td><td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_z8KpA8qHykzd" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,172</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_z5XepsXcNK05" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, Plant and Equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,715</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_iI_z4REAod7NjO4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_zIVCHgFXz8C3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Tangible Assets</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,887</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedTrademarksGross_iI_z6iQs3VeKIG7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tradenames and Trademarks</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">660,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedLicenseAgreementsGross_iI_zJWTLnSif2t4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">810,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsGrossAsset_iI_zBESP3SUAUW7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Intangible Assets</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,470,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_zI0hAfgUf2Bb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,332,113</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_zTrzdXh5cTDh" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Consideration</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,912,000</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_ze7Hi1NwVw5k" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; color: #027D01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"/> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The results of operations of Naturaleaf for the period from April 30, 2021 through December 31, 2022, are included in the Company's consolidated financial statements as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; color: #027D01"/> 83095 <p id="xdx_891_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_zgY4XqjWC429" style="margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zReHnvOxd5n9">Schedule of purchase price as of the acquisition</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_303_134_zC9KzJ46vPSg" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Naturaleaf Asset Acquisition (Details)"> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_496_20221231_zsnmuE9rkB46" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--Cash_iI_zQGGUKcC7g45" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0613">--</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--InventoryGross_iI_zavevIgzR9Bd" style="vertical-align: bottom; background-color: white"> <td style="width: 77%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 20%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,172</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_zuwxkI34C3O" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, plant and equipment</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,715</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_iI_z2qn4BSykUr7" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long Term Deposits</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_znFrc9JYUZY8" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identifiable intangible assets</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">800,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_znpAsWN2M8yc" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,985,113</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iI_zyiFgAZf3eb4" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0625">--</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_iI_zBvBXmEOrBu4" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total consideration</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2,890,000</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 72172 26715 6000 800000 1985113 2890000 62223 <p id="xdx_894_eus-gaap--BusinessCombinationSegmentAllocationTableTextBlock_zD4GCHrXgMRe" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zDPsUuF6Z796" style="font-style: normal; font-weight: normal; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">Business Combination</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30A_134_zsJ3gENUmDK1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Naturaleaf Asset Acquisition (Details 1)"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_49E_20221231_z7iHfnmlx0Qa" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_zHXdTiZsCW4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Assets</span></td><td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_z8KpA8qHykzd" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,172</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_z5XepsXcNK05" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, Plant and Equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,715</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_iI_z4REAod7NjO4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_zIVCHgFXz8C3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Tangible Assets</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,887</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedTrademarksGross_iI_z6iQs3VeKIG7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tradenames and Trademarks</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">660,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedLicenseAgreementsGross_iI_zJWTLnSif2t4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">810,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsGrossAsset_iI_zBESP3SUAUW7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Intangible Assets</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,470,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_zI0hAfgUf2Bb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,332,113</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_zTrzdXh5cTDh" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Consideration</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,912,000</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 15000 72172 26715 6000 119887 660000 810000 1470000 1332113 2912000 <p id="xdx_80A_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zKft5sCkubY5" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4. <span id="xdx_82B_zXybBlTZSpyg">Accounts Receivable and Advance from Clients</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable was comprised of the following:</span></p> <p style="margin: 0"/> <p style="margin: 0; text-indent: 0.25in"/> <p id="xdx_894_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z5UFkfHH7eKl" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zWjFLSxZjDOc">Schedule of Accounts receivable and advance from clients</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_304_134_zfqD3asthbob" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable and Advance from Clients (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_494_20221231_zpL3dLNCfW7l"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_49C_20211231_zYW09n1XeXBh"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/> 2022</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td></tr> <tr id="xdx_40D_eus-gaap--AccountsReceivableGross_iI_zlJnjTQVeRHk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts Receivable – Trade</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">469,111</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,856</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_zezUAFtgbjh6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Allowance for Doubtful Accounts</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,071</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(82,540</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40A_eus-gaap--AccountsAndNotesReceivableNet_iI_zPdTm1rFqXv8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts Receivable, net</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">465,040</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,316</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had allowances for bad debt expense during the years ended December 31, 2022 and 2021 of $<span id="xdx_907_ecustom--AllowancesForBadebtExpense_c20220101__20221231_zsKJ2bB2Ank4">5,438 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90A_ecustom--AllowancesForBadebtExpense_c20210101__20211231_z5HcjWcpgos7">54,435</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Advances from Clients had the following activity for 2022 and 2021:</span></p> <p id="xdx_894_eus-gaap--DepositLiabilitiesTypeTableTextBlock_zh0oimBkrEnd" style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"><span id="xdx_8BC_zFEsrPr3FsJc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposit Liabilities, Type </span></p> <p style="margin: 0"/> <p style="margin: 0"/> <p style="margin: 0"/> <table cellpadding="0" cellspacing="0" id="xdx_306_134_zjXZB6ya9nz9" style="font: 10pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable and Advance from Clients (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="width: 10%; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--RestructuringReserveCurrent_iI_c20211231_zWHfgPB5kyoi" style="width: 18%; font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,843</span></td><td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Additional deposits received</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--DepositLiabilityCurrent_iI_c20211231_zXdX5twy3w46" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Additional Deposits received"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">404,143</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Less: Deposits recognized as revenue</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--DepositsRecognizedAsRevenue_iNI_di_c20211231_zzFcmqGOzIil" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Deposits Recognized as revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(381,094</span></td><td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--OtherLiabilitiesCurrent_iI_c20211231_zjE8kXy6fnCh" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,892</span></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_495_20221231_zGynxQGhXo3g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td></tr> <tr id="xdx_403_eus-gaap--RestructuringReserveCurrent_iI_zk1iP0ig5kmc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,892</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--DepositLiabilityCurrent_iI_zms8YMezmX54" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Additional deposits received</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">691,769</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--DepositsRecognizedAsRevenue_iNI_di_znXe4MHq3ohi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Less: Deposits recognized as revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(522,663</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40B_eus-gaap--OtherLiabilitiesCurrent_iI_zFi07joCtJx9" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280,705</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zDcgFm7BXWY7" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z5UFkfHH7eKl" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zWjFLSxZjDOc">Schedule of Accounts receivable and advance from clients</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_304_134_zfqD3asthbob" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable and Advance from Clients (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_494_20221231_zpL3dLNCfW7l"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_49C_20211231_zYW09n1XeXBh"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/> 2022</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td></tr> <tr id="xdx_40D_eus-gaap--AccountsReceivableGross_iI_zlJnjTQVeRHk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts Receivable – Trade</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">469,111</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,856</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_zezUAFtgbjh6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Allowance for Doubtful Accounts</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,071</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(82,540</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40A_eus-gaap--AccountsAndNotesReceivableNet_iI_zPdTm1rFqXv8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts Receivable, net</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">465,040</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,316</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had allowances for bad debt expense during the years ended December 31, 2022 and 2021 of $<span id="xdx_907_ecustom--AllowancesForBadebtExpense_c20220101__20221231_zsKJ2bB2Ank4">5,438 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90A_ecustom--AllowancesForBadebtExpense_c20210101__20211231_z5HcjWcpgos7">54,435</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Advances from Clients had the following activity for 2022 and 2021:</span></p> <p id="xdx_894_eus-gaap--DepositLiabilitiesTypeTableTextBlock_zh0oimBkrEnd" style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"><span id="xdx_8BC_zFEsrPr3FsJc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposit Liabilities, Type </span></p> <p style="margin: 0"/> <p style="margin: 0"/> <p style="margin: 0"/> <table cellpadding="0" cellspacing="0" id="xdx_306_134_zjXZB6ya9nz9" style="font: 10pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable and Advance from Clients (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="width: 10%; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--RestructuringReserveCurrent_iI_c20211231_zWHfgPB5kyoi" style="width: 18%; font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,843</span></td><td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Additional deposits received</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--DepositLiabilityCurrent_iI_c20211231_zXdX5twy3w46" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Additional Deposits received"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">404,143</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Less: Deposits recognized as revenue</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--DepositsRecognizedAsRevenue_iNI_di_c20211231_zzFcmqGOzIil" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Deposits Recognized as revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(381,094</span></td><td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--OtherLiabilitiesCurrent_iI_c20211231_zjE8kXy6fnCh" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,892</span></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_495_20221231_zGynxQGhXo3g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td></tr> <tr id="xdx_403_eus-gaap--RestructuringReserveCurrent_iI_zk1iP0ig5kmc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,892</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--DepositLiabilityCurrent_iI_zms8YMezmX54" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Additional deposits received</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">691,769</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--DepositsRecognizedAsRevenue_iNI_di_znXe4MHq3ohi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Less: Deposits recognized as revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(522,663</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40B_eus-gaap--OtherLiabilitiesCurrent_iI_zFi07joCtJx9" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280,705</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 469111 93856 4071 82540 465040 11316 5438 54435 <p id="xdx_894_eus-gaap--DepositLiabilitiesTypeTableTextBlock_zh0oimBkrEnd" style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0"><span id="xdx_8BC_zFEsrPr3FsJc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposit Liabilities, Type </span></p> <p style="margin: 0"/> <p style="margin: 0"/> <p style="margin: 0"/> <table cellpadding="0" cellspacing="0" id="xdx_306_134_zjXZB6ya9nz9" style="font: 10pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable and Advance from Clients (Details 1)"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2020</span></td><td style="width: 10%; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--RestructuringReserveCurrent_iI_c20211231_zWHfgPB5kyoi" style="width: 18%; font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,843</span></td><td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Additional deposits received</span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--DepositLiabilityCurrent_iI_c20211231_zXdX5twy3w46" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Additional Deposits received"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">404,143</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Less: Deposits recognized as revenue</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--DepositsRecognizedAsRevenue_iNI_di_c20211231_zzFcmqGOzIil" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Deposits Recognized as revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(381,094</span></td><td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--OtherLiabilitiesCurrent_iI_c20211231_zjE8kXy6fnCh" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right" title="Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,892</span></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_495_20221231_zGynxQGhXo3g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td></tr> <tr id="xdx_403_eus-gaap--RestructuringReserveCurrent_iI_zk1iP0ig5kmc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,892</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--DepositLiabilityCurrent_iI_zms8YMezmX54" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Additional deposits received</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">691,769</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--DepositsRecognizedAsRevenue_iNI_di_znXe4MHq3ohi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Less: Deposits recognized as revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(522,663</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40B_eus-gaap--OtherLiabilitiesCurrent_iI_zFi07joCtJx9" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280,705</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 88843 404143 381094 111892 111892 691769 522663 280705 <p id="xdx_80D_eus-gaap--InventoryDisclosureTextBlock_zhPanXKsFcK8" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5. <span id="xdx_826_zj7a6myzVlM9">Inventory</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p id="xdx_895_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z74Dp2ZLUV34" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Schedule of inventory</span></p> <table cellpadding="0" cellspacing="0" id="xdx_30B_134_zDHHe6uuZqAg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventory (Details)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_495_20221231_zgghYOfLEvfg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_493_20211231_zHFG5Dwcbaf2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"/><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></td></tr> <tr id="xdx_40A_eus-gaap--InventoryRawMaterials_iI_zHZfOXHUASnc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw Materials</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,464</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,900</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--InventoryWorkInProcess_iI_zBzyb2LsA55e" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work In Process</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">206,306</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136,266</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_ecustom--FinishedGoodsSoil_iI_zqdiE5Cjgi6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished Goods – Soil</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,594</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--InventoryFinishedGoods_iI_zWNKGC7ELsT3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished Goods – Cannabis Retail</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,644</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,848</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--InventoryNet_iI_zLD3WSZtVdgh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Inventory</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">352,971</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,608</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A8_zJQFoV4Etm59" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z74Dp2ZLUV34" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Schedule of inventory</span></p> <table cellpadding="0" cellspacing="0" id="xdx_30B_134_zDHHe6uuZqAg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventory (Details)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_495_20221231_zgghYOfLEvfg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_493_20211231_zHFG5Dwcbaf2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; font-weight: bold; text-align: center"/><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></td></tr> <tr id="xdx_40A_eus-gaap--InventoryRawMaterials_iI_zHZfOXHUASnc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw Materials</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,464</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,900</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--InventoryWorkInProcess_iI_zBzyb2LsA55e" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work In Process</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">206,306</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">136,266</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_ecustom--FinishedGoodsSoil_iI_zqdiE5Cjgi6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished Goods – Soil</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58,594</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--InventoryFinishedGoods_iI_zWNKGC7ELsT3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished Goods – Cannabis Retail</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,644</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,848</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--InventoryNet_iI_zLD3WSZtVdgh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Inventory</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">352,971</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">278,608</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 38464 60900 206306 136266 66557 58594 41644 22848 352971 278608 <p id="xdx_80A_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z22JFVhbAQFj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6. <span id="xdx_825_ztu5yAgwgGHj">Property and Equipment, net</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net, was comprised of the following:</span></p> <p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zhaZlEk0FAVj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_z2iNuiTiOmYf">Schedule of property and equipment</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_301_134_zKrEyeFIb9wh" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, net (Details)"> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"/><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zFn1yUhddtu7" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,380</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,574</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pdp0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zHpbFTjKoh8e" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,204</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pdp0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zWroZ38ktoTg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,204</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Fixtures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zQo97cpKCiVg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,328</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z2HhukI57Ard" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,328</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and Equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z7dVerw6D7bc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,520</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zeGmmMXiTE95" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">376,745</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold Improvements</span></td><td style="font: 7pt Arial Narrow, Helvetica, Sans-Serif; color: #027D01; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 7pt Arial Narrow, Helvetica, Sans-Serif; color: #027D01; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zDJ93K0K7th7" style="border-bottom: Black 1pt solid; font: 7pt Arial Narrow, Helvetica, Sans-Serif; color: #027D01; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #027D01">----</span></td><td style="font: 7pt Arial Narrow, Helvetica, Sans-Serif; padding-bottom: 1pt; color: #027D01; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zcKM4xYha0H2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0726">—</span>  </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_z1w0pS3FWL94" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">427,432</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231_zdyv9LjFRfG4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,851</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Accumulated Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_z4X4Maf6dwT2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(113,650</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zJEqKoIzTbP8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(56,019</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--PropertyPlantAndEquipmentNet1_iI_pp0p0_c20221231_zvRVGAq2kZv8" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,782</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNet1_iI_pp0p0_c20211231_zucQk6hAJTn1" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">375,832</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_zMW38g4KnHg3" style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--PropertyPlantAndEquipmentTextBlock_zhaZlEk0FAVj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_z2iNuiTiOmYf">Schedule of property and equipment</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_301_134_zKrEyeFIb9wh" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment, net (Details)"> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"/><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zFn1yUhddtu7" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,380</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,574</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pdp0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zHpbFTjKoh8e" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,204</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pdp0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zWroZ38ktoTg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,204</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Fixtures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zQo97cpKCiVg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,328</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z2HhukI57Ard" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,328</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and Equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_z7dVerw6D7bc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,520</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zeGmmMXiTE95" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">376,745</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold Improvements</span></td><td style="font: 7pt Arial Narrow, Helvetica, Sans-Serif; color: #027D01; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 7pt Arial Narrow, Helvetica, Sans-Serif; color: #027D01; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zDJ93K0K7th7" style="border-bottom: Black 1pt solid; font: 7pt Arial Narrow, Helvetica, Sans-Serif; color: #027D01; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #027D01">----</span></td><td style="font: 7pt Arial Narrow, Helvetica, Sans-Serif; padding-bottom: 1pt; color: #027D01; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zcKM4xYha0H2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0726">—</span>  </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_z1w0pS3FWL94" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">427,432</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231_zdyv9LjFRfG4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">431,851</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Accumulated Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_z4X4Maf6dwT2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(113,650</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zJEqKoIzTbP8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(56,019</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--PropertyPlantAndEquipmentNet1_iI_pp0p0_c20221231_zvRVGAq2kZv8" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,782</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--PropertyPlantAndEquipmentNet1_iI_pp0p0_c20211231_zucQk6hAJTn1" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">375,832</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 47380 39574 13204 13204 2328 2328 364520 376745 427432 431851 113650 56019 313782 375832 <p id="xdx_806_eus-gaap--IntangibleAssetsDisclosureTextBlock_zQDmvSzE8Mod" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7. <span id="xdx_823_zYONSi32Y5J">Intangible Assets</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A significant amount of the Company’s current identified intangible assets were assumed upon consummation of the Naturaleaf acquisition on April 30, 2021. The Company has incurred capitalizable costs in connection with patent applications that it started work on. Identified intangible assets consisted of the following at the dates indicated below:</span></p> <p id="xdx_896_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_z0nkmqMC4R0e" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zttVTpQNbzt4">Schedule of intangible assets</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_300_134_z4JvaGQJkkee" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible Assets (Details)"> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="15" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross carrying amount</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated amortization</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying value</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated useful life</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zY9kclaU2Pkj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">818,464</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td> <td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zFOgrJ3UcIPl" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,552</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zQyzBN4DUW9d" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">683,912</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--FiniteLivedIntangibleAssetUsefulLifeOne_dtY_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zoZfrKkIoN4g" style="text-align: right" title="Estimated Useful Life"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zHiELNYizQtj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">660,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zDWVUMrzxcTg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,670</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zypuYgRxlKuj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">539,330</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--FiniteLivedIntangibleAssetUsefulLifeOne_dtY_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zaeRtLPMpsT7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible assets, net</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20221231_zwwtKEx6ZFF1" style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,488,464</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td> <td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20221231_zUcfziRhLg9c" style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255,222</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_ecustom--FiniteLivedIntangibleAssetsNet1_iI_pp0p0_c20221231_ztYyvOgGD6A2" style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,223,242</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zICanK4CnXx" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted-average amortization period for intangible assets we acquired during the year ended December 31, 2022, was approximately <span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231_z2BQ3JD2hmfi">11.47 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expense for intangible assets was $<span id="xdx_90A_eus-gaap--OtherDepreciationAndAmortization_c20220101__20221231_zdqnkazhNma8">186,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> and $<span id="xdx_902_eus-gaap--OtherDepreciationAndAmortization_c20210101__20211231_z1ti8ATCLgYb">62,223</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> for the years ended December 31, 2022 and 2021, respectively. Total estimated amortization expense for our intangible assets for the years 2023 through 2027 is as follows:</span></p> <p id="xdx_892_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zPDeSOBHQSR8" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B2_zpwWRtjTyrXb">Schedule of estimated amortization expense</span></b></span></p> <table cellpadding="0" cellspacing="0" id="xdx_309_134_zVLS4E6Dd7Ql" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible Assets (Details 1)"> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_492_20221231_zUz4gGs8jnrd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="padding-bottom: 1pt"><p style="margin: 0; text-align: center"/></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended<br/> December 31, 2022</b></span></td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zt20iZSKU33b" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 43%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zEuWQLE5mhvd" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_zJJPXwcuc0pa" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_zshjwd7Sl9Sk" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">145,997</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_zwDbCtzchGli" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_zDLM4p1lLEGg" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td/> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">463,781</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A0_zfV1ZMzFLv5f" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_z0nkmqMC4R0e" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zttVTpQNbzt4">Schedule of intangible assets</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_300_134_z4JvaGQJkkee" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible Assets (Details)"> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="15" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Gross carrying amount</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated amortization</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Carrying value</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Estimated useful life</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20201231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zY9kclaU2Pkj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">818,464</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td> <td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zFOgrJ3UcIPl" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,552</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zQyzBN4DUW9d" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">683,912</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--FiniteLivedIntangibleAssetUsefulLifeOne_dtY_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zoZfrKkIoN4g" style="text-align: right" title="Estimated Useful Life"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15 years</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zHiELNYizQtj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">660,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zDWVUMrzxcTg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,670</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zypuYgRxlKuj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">539,330</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--FiniteLivedIntangibleAssetUsefulLifeOne_dtY_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zaeRtLPMpsT7" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible assets, net</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20221231_zwwtKEx6ZFF1" style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,488,464</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td> <td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20221231_zUcfziRhLg9c" style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255,222</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98F_ecustom--FiniteLivedIntangibleAssetsNet1_iI_pp0p0_c20221231_ztYyvOgGD6A2" style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,223,242</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 818464 134552 683912 15 years 660000 120670 539330 5 years 1488464 255222 1223242 P11Y5M19D 186000 62223 <p id="xdx_892_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zPDeSOBHQSR8" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B2_zpwWRtjTyrXb">Schedule of estimated amortization expense</span></b></span></p> <table cellpadding="0" cellspacing="0" id="xdx_309_134_zVLS4E6Dd7Ql" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangible Assets (Details 1)"> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_492_20221231_zUz4gGs8jnrd" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="3" style="padding-bottom: 1pt"><p style="margin: 0; text-align: center"/></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="padding-right: 0pt; text-align: center; padding-left: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended<br/> December 31, 2022</b></span></td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_zt20iZSKU33b" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 43%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zEuWQLE5mhvd" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_zJJPXwcuc0pa" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_zshjwd7Sl9Sk" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">145,997</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_zwDbCtzchGli" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_zDLM4p1lLEGg" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td/> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">463,781</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 186000 186000 186000 145997 54000 463781 <p id="xdx_80C_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zBc7R7iuuHfc" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8. <span id="xdx_82F_zyY3ay7gRb5a">Accrued and Other Current Liabilities</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued and other current liabilities consisted of the following:</span></p> <p id="xdx_895_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z6hr58ho9kdl" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zUX2Togmreq7">Schedule of accrued and other current liabilities</span></span></p> <p style="margin: 0"/> <table cellpadding="0" cellspacing="0" id="xdx_30B_133_zWBHh1OeQvXb" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued and Other Current Liabilities (Details)"> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_498_20221231_zMEyW8obSM0c" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_49F_20211231_zU4dJ5kJhleh" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"/><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></td></tr> <tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_iI_zXtOZAzoAcpj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued Interest</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,130</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,137</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--AccruedSalariesCurrent_iI_zx0gnyIgfmt5" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued Payroll</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,029</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,428</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_zhu9uEFRZfua" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales Tax Payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">592</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AccountsPayableOtherCurrent_iI_zlEdWdwdkFa2" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Accrued Expenses &amp; Payables</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">168,258</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,559</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_zvT7p41Y0b99" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued and other current liabilities</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">233,348</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">161,716</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AD_zEO3OdugjRre" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z6hr58ho9kdl" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zUX2Togmreq7">Schedule of accrued and other current liabilities</span></span></p> <p style="margin: 0"/> <table cellpadding="0" cellspacing="0" id="xdx_30B_133_zWBHh1OeQvXb" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued and Other Current Liabilities (Details)"> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_498_20221231_zMEyW8obSM0c" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_49F_20211231_zU4dJ5kJhleh" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"/><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td><td style="text-align: center; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></td></tr> <tr id="xdx_40C_eus-gaap--AccruedLiabilitiesCurrent_iI_zXtOZAzoAcpj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued Interest</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,130</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,137</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--AccruedSalariesCurrent_iI_zx0gnyIgfmt5" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued Payroll</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,029</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,428</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_zhu9uEFRZfua" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales Tax Payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,931</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">592</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--AccountsPayableOtherCurrent_iI_zlEdWdwdkFa2" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Accrued Expenses &amp; Payables</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">168,258</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,559</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_zvT7p41Y0b99" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued and other current liabilities</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">233,348</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">161,716</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 39130 74137 22029 18428 3931 592 168258 68559 233348 161716 <p id="xdx_80C_ecustom--StockPayableTextBlock_zOy2KtMQQvk7" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9. <span id="xdx_821_zzywSYNTMb34">Stock Payable</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following summarizes the changes in common stock payable:</span></p> <p id="xdx_89A_ecustom--ScheduleOfStockPayableTableTextBlock_zMdyCdXf1NL4" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zhFmUFup8AG3">Schedule of stock payable</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30B_134_zXswD83VR7lc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Payable (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--StockPayableAmounts_iS_pp0p0_c20220101__20221231_zGkLephGbU94" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0795">—</span>  </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 70%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Payments received on shares not issued</span></td><td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--AdditionalExpensedIncurredAmount_pp0p0_c20220101__20221231_zmfi62yyEmZ1" style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,342</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--StockPayableAmounts_iE_pp0p0_c20220101__20221231_znHFMGnvctj3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,342</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_z2QJ7fUVKRc5" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_ecustom--ScheduleOfStockPayableTableTextBlock_zMdyCdXf1NL4" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zhFmUFup8AG3">Schedule of stock payable</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30B_134_zXswD83VR7lc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Payable (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_ecustom--StockPayableAmounts_iS_pp0p0_c20220101__20221231_zGkLephGbU94" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0795">—</span>  </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 70%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Payments received on shares not issued</span></td><td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_ecustom--AdditionalExpensedIncurredAmount_pp0p0_c20220101__20221231_zmfi62yyEmZ1" style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,342</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_ecustom--StockPayableAmounts_iE_pp0p0_c20220101__20221231_znHFMGnvctj3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,342</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 74342 74342 <p id="xdx_80E_ecustom--OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock_zOoWkBmlHxkf" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10. <span id="xdx_82C_zpByNXMvyeD4">Operating Lease Right-of-Use Asset/Operating Lease Liability</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our headquarters are located at 200 Union Street, Ste. 200, Lakewood, CO 80228. Our offices are not leased but granted pursuant to an accommodation that creates no tenancy, leasehold, or other real property interest. Our accommodation expires on August 31, 2023. Our monthly payment in exchange for the accommodation is $3,250.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company leases property under various operating leases. Property leases include retail and cultivation space with fixed rent payments and lease terms ranging from one to two years. The Company is obligated to pay the lessor for maintenance, real estate taxes, insurance and other operating expenses on certain property leases. These expenses are variable and are not included in the measurement of the lease asset or lease liability. These expenses are recognized as variable rent expense when incurred.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s lease portfolio consists of the following.</span></p> <p id="xdx_894_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_zQ4wzSveVCVh" style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zmXl1SxqDwdf" style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">Schedule of Other Operating Cost and Expense</span></span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 48px; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">o</span></td> <td style="border: windowtext 1pt solid; padding-right: 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1004 S. Tejon Street, Colorado Springs, CO 80903; The Company assumed a lease originally entered into on February 12, 2016, which was the subject of a extension agreement dated April 5, 2022. The term of the lease was extended from May 1, 2022 until April 30, 2027. The Company's monthly rental payments from January 1, 2022 to May 1, 2022 was $3,700. From May 1, 2022 through the year ended December 31, 2022, monthly rent was $3,875. Remaining rental payments due for the extended period are:   May 1, 2022 to April 30, 2023 $3,875 May 1, 2023 to April 30, 2024 $4,050 May 1, 2024 to April 30, 2025 $4,225 May 1, 2025 to April 30, 2026 $4,400 May 1, 2026 to April 30, 2027 $4,575</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 72.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30E_134_z0d36A5J12se" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border: Black 1pt solid; width: 78%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">May 1, 2022 to April 30, 2023</span></td> <td id="xdx_987_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--May2022ToApril2023Member_zFVzv4gmgMV8" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$3,875</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">May 1, 2023 to April 30, 2024</span></td> <td id="xdx_984_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--May2023ToApril2024Member_z280EvX2PWMi" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$4,050</span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">May 1, 2024 to April 30, 2025</span></td> <td id="xdx_987_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--May2024ToApril2025Member_zBNuy8i04X69" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$4,225</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">May 1, 2025 to April 30, 2026</span></td> <td id="xdx_988_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--May2025ToApril2026Member_zM8HFPcXSEJg" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$4,400</span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">May 1, 2026 to April 30, 2027</span></td> <td id="xdx_98F_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--May2026ToApril2027Member_zWmRvQkgZtHh" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$4,575</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 72.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0.3pt 0.25pt 72.25pt; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 48px; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">o</span></td> <td style="padding-right: 0.3pt; padding-bottom: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909 subject to a one-year term expiring June 30, 2023 with a monthly rent of $5,000.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 48px; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">o</span></td> <td style="border: windowtext 1pt solid; padding-right: 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5870 Lehman Drive Suite 200, Colorado Springs, CO 80918 The Company and landlord  previously entered into a lease in 2017 which expired December 31, 2022. At December 31, 2022, the Company's monthly rent was $2,732. On April 26, 2022, the Company and landlord entered into an extension agreement which extended the tenancy from January 1, 2023 through January 1, 2027. Rental payments due for the extended period are:   January 1, 2023 $2,898 January 1, 2024 $2,985 January 1, 2025 $3,075 January 1, 2026 $3,167 January 1, 2027 $3,262</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"/> <p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_301_134_z5Na4AFhkKV5" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border: Black 1pt solid; width: 76%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">January 1, 2023</span></td> <td id="xdx_98B_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--January2023Member_z9oypw4CrbHj" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 24%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$2,898</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">January 1, 2024</span></td> <td id="xdx_98D_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--January2024Member_zLlokiGNsObl" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$2,985</span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">January 1, 2025</span></td> <td id="xdx_983_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--January2025Member_zuorCFQcgXb6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$3,075</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">January 1, 2026</span></td> <td id="xdx_98E_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--January2026Member_zkmilvWstixf" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$3,167</span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">January 1, 2027</span></td> <td id="xdx_989_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--January2027Member_zXS9ovtw9Ri5" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$3,262</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"/> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 48px; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">o</span></td> <td style="border: windowtext 1pt solid; padding-right: 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2611 Durango Drive, CO Springs, CO. The Company and landlord entered into a lease on March 10, 2021, which terminated on May 31, 2022. On June 23, 2021, the Company and landlord entered into an extension of the lease for a term of thirty-six months, beginning June 1, 2022 and terminating June 1, 2024. At December 31, 2022, monthly rent was $11,000. Rental payments due for the extended period are:       June 1, 2022 to June 1, 2023 $11,000 June 1, 2023 to June 1, 2024 $11,880 June 1, 2025 to June 1, 2025 $12,830  </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"/> <p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_306_134_zbWdWVYn3em2" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border: Black 1pt solid; width: 70%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">June 1, 2022 to June 1, 2023</span></td> <td id="xdx_985_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--June2022ToJune2023Member_zgYcFiELUUCa" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 30%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$11,000</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">June 1, 2023 to June 1, 2024</span></td> <td id="xdx_98F_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--June2023ToJune2024Member_zNB3wykWh9Gj" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$11,880</span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">June 1, 2025 to June 1, 2025</span></td> <td id="xdx_986_eus-gaap--SaleLeasebackTransactionRentExpense_iT_c20220101__20221231__us-gaap--AwardDateAxis__custom--June2024ToJune2025Member_z1J2sNQxQba7" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$12,830</span></td></tr> </table> <p id="xdx_8A4_zVzQjHi0J3L4" style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 12, 2022, the Company entered into an accommodation for office space, effective September 1, 2022, located at 200 Union St., Suite 200, Lakewood, CO 80228. The accommodation creates no tenancy, leasehold or other real property interest concerning the Registrant. The Registrant's telephone number is unchanged. We determined under ASC 842, due to the nature of the accommodation that the membership agreement met the criteria of ASC 842-20-25-2, and as such, it was not necessary to capitalize the accomodation, and the membership fee will be recognized on a monthly straight-line basis.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 1, 2020, as part of the Naturaleaf Acquisition, the Company entered into leases for grow facilities and dispensaries. These leases were determined to be operating leases under ASC 842, and such leases were capitalized. It was determined that the Tejon lease, due to the short-term nature of the lease, met the criteria of ASC 842-20-25-2, and as such, it was not necessary to capitalize the lease, and rent would be recognized on a straight-line basis.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records the lease asset and lease liability at the present value of lease payments over the lease term. The leases typically do not provide an implicit rate; therefore, the Company uses its estimated incremental borrowing rate at the time of lease commencement to discount the present value of lease payments. The Company’s discount rate for operating leases at December 31, 2022 was 12.5%. Leases often include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. Lease expense is recognized on a straight-line basis over the lease term to the extent that collection is considered probable. As a result, the Company has been recognizing rents as they become payable.</span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the aggregate remaining annual lease payments of operating leases liabilities are as follows:</span></p> <p id="xdx_890_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zDfWLE6OUxo3" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zRWQeA34FL72">Schedule of operating leases liabilities</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_302_134_zCEKmCjbS7Gg" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_496_20221231_zh1aBZ2TUhO7" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating<br/> Leases</b></span></td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_z8cVFIUXLxS7" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">604,020</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_zeikc2Z9DO73" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">604,020</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--LessAmountRepresentingInterest_iNI_di_zVxOoUwBRFk" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: amount representing interest</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0839">-</span></span></td></tr> <tr id="xdx_400_ecustom--PresentValueOfFutureMinimumLeasePayments_iI_zhQuIRBIj0Gc" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of future minimum lease payments</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">604,020</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--CurrentObligationsUnderLeases_iNI_di_zDoUve0dBIJ6" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: current obligations under leases</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181,661</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--CapitalLeaseObligations_iI_zZRri91tYlyd" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term lease obligations</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">422,359</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0; text-align: justify"/> <p id="xdx_8A1_zUa1YIXXViU6" style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-indent: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the aggregate remaining minimal annual lease payments under these operating leases were as follows: </span></p> <p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zXvXimvnkwYj" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zf78El5z76Y9">Schedule of remaining minimal annual lease payments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 2)"> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20221231_ztr8H3WX70B" style="width: 43%; text-align: right" title="2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">604,020</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20221231_z5WMECClK67d" style="border-bottom: black 2.25pt double; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>604,020</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_zunXyhsb2pQb" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_zQ4wzSveVCVh" style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zmXl1SxqDwdf" style="font-style: normal; font-weight: 400; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(255, 255, 255)">Schedule of Other Operating Cost and Expense</span></span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 48px; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">o</span></td> <td style="border: windowtext 1pt solid; padding-right: 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1004 S. Tejon Street, Colorado Springs, CO 80903; The Company assumed a lease originally entered into on February 12, 2016, which was the subject of a extension agreement dated April 5, 2022. The term of the lease was extended from May 1, 2022 until April 30, 2027. The Company's monthly rental payments from January 1, 2022 to May 1, 2022 was $3,700. From May 1, 2022 through the year ended December 31, 2022, monthly rent was $3,875. Remaining rental payments due for the extended period are:   May 1, 2022 to April 30, 2023 $3,875 May 1, 2023 to April 30, 2024 $4,050 May 1, 2024 to April 30, 2025 $4,225 May 1, 2025 to April 30, 2026 $4,400 May 1, 2026 to April 30, 2027 $4,575</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 72.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30E_134_z0d36A5J12se" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border: Black 1pt solid; width: 78%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">May 1, 2022 to April 30, 2023</span></td> <td id="xdx_987_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--May2022ToApril2023Member_zFVzv4gmgMV8" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 22%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$3,875</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">May 1, 2023 to April 30, 2024</span></td> <td id="xdx_984_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--May2023ToApril2024Member_z280EvX2PWMi" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$4,050</span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">May 1, 2024 to April 30, 2025</span></td> <td id="xdx_987_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--May2024ToApril2025Member_zBNuy8i04X69" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$4,225</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">May 1, 2025 to April 30, 2026</span></td> <td id="xdx_988_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--May2025ToApril2026Member_zM8HFPcXSEJg" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$4,400</span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">May 1, 2026 to April 30, 2027</span></td> <td id="xdx_98F_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--May2026ToApril2027Member_zWmRvQkgZtHh" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$4,575</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 72.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0.3pt 0.25pt 72.25pt; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 48px; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">o</span></td> <td style="padding-right: 0.3pt; padding-bottom: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909 subject to a one-year term expiring June 30, 2023 with a monthly rent of $5,000.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 48px; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">o</span></td> <td style="border: windowtext 1pt solid; padding-right: 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5870 Lehman Drive Suite 200, Colorado Springs, CO 80918 The Company and landlord  previously entered into a lease in 2017 which expired December 31, 2022. At December 31, 2022, the Company's monthly rent was $2,732. On April 26, 2022, the Company and landlord entered into an extension agreement which extended the tenancy from January 1, 2023 through January 1, 2027. Rental payments due for the extended period are:   January 1, 2023 $2,898 January 1, 2024 $2,985 January 1, 2025 $3,075 January 1, 2026 $3,167 January 1, 2027 $3,262</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"/> <p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_301_134_z5Na4AFhkKV5" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border: Black 1pt solid; width: 76%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">January 1, 2023</span></td> <td id="xdx_98B_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--January2023Member_z9oypw4CrbHj" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 24%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$2,898</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">January 1, 2024</span></td> <td id="xdx_98D_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--January2024Member_zLlokiGNsObl" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$2,985</span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">January 1, 2025</span></td> <td id="xdx_983_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--January2025Member_zuorCFQcgXb6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$3,075</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">January 1, 2026</span></td> <td id="xdx_98E_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--January2026Member_zkmilvWstixf" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$3,167</span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">January 1, 2027</span></td> <td id="xdx_989_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--January2027Member_zXS9ovtw9Ri5" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$3,262</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"/> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 48px; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">o</span></td> <td style="border: windowtext 1pt solid; padding-right: 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2611 Durango Drive, CO Springs, CO. The Company and landlord entered into a lease on March 10, 2021, which terminated on May 31, 2022. On June 23, 2021, the Company and landlord entered into an extension of the lease for a term of thirty-six months, beginning June 1, 2022 and terminating June 1, 2024. At December 31, 2022, monthly rent was $11,000. Rental payments due for the extended period are:       June 1, 2022 to June 1, 2023 $11,000 June 1, 2023 to June 1, 2024 $11,880 June 1, 2025 to June 1, 2025 $12,830  </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"/> <p style="font: 10pt/105% Times New Roman, Times, Serif; margin: 0 0 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_306_134_zbWdWVYn3em2" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border: Black 1pt solid; width: 70%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">June 1, 2022 to June 1, 2023</span></td> <td id="xdx_985_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--June2022ToJune2023Member_zgYcFiELUUCa" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 30%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$11,000</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">June 1, 2023 to June 1, 2024</span></td> <td id="xdx_98F_eus-gaap--SaleLeasebackTransactionRentExpense_c20220101__20221231__us-gaap--AwardDateAxis__custom--June2023ToJune2024Member_zNB3wykWh9Gj" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$11,880</span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">June 1, 2025 to June 1, 2025</span></td> <td id="xdx_986_eus-gaap--SaleLeasebackTransactionRentExpense_iT_c20220101__20221231__us-gaap--AwardDateAxis__custom--June2024ToJune2025Member_z1J2sNQxQba7" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify; line-height: 105%" title="Rental expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 105%">$12,830</span></td></tr> </table> 3875 4050 4225 4400 4575 2898 2985 3075 3167 3262 11000 11880 12830 <p id="xdx_890_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zDfWLE6OUxo3" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zRWQeA34FL72">Schedule of operating leases liabilities</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_302_134_zCEKmCjbS7Gg" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_496_20221231_zh1aBZ2TUhO7" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating<br/> Leases</b></span></td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_z8cVFIUXLxS7" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 71%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1pt solid; width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">604,020</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_zeikc2Z9DO73" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">604,020</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--LessAmountRepresentingInterest_iNI_di_zVxOoUwBRFk" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: amount representing interest</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0839">-</span></span></td></tr> <tr id="xdx_400_ecustom--PresentValueOfFutureMinimumLeasePayments_iI_zhQuIRBIj0Gc" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of future minimum lease payments</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">604,020</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--CurrentObligationsUnderLeases_iNI_di_zDoUve0dBIJ6" style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: current obligations under leases</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">181,661</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--CapitalLeaseObligations_iI_zZRri91tYlyd" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term lease obligations</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">422,359</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0; text-align: justify"/> 604020 604020 604020 -181661 422359 <p id="xdx_89B_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zXvXimvnkwYj" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zf78El5z76Y9">Schedule of remaining minimal annual lease payments</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 2)"> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_c20221231_ztr8H3WX70B" style="width: 43%; text-align: right" title="2023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">604,020</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20221231_z5WMECClK67d" style="border-bottom: black 2.25pt double; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>604,020</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 604020 604020 <p id="xdx_80F_eus-gaap--DebtDisclosureTextBlock_zJgSO00z0SH2" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 11. <span id="xdx_826_zTVaO5ohQNMl">Loans Payable</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PPP Loans</i></span></p> <p style="margin: 0; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 27, 2020, the CARES Act was enacted to provide financial aid to family and businesses impacted by the COVID-19 pandemic. The Company participated in the CARES Act, and on August 6, 2020, the Company entered into a note payable with a bank under the Small Business Administration (“SBA”) Paycheck Protection Program (“PPP loan”) in the amount of $109,914. This loan payable matured on August 6, 2022, with a fixed interest rate of 1% per annum with interest deferred for six months. The PPP loan has an initial term of two years and is unsecured and guaranteed by the SBA. On March 1, 2021, the Company applied for and received forgiveness of the principal of $109,914 and interest of $632.01 on the PPP loan.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 23, 2021, the Company entered into a second note payable with a bank under the SBA PPP Loan in the amount of $130,186. The PPP Loan is subject to the same terms of forgiveness as above. On September 27, 2021, the SBA forgave the principal of $130,186 and any accrued interest.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendment to Naturaleaf Seller Note</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 29, 2022, the Company and Medihemp, LLC, and its wholly owned subsidiary, SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., all collectively doing business as "Naturaleaf," (hereafter, "Naturaleaf") entered into an amendment to the previously disclosed material definitive agreement dated March 11, 2021.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The original material definitive agreement disclosed the Company's acquisition of assets from Naturaleaf, including, but not limited to: Naturaleaf's fixed assets, Medical Marijuana Center licenses, a Medical Cannabis’ Medical Marijuana Infused Product Manufacturer license, a Medical Marijuana Optional Premises Cultivation license, customer accounts, intellectual property, goodwill, and leases. As consideration for the purchase, the Company agreed to pay an aggregate purchase price of $2,200,000 in cash and 3,000,000 shares of Registrant's common stock.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The parties agreed to a payment schedule, requiring the Company to first pay an initial non-refundable payment of $20,000, credited against the purchase price. Thereafter, upon the party's completion of due diligence, and their receipt of contingent approval letters for the transfer of the Cannabis Licenses from the Colorado Marijuana Enforcement Division and the City of Colorado Springs (the "Closing"), the Company agreed to pay Naturaleaf $1,080,000 and issue Naturaleaf, or its designees, 3,000,000 shares of the Company's restricted common stock. The balance of the purchase price of $1,100,000 was payable based upon a promissory note issued by the Company, which included 10% interest. The note was due one year after Closing. On April 30, 2021, the Closing occurred, and the Company paid Naturaleaf $1,080,000 and issued 3,000,000 shares of restricted stock.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 29, 2022, the Company and the previous owners of Naturaleaf agreed to an amendment of the note. The Company paid $550,000 of the principal, combined with accrued interest of $110,000 in exhchange for a new note with a principal balance of $550,000, interest per annum of 12% and a maturity date of April 29, 2023.</span></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"/> <p style="margin: 0; text-align: justify"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zQ2Wjpb7MSA9" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 12. <span id="xdx_828_zoJrepwSFqzc">Related Party Transactions </span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 22, 2022, the Company issued a promissory note to Ellis Smith in exchange for $150,000. Interest on the note is 15% per annum. The note has a maturity date of May 21, 2023. If not paid within ten days of maturity, the note contains default interest of 18% per annum and a late charge penalty of 5% of the principal amount due.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80B_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zF20rJ8YwiK3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 13. <span id="xdx_82E_zpGQhZ0uO8ke">Stock Based Compensation</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company issued stock-based compensation for employees and service providers pursuant to its 2015 Equity Incentive Plan.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted Shares</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, the Company grants certain employees restricted shares of its common stock to provide further compensation in-lieu of wages and to align the employee’s interests with the interests of its stockholders. Because vesting is based on continued employment, these equity-based incentives are also intended to attract, retain and motivate personnel upon whose judgment, initiative and effort the Company’s success is largely dependent.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company granted 2,000,000 restricted shares and recognized $78,342 in associated employee stock-based compensation expenses. The fair value of restricted stock unit is determined based on the quoted closing price of the Company’s common stock on the date granted. As of December 31, 2022, none of the shares were issued, and the entire amount is recorded as stock payable.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company issued a total of 5,750,000 restricted shares to service providers and consultants for services rendered and recognized expenses of $219,940. The fair value of restricted stock is determined based on the quoted closing price of the Company’s common stock on the date granted.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net Loss Per Share</i></span></p> <p style="margin: 0; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding during the reporting period. Diluted net loss per share is computed similarly to basic loss per share, except that it includes the potential dilution that could occur if dilutive securities are exercised.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding stock options and common stock warrants are considered anti-dilutive because we are in a net loss position. Accordingly, the number of weighted average shares outstanding for basic and fully diluted net loss per share are the same.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following summarizes equity instruments that may, in the future, have a dilutive effect on earnings per share:</span></p> <p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zjpv2auEWIb" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zMG1eWyCSTK7">Schedule of stock based compensation</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30F_134_zCK2hWjcGXf1" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stock Based Compensation (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_49D_20221231_zvGWYhAmPDqf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_497_20211231_zn1cX3j9aHlg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, <br/> 2022</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></td></tr> <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstanding_iI_zpfv3OF4H458" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td> <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0866">—</span> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0867">—</span></span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--ConvertibleNotesPayable_iI_zotc7nkkkpme" style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Payable</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>                </b><span style="-sec-ix-hidden: xdx2ixbrl0869">—</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">275,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--DilutiveSecuritiesAmount_iI_zXG97Alt7nu6" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0872">—</span> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>275,000</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zqkUsQWuorph" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company did not issue or approve any warrants.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zjpv2auEWIb" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zMG1eWyCSTK7">Schedule of stock based compensation</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30F_134_zCK2hWjcGXf1" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Stock Based Compensation (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_49D_20221231_zvGWYhAmPDqf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_497_20211231_zn1cX3j9aHlg" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, <br/> 2022</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2021</b></span></td></tr> <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstanding_iI_zpfv3OF4H458" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td> <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0866">—</span> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0867">—</span></span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--ConvertibleNotesPayable_iI_zotc7nkkkpme" style="vertical-align: bottom; background-color: white"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Payable</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>                </b><span style="-sec-ix-hidden: xdx2ixbrl0869">—</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">275,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--DilutiveSecuritiesAmount_iI_zXG97Alt7nu6" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="-sec-ix-hidden: xdx2ixbrl0872">—</span> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>275,000</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 275000 275000 <p id="xdx_80D_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zprcRXXWxoLk" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 14. <span id="xdx_825_zwyjztifmQO6">Shareholders’ Equity</span></b></span></p> <p style="margin: 0; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred Stock</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $0.01 par value. No shares of preferred stock were issued and outstanding at December 31, 2022, and 2021, respectively.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common Stock</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company issued 2,500,000 registered shares of common stock in exchange for net proceeds of $117,628.50 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019, with White Lion Capital LLC. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company issued 1,000,000 restricted shares of common stock for consulting services. The Company recognized stock compensation of $50,000 related to the issuance based on the fair market value on the date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company issued 4,750,000 restricted shares of common stock in exchange for marketing and investor relations services. The Company recognized stock compensation of $169,979 related to the issuance based on the fair market value on the date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company issued 2,000,000 shares to employees for services rendered under contract. The Company recognized stock compensation of $46,226 related to the issuance based on the fair market value on the date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company issued 8,050,000 registered shares of common stock in exchange for net proceeds of $1,241,043 pursuant to the Common Stock Purchase Agreement entered into on October 11, 2019 with White Lion Capital LLC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company issued 3,000,000 shares of its restricted common stock to the sellers of Naturaleaf, as part of the acquisition of assets of Naturaleaf. The shares had a value of $690,000 based on a closing market price on April 30, 2021 of $0.23 per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, warrants with a cashless exercise provision were exercised for 125,000 restricted shares, of which, a warrant for 100,000 shares was exercised by an officer/director of the Company.</span></p> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zWitmHudGNE7" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 15. <span id="xdx_82A_zbNK75Tcq5jk">Commitments and Contingencies</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Legal</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of its business, the Company becomes involved in various legal proceedings involving various matters. As of December 31, 2022, there are no pending legal proceedings involving the Company. The Company's expenses legal fees in the period they are incurred.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Employment Litigation </i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 15, 2019, a civil action was filed against the Company and Mr. Terry Buffalo, our former chief executive officer and director, and Mr. Ellis Smith, our current chief executive and financial officer and director, in Denver County District Court, Case Number 2019CV034380. The complaint sought a declaratory judgment and damages related to Plaintiff’s allegation that she was misclassified as an independent contractor while working for the Company. Plaintiff alleged she was owed unpaid overtime, liquidated damages, wages, statutory penalties, and other compensatory damages for her misclassification and alleged wrongful termination. Plaintiff’s suit against Mr. Buffalo and Mr. Smith alleged that each was the alter ego of the Company and is, therefore, jointly and severally liable. The Company filed a counterclaim against Plaintiff alleging misappropriation of trade secrets, breach of contract, and other claims relating to her theft of confidential and proprietary information. On January 24, 2022, a settlement agreement was entered into by all parties, and the action was dismissed.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Settlement Agreement provides for a cash settlement of $350,000 to be paid over a 2-year period, and as a result, at December 31, 2022, the Company has recognized a total of liability of $350,000, of which $125,000 is classified as current.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_82A_z1GLYGjE8vvb">Note 16. </span></b></span><b><span id="xdx_82E_zpTlDF56qCbi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income Taxes</span></b></p> <p style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table displays a reconciliation from the U.S. statutory rate to the effective tax rate and the provision for (benefit from) income taxes for the years ended December 31, 2022, and 2021, respectively:</span></p> <p id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zdyRozHv2Qwe" style="margin: 0 0 8pt"><span id="xdx_8B1_zo991xe1qeY3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of income tax rate</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_306_134_zJreU1xbUKg3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of income tax rate</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_49B_20220101__20221231_zdipBQnNgJ7k" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_49A_20210101__20211231_zuYLf4zE48d9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="7" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Years Ended</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--CurrentFederalTaxExpenseBenefit_zxjzgaRhWYh3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income Tax Provision (Benefit)</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">428,083</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(623,358</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_409_ecustom--NondeductibleExpensesIncludingNondeductiblePremergerLosses_iN_di_zDOSKYm3sqxh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-deductible expenses including non-deductible pre-merger losses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187,711</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">163,495</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zbVYQ0wxPEVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(615,794</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">459,863</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--CurrentIncomeTaxExpenseBenefit_znJzd8aNUCNb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Income Tax Benefit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0894">—</span>  </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0895">—</span>  </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zBK48RI3EeU2" style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets (liabilities) consisted of the following:</span></p> <p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zarCGLYrZ2T6" style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z0jczVw5Pluc">Schedule of deferred tax assets</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_303_134_zTZuX9dWFB49" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_491_20221231_zqbqEPoTA6p3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_494_20211231_zVvekTgd3Pl2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zUbBWwsCfWH2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Deferred Tax Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxLiabilitiesLeasingArrangements_iNI_di_zQNMPFDUdw8l" style="vertical-align: bottom; background-color: White"> <td style="width: 56%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease Liability Expense</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0902">—</span>  </span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24,457</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilities_iI_zVWT6uTqIjlj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Deferred Tax Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsOtherTaxCarryforwards_iI_zhsqZT2ChKR1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforwards</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,152,244</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,230,904</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_z7cPHSxCE7vj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of Use Asset</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0911">—</span>  </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,457</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_zUiFArDPLC3e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allowance for Doubtful Accounts</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,040</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,735</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsGross_iI_zHSMMgDRKCoc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Deferred Tax Assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,153,284</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,248,639</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_zP6cluAnT2b5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation Allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,153,284</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,248,639</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zb3CpixqZUMh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Deferred Tax Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0923">—</span>  </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0924">—</span>  </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zcp2ngI2dGEb" style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 8pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determined that it is not more likely than not that its deferred tax asset would be realizable, accordingly, the Company recorded a valuation allowance for the full amount of its deferred tax asset, resulting in a zero carrying value of the Company’s deferred tax asset and no benefit from or provision for income taxes for the years ended December 31, 2022 and 2021. Federal and state operating loss carry forwards are $4,368,664 and $4,812,598 as of December 31, 2022 and 2021, respectively and begin to expire in 2035. The years 2019, 2020, 2021 remain subject to examination by the Company’s major tax jurisdictions. Utilization of the net operating loss carry forwards and credits may be subject to a substantial annual limitation due to ownership change limitations provided by Section 382 of the Internal Revenue Code of 1986, as amended, and similar state provisions. The Company is subject to Section 280(e ) since it sells cannabis with THC.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zdyRozHv2Qwe" style="margin: 0 0 8pt"><span id="xdx_8B1_zo991xe1qeY3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of income tax rate</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_306_134_zJreU1xbUKg3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule of income tax rate</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_49B_20220101__20221231_zdipBQnNgJ7k" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_49A_20210101__20211231_zuYLf4zE48d9" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="7" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Years Ended</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--CurrentFederalTaxExpenseBenefit_zxjzgaRhWYh3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income Tax Provision (Benefit)</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">428,083</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(623,358</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_409_ecustom--NondeductibleExpensesIncludingNondeductiblePremergerLosses_iN_di_zDOSKYm3sqxh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-deductible expenses including non-deductible pre-merger losses</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187,711</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">163,495</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_zbVYQ0wxPEVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(615,794</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">459,863</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--CurrentIncomeTaxExpenseBenefit_znJzd8aNUCNb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Income Tax Benefit</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0894">—</span>  </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0895">—</span>  </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 428083 -623358 -187711 -163495 -615794 459863 <p id="xdx_89E_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zarCGLYrZ2T6" style="margin: 0 0 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_z0jczVw5Pluc">Schedule of deferred tax assets</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_303_134_zTZuX9dWFB49" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_491_20221231_zqbqEPoTA6p3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_494_20211231_zVvekTgd3Pl2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zUbBWwsCfWH2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Deferred Tax Liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxLiabilitiesLeasingArrangements_iNI_di_zQNMPFDUdw8l" style="vertical-align: bottom; background-color: White"> <td style="width: 56%; text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease Liability Expense</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0902">—</span>  </span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24,457</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilities_iI_zVWT6uTqIjlj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Deferred Tax Assets</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsOtherTaxCarryforwards_iI_zhsqZT2ChKR1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net operating loss carryforwards</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,152,244</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,230,904</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_z7cPHSxCE7vj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of Use Asset</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0911">—</span>  </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,457</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_zUiFArDPLC3e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Allowance for Doubtful Accounts</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,040</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,735</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsGross_iI_zHSMMgDRKCoc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Deferred Tax Assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,153,284</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,248,639</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_zP6cluAnT2b5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation Allowance</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,153,284</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,248,639</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iI_zb3CpixqZUMh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Deferred Tax Assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0923">—</span>  </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0924">—</span>  </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 24457 1152244 1230904 24457 1040 17735 1153284 1248639 1153284 1248639 <p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_zf68D1XXoSGd" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 17. <span id="xdx_829_zcoi5s5SGWhe">Subsequent Events</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 855-10, the Company has analyzed its operations after consolidated financial statements were available to be issued and determined that there were no other significant subsequent events or transactions that would require recognition or disclosure in the consolidated financial statements for the year ended December 31, 2022, other than as follows.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023, the Company issued to its officers and directors <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20230101__20230331__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxcWToudAWwe">2,175,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted shares.</span></p> 2175000 EXCEL 68 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 69 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 70 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 71 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 51 294 1 false 25 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://ammj/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://ammj/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://ammj/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://ammj/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://ammj/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY Sheet http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY Statements 6 false false R7.htm 00000007 - Disclosure - Description of Business. Sheet http://ammj/role/DescriptionOfBusiness. Description of Business. Notes 7 false false R8.htm 00000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Naturaleaf Asset Acquisition Sheet http://ammj/role/NaturaleafAssetAcquisition Naturaleaf Asset Acquisition Notes 9 false false R10.htm 00000010 - Disclosure - Accounts Receivable and Advance from Clients Sheet http://ammj/role/AccountsReceivableAndAdvanceFromClients Accounts Receivable and Advance from Clients Notes 10 false false R11.htm 00000011 - Disclosure - Inventory Sheet http://ammj/role/Inventory Inventory Notes 11 false false R12.htm 00000012 - Disclosure - Property and Equipment, net Sheet http://ammj/role/PropertyAndEquipmentNet Property and Equipment, net Notes 12 false false R13.htm 00000013 - Disclosure - Intangible Assets Sheet http://ammj/role/IntangibleAssets Intangible Assets Notes 13 false false R14.htm 00000014 - Disclosure - Accrued and Other Current Liabilities Sheet http://ammj/role/AccruedAndOtherCurrentLiabilities Accrued and Other Current Liabilities Notes 14 false false R15.htm 00000015 - Disclosure - Stock Payable Sheet http://ammj/role/StockPayable Stock Payable Notes 15 false false R16.htm 00000016 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability Sheet http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiability Operating Lease Right-of-Use Asset/Operating Lease Liability Notes 16 false false R17.htm 00000017 - Disclosure - Loans Payable Sheet http://ammj/role/LoansPayable Loans Payable Notes 17 false false R18.htm 00000018 - Disclosure - Related Party Transactions Sheet http://ammj/role/RelatedPartyTransactions Related Party Transactions Notes 18 false false R19.htm 00000019 - Disclosure - Stock Based Compensation Sheet http://ammj/role/StockBasedCompensation Stock Based Compensation Notes 19 false false R20.htm 00000020 - Disclosure - Shareholders??? Equity Sheet http://ammj/role/ShareholdersEquity Shareholders??? Equity Notes 20 false false R21.htm 00000021 - Disclosure - Income Taxes Sheet http://ammj/role/IncomeTaxes Income Taxes Notes 21 false false R22.htm 00000022 - Disclosure - Subsequent Events Sheet http://ammj/role/SubsequentEvents Subsequent Events Notes 22 false false R23.htm 00000023 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 23 false false R24.htm 00000024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies 24 false false R25.htm 00000025 - Disclosure - Naturaleaf Asset Acquisition (Tables) Sheet http://ammj/role/NaturaleafAssetAcquisitionTables Naturaleaf Asset Acquisition (Tables) Tables http://ammj/role/NaturaleafAssetAcquisition 25 false false R26.htm 00000026 - Disclosure - Accounts Receivable and Advance from Clients (Tables) Sheet http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables Accounts Receivable and Advance from Clients (Tables) Tables http://ammj/role/AccountsReceivableAndAdvanceFromClients 26 false false R27.htm 00000027 - Disclosure - Inventory (Tables) Sheet http://ammj/role/InventoryTables Inventory (Tables) Tables http://ammj/role/Inventory 27 false false R28.htm 00000028 - Disclosure - Property and Equipment, net (Tables) Sheet http://ammj/role/PropertyAndEquipmentNetTables Property and Equipment, net (Tables) Tables http://ammj/role/PropertyAndEquipmentNet 28 false false R29.htm 00000029 - Disclosure - Intangible Assets (Tables) Sheet http://ammj/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://ammj/role/IntangibleAssets 29 false false R30.htm 00000030 - Disclosure - Accrued and Other Current Liabilities (Tables) Sheet http://ammj/role/AccruedAndOtherCurrentLiabilitiesTables Accrued and Other Current Liabilities (Tables) Tables http://ammj/role/AccruedAndOtherCurrentLiabilities 30 false false R31.htm 00000031 - Disclosure - Stock Payable (Tables) Sheet http://ammj/role/StockPayableTables Stock Payable (Tables) Tables http://ammj/role/StockPayable 31 false false R32.htm 00000032 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables) Sheet http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables) Tables http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiability 32 false false R33.htm 00000033 - Disclosure - Stock Based Compensation (Tables) Sheet http://ammj/role/StockBasedCompensationTables Stock Based Compensation (Tables) Tables http://ammj/role/StockBasedCompensation 33 false false R34.htm 00000034 - Disclosure - Income Taxes (Tables) Sheet http://ammj/role/IncomeTaxesTables Income Taxes (Tables) Tables http://ammj/role/IncomeTaxes 34 false false R35.htm 00000035 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) Sheet http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails Basis of Presentation and Summary of Significant Accounting Policies (Details) Details http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 35 false false R36.htm 00000036 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) Sheet http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) Details http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables 36 false false R37.htm 00000037 - Disclosure - Naturaleaf Asset Acquisition (Details) Sheet http://ammj/role/NaturaleafAssetAcquisitionDetails Naturaleaf Asset Acquisition (Details) Details http://ammj/role/NaturaleafAssetAcquisitionTables 37 false false R38.htm 00000038 - Disclosure - Naturaleaf Asset Acquisition (Details 1) Sheet http://ammj/role/NaturaleafAssetAcquisitionDetails1 Naturaleaf Asset Acquisition (Details 1) Details http://ammj/role/NaturaleafAssetAcquisitionTables 38 false false R39.htm 00000039 - Disclosure - Naturaleaf Asset Acquisition (Details Narrative) Sheet http://ammj/role/NaturaleafAssetAcquisitionDetailsNarrative Naturaleaf Asset Acquisition (Details Narrative) Details http://ammj/role/NaturaleafAssetAcquisitionTables 39 false false R40.htm 00000040 - Disclosure - Accounts Receivable and Advance from Clients (Details) Sheet http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails Accounts Receivable and Advance from Clients (Details) Details http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables 40 false false R41.htm 00000041 - Disclosure - Accounts Receivable and Advance from Clients (Details 1) Sheet http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails1 Accounts Receivable and Advance from Clients (Details 1) Details http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables 41 false false R42.htm 00000042 - Disclosure - Accounts Receivable and Advance from Clients (Details Narrative) Sheet http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetailsNarrative Accounts Receivable and Advance from Clients (Details Narrative) Details http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables 42 false false R43.htm 00000043 - Disclosure - Inventory (Details) Sheet http://ammj/role/InventoryDetails Inventory (Details) Details http://ammj/role/InventoryTables 43 false false R44.htm 00000044 - Disclosure - Property and Equipment, net (Details) Sheet http://ammj/role/PropertyAndEquipmentNetDetails Property and Equipment, net (Details) Details http://ammj/role/PropertyAndEquipmentNetTables 44 false false R45.htm 00000045 - Disclosure - Intangible Assets (Details) Sheet http://ammj/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://ammj/role/IntangibleAssetsTables 45 false false R46.htm 00000046 - Disclosure - Intangible Assets (Details 1) Sheet http://ammj/role/IntangibleAssetsDetails1 Intangible Assets (Details 1) Details http://ammj/role/IntangibleAssetsTables 46 false false R47.htm 00000047 - Disclosure - Intangible Assets (Details Narrative) Sheet http://ammj/role/IntangibleAssetsDetailsNarrative Intangible Assets (Details Narrative) Details http://ammj/role/IntangibleAssetsTables 47 false false R48.htm 00000048 - Disclosure - Accrued and Other Current Liabilities (Details) Sheet http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails Accrued and Other Current Liabilities (Details) Details http://ammj/role/AccruedAndOtherCurrentLiabilitiesTables 48 false false R49.htm 00000049 - Disclosure - Stock Payable (Details) Sheet http://ammj/role/StockPayableDetails Stock Payable (Details) Details http://ammj/role/StockPayableTables 49 false false R50.htm 00000050 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details) Sheet http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails Operating Lease Right-of-Use Asset/Operating Lease Liability (Details) Details http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables 50 false false R51.htm 00000051 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1) Sheet http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1 Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1) Details http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables 51 false false R52.htm 00000052 - Disclosure - Schedule of remaining minimal annual lease payments (Details) Sheet http://ammj/role/ScheduleOfRemainingMinimalAnnualLeasePaymentsDetails Schedule of remaining minimal annual lease payments (Details) Details 52 false false R53.htm 00000053 - Disclosure - Stock Based Compensation (Details) Sheet http://ammj/role/StockBasedCompensationDetails Stock Based Compensation (Details) Details http://ammj/role/StockBasedCompensationTables 53 false false R54.htm 00000054 - Disclosure - Income Taxes (Details) Sheet http://ammj/role/IncomeTaxesDetails Income Taxes (Details) Details http://ammj/role/IncomeTaxesTables 54 false false R55.htm 00000055 - Disclosure - Income Taxes (Details 1) Sheet http://ammj/role/IncomeTaxesDetails1 Income Taxes (Details 1) Details http://ammj/role/IncomeTaxesTables 55 false false R56.htm 00000056 - Disclosure - Subsequent Events (Details Narrative) Sheet http://ammj/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://ammj/role/SubsequentEvents 56 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate - acc_10k.htm 26 [dqc-0004-Element-Values-Are-Equal] Liabilities with a value of 2746579 is not equal to the total of LiabilitiesCurrent, LiabilitiesNoncurrent with a value of 2099220 + 612960. These values should be equal. The properties of this Liabilities fact are Context: AsOf2022-12-31, Unit: USD, Rule Element Id: 9281. acc_10k.htm 4024, 4053, 4058 acc_10k.htm ammj-20221231.xsd ammj-20221231_cal.xml ammj-20221231_def.xml ammj-20221231_lab.xml ammj-20221231_pre.xml ex31_1.htm ex31_2.htm ex32_1.htm image_001.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 74 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "acc_10k.htm": { "axisCustom": 0, "axisStandard": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 392, "http://xbrl.sec.gov/dei/2022": 33 }, "contextCount": 51, "dts": { "calculationLink": { "local": [ "ammj-20221231_cal.xml" ] }, "definitionLink": { "local": [ "ammj-20221231_def.xml" ] }, "inline": { "local": [ "acc_10k.htm" ] }, "labelLink": { "local": [ "ammj-20221231_lab.xml" ] }, "presentationLink": { "local": [ "ammj-20221231_pre.xml" ] }, "schema": { "local": [ "ammj-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 407, "entityCount": 1, "hidden": { "http://ammj/20221231": 14, "http://fasb.org/us-gaap/2022": 38, "http://xbrl.sec.gov/dei/2022": 5, "total": 57 }, "keyCustom": 54, "keyStandard": 240, "memberCustom": 14, "memberStandard": 11, "nsprefix": "ammj", "nsuri": "http://ammj/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://ammj/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Accounts Receivable and Advance from Clients", "menuCat": "Notes", "order": "10", "role": "http://ammj/role/AccountsReceivableAndAdvanceFromClients", "shortName": "Accounts Receivable and Advance from Clients", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Inventory", "menuCat": "Notes", "order": "11", "role": "http://ammj/role/Inventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Property and Equipment, net", "menuCat": "Notes", "order": "12", "role": "http://ammj/role/PropertyAndEquipmentNet", "shortName": "Property and Equipment, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Intangible Assets", "menuCat": "Notes", "order": "13", "role": "http://ammj/role/IntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Accrued and Other Current Liabilities", "menuCat": "Notes", "order": "14", "role": "http://ammj/role/AccruedAndOtherCurrentLiabilities", "shortName": "Accrued and Other Current Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ammj:StockPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Stock Payable", "menuCat": "Notes", "order": "15", "role": "http://ammj/role/StockPayable", "shortName": "Stock Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ammj:StockPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability", "menuCat": "Notes", "order": "16", "role": "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiability", "shortName": "Operating Lease Right-of-Use Asset/Operating Lease Liability", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Loans Payable", "menuCat": "Notes", "order": "17", "role": "http://ammj/role/LoansPayable", "shortName": "Loans Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "18", "role": "http://ammj/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Stock Based Compensation", "menuCat": "Notes", "order": "19", "role": "http://ammj/role/StockBasedCompensation", "shortName": "Stock Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://ammj/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Shareholders\u2019 Equity", "menuCat": "Notes", "order": "20", "role": "http://ammj/role/ShareholdersEquity", "shortName": "Shareholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "21", "role": "http://ammj/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "22", "role": "http://ammj/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "23", "role": "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "24", "role": "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Naturaleaf Asset Acquisition (Tables)", "menuCat": "Tables", "order": "25", "role": "http://ammj/role/NaturaleafAssetAcquisitionTables", "shortName": "Naturaleaf Asset Acquisition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Accounts Receivable and Advance from Clients (Tables)", "menuCat": "Tables", "order": "26", "role": "http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables", "shortName": "Accounts Receivable and Advance from Clients (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Inventory (Tables)", "menuCat": "Tables", "order": "27", "role": "http://ammj/role/InventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Property and Equipment, net (Tables)", "menuCat": "Tables", "order": "28", "role": "http://ammj/role/PropertyAndEquipmentNetTables", "shortName": "Property and Equipment, net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Intangible Assets (Tables)", "menuCat": "Tables", "order": "29", "role": "http://ammj/role/IntangibleAssetsTables", "shortName": "Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://ammj/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Accrued and Other Current Liabilities (Tables)", "menuCat": "Tables", "order": "30", "role": "http://ammj/role/AccruedAndOtherCurrentLiabilitiesTables", "shortName": "Accrued and Other Current Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ammj:StockPayableTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ammj:ScheduleOfStockPayableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Stock Payable (Tables)", "menuCat": "Tables", "order": "31", "role": "http://ammj/role/StockPayableTables", "shortName": "Stock Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ammj:StockPayableTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "ammj:ScheduleOfStockPayableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables)", "menuCat": "Tables", "order": "32", "role": "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables", "shortName": "Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Stock Based Compensation (Tables)", "menuCat": "Tables", "order": "33", "role": "http://ammj/role/StockBasedCompensationTables", "shortName": "Stock Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "34", "role": "http://ammj/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)", "menuCat": "Details", "order": "35", "role": "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_AllOtherSegmentsMember", "decimals": "0", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "36", "role": "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Naturaleaf Asset Acquisition (Details)", "menuCat": "Details", "order": "37", "role": "http://ammj/role/NaturaleafAssetAcquisitionDetails", "shortName": "Naturaleaf Asset Acquisition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessCombinationSegmentAllocationTableTextBlock", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Naturaleaf Asset Acquisition (Details 1)", "menuCat": "Details", "order": "38", "role": "http://ammj/role/NaturaleafAssetAcquisitionDetails1", "shortName": "Naturaleaf Asset Acquisition (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessCombinationSegmentAllocationTableTextBlock", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LegalFees", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Naturaleaf Asset Acquisition (Details Narrative)", "menuCat": "Details", "order": "39", "role": "http://ammj/role/NaturaleafAssetAcquisitionDetailsNarrative", "shortName": "Naturaleaf Asset Acquisition (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LegalFees", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "ammj:ConsultingAndAdvisoryRevenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://ammj/role/ConsolidatedStatementsOfOperations", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "ammj:ConsultingAndAdvisoryRevenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Accounts Receivable and Advance from Clients (Details)", "menuCat": "Details", "order": "40", "role": "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails", "shortName": "Accounts Receivable and Advance from Clients (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DepositLiabilitiesTypeTableTextBlock", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RestructuringReserveCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Accounts Receivable and Advance from Clients (Details 1)", "menuCat": "Details", "order": "41", "role": "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails1", "shortName": "Accounts Receivable and Advance from Clients (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:DepositLiabilitiesTypeTableTextBlock", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RestructuringReserveCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "ammj:AllowancesForBadebtExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Accounts Receivable and Advance from Clients (Details Narrative)", "menuCat": "Details", "order": "42", "role": "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetailsNarrative", "shortName": "Accounts Receivable and Advance from Clients (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "ammj:AllowancesForBadebtExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Inventory (Details)", "menuCat": "Details", "order": "43", "role": "http://ammj/role/InventoryDetails", "shortName": "Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - Property and Equipment, net (Details)", "menuCat": "Details", "order": "44", "role": "http://ammj/role/PropertyAndEquipmentNetDetails", "shortName": "Property and Equipment, net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - Intangible Assets (Details)", "menuCat": "Details", "order": "45", "role": "http://ammj/role/IntangibleAssetsDetails", "shortName": "Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - Intangible Assets (Details 1)", "menuCat": "Details", "order": "46", "role": "http://ammj/role/IntangibleAssetsDetails1", "shortName": "Intangible Assets (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - Intangible Assets (Details Narrative)", "menuCat": "Details", "order": "47", "role": "http://ammj/role/IntangibleAssetsDetailsNarrative", "shortName": "Intangible Assets (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - Accrued and Other Current Liabilities (Details)", "menuCat": "Details", "order": "48", "role": "http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails", "shortName": "Accrued and Other Current Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ammj:ScheduleOfStockPayableTableTextBlock", "ammj:StockPayableTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "ammj:AdditionalExpensedIncurredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - Stock Payable (Details)", "menuCat": "Details", "order": "49", "role": "http://ammj/role/StockPayableDetails", "shortName": "Stock Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ammj:ScheduleOfStockPayableTableTextBlock", "ammj:StockPayableTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "ammj:AdditionalExpensedIncurredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "5", "role": "http://ammj/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-012022-12-31_custom_May2022ToApril2023Member", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SaleLeasebackTransactionRentExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)", "menuCat": "Details", "order": "50", "role": "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails", "shortName": "Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)", "menuCat": "Details", "order": "51", "role": "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1", "shortName": "Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - Schedule of remaining minimal annual lease payments (Details)", "menuCat": "Details", "order": "52", "role": "http://ammj/role/ScheduleOfRemainingMinimalAnnualLeasePaymentsDetails", "shortName": "Schedule of remaining minimal annual lease payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleNotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - Stock Based Compensation (Details)", "menuCat": "Details", "order": "53", "role": "http://ammj/role/StockBasedCompensationDetails", "shortName": "Stock Based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleNotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - Income Taxes (Details)", "menuCat": "Details", "order": "54", "role": "http://ammj/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxLiabilitiesLeasingArrangements", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - Income Taxes (Details 1)", "menuCat": "Details", "order": "55", "role": "http://ammj/role/IncomeTaxesDetails1", "shortName": "Income Taxes (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxLiabilitiesLeasingArrangements", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2023-01-012023-03-31_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - Subsequent Events (Details Narrative)", "menuCat": "Details", "order": "56", "role": "http://ammj/role/SubsequentEventsDetailsNarrative", "shortName": "Subsequent Events (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2023-01-012023-03-31_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY", "menuCat": "Statements", "order": "6", "role": "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Description of Business.", "menuCat": "Notes", "order": "7", "role": "http://ammj/role/DescriptionOfBusiness.", "shortName": "Description of Business.", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies", "shortName": "Basis of Presentation and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AssetAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Naturaleaf Asset Acquisition", "menuCat": "Notes", "order": "9", "role": "http://ammj/role/NaturaleafAssetAcquisition", "shortName": "Naturaleaf Asset Acquisition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "acc_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AssetAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 25, "tag": { "ammj_AdditionalExpensedIncurredAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additional Expensed Incurred, Amount" } } }, "localname": "AdditionalExpensedIncurredAmount", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/StockPayableDetails" ], "xbrltype": "monetaryItemType" }, "ammj_AdvanceFromClient": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Advances from Clients" } } }, "localname": "AdvanceFromClient", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ammj_AdvancesFromClients": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "AdvancesFromClients", "negatedLabel": "Advances from Clients" } } }, "localname": "AdvancesFromClients", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ammj_AllowancesForBadebtExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "allowances for bad debt expense" } } }, "localname": "AllowancesForBadebtExpense", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ammj_BadDebtExpense": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Bad Debt Expense", "verboseLabel": "[custom:BadDebtExpense]" } } }, "localname": "BadDebtExpense", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ammj_BasicAndDilutedWeightedAverageCommonSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted weighted average common shares outstanding" } } }, "localname": "BasicAndDilutedWeightedAverageCommonSharesOutstanding", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "ammj_BasicNetLossPerCommonShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted net loss per common share" } } }, "localname": "BasicNetLossPerCommonShare", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "ammj_BrandMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Brand [Member]" } } }, "localname": "BrandMember", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "ammj_CannabisProducts": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Cannabis Products" } } }, "localname": "CannabisProducts", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ammj_CannabisSalesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cannabis Sales" } } }, "localname": "CannabisSalesPolicyTextBlock", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ammj_ConsultingAndAdvisoryRevenues": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Consulting Services" } } }, "localname": "ConsultingAndAdvisoryRevenues", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ammj_ConsultingServicesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ConsultingServicesPolicyTextBlock", "verboseLabel": "Consulting Services" } } }, "localname": "ConsultingServicesPolicyTextBlock", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ammj_CostOfCannabisProduct": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_CostOfRevenue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost of Cannabis Products" } } }, "localname": "CostOfCannabisProduct", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ammj_CostOfConsultingAndAdvisory": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_CostOfRevenue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost of Consulting Services" } } }, "localname": "CostOfConsultingAndAdvisory", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ammj_CostOfEquipmentSupplies": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_CostOfRevenue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost of Products and Equipment" } } }, "localname": "CostOfEquipmentSupplies", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ammj_CurrentObligationsUnderLeases": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Less: current obligations under leases", "negatedLabel": "Less: current obligations under leases" } } }, "localname": "CurrentObligationsUnderLeases", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "ammj_DebtForgiveness": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "DebtForgiveness", "negatedLabel": "Debt Forgiveness" } } }, "localname": "DebtForgiveness", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ammj_DebtInstrumentDecreaseForgivenes": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "DebtInstrumentDecreaseForgivenes", "negatedLabel": "Debt Forgiveness" } } }, "localname": "DebtInstrumentDecreaseForgivenes", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ammj_DepositAssetsCurrent": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deposits" } } }, "localname": "DepositAssetsCurrent", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ammj_DepositsRecognizedAsRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "DepositsRecognizedAsRevenue", "negatedLabel": "Less: Deposits recognized as revenue" } } }, "localname": "DepositsRecognizedAsRevenue", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails1" ], "xbrltype": "monetaryItemType" }, "ammj_DepreciationExpense": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Depreciation and amortization" } } }, "localname": "DepreciationExpense", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ammj_DilutiveSecuritiesAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "DilutiveSecuritiesAmount", "verboseLabel": "Total" } } }, "localname": "DilutiveSecuritiesAmount", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "ammj_DisclosureOperatingLeaseRightofuseAssetoperatingLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Right-of-use Assetoperating Lease Liability", "verboseLabel": "Schedule Of Remaining Minimal Annual Lease Payments" } } }, "localname": "DisclosureOperatingLeaseRightofuseAssetoperatingLeaseLiabilityAbstract", "nsuri": "http://ammj/20221231", "xbrltype": "stringItemType" }, "ammj_DisclosureStockPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Payable" } } }, "localname": "DisclosureStockPayableAbstract", "nsuri": "http://ammj/20221231", "xbrltype": "stringItemType" }, "ammj_EquipmentSuppliesRevenues": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Product & Equipment" } } }, "localname": "EquipmentSuppliesRevenues", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ammj_FinishedGoodsSoil": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finished Goods \u2013 Soil" } } }, "localname": "FinishedGoodsSoil", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "ammj_FiniteLivedIntangibleAssetUsefulLifeOne": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Estimated Useful Life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLifeOne", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "ammj_FiniteLivedIntangibleAssetsGrossAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total Intangible Assets" } } }, "localname": "FiniteLivedIntangibleAssetsGrossAsset", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "ammj_FiniteLivedIntangibleAssetsNet1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[custom:FiniteLivedIntangibleAssetsNet1-0]" } } }, "localname": "FiniteLivedIntangibleAssetsNet1", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ammj_ImpactOfCovid19PandemicPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impact of the COVID-19 Pandemic" } } }, "localname": "ImpactOfCovid19PandemicPolicyTextBlock", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ammj_January2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "January 2023 [Member]" } } }, "localname": "January2023Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_January2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "January 2024 [Member]" } } }, "localname": "January2024Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_January2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "January 2025 [Member]" } } }, "localname": "January2025Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_January2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "January 2026 [Member]" } } }, "localname": "January2026Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_January2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "January 2027 [Member]" } } }, "localname": "January2027Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_June2022ToJune2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "June 2022 To June 2023 [Member]" } } }, "localname": "June2022ToJune2023Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_June2023ToJune2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "June 2023 To June 2024 [Member]" } } }, "localname": "June2023ToJune2024Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_June2024ToJune2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "June 2024 To June 2025 [Member]" } } }, "localname": "June2024ToJune2025Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_LessAmountRepresentingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "LessAmountRepresentingInterest", "negatedLabel": "Less: amount representing interest" } } }, "localname": "LessAmountRepresentingInterest", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "ammj_LitigationPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Litigation payable" } } }, "localname": "LitigationPayable", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ammj_LitigationSettlement": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Litigation Settlement" } } }, "localname": "LitigationSettlement", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ammj_LitigationSettlementCurrent": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Litigation Settlement, current" } } }, "localname": "LitigationSettlementCurrent", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ammj_LlitigationSettlementExpense": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Litigation Settlement Expense" } } }, "localname": "LlitigationSettlementExpense", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ammj_LoyaltyRewardProgramPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loyalty Reward Program" } } }, "localname": "LoyaltyRewardProgramPolicyTextBlock", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ammj_May2022ToApril2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "May 2022 To April 2023 [Member]" } } }, "localname": "May2022ToApril2023Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_May2023ToApril2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "May 2023 To April 2024 [Member]" } } }, "localname": "May2023ToApril2024Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_May2024ToApril2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "May 2024 To April 2025 [Member]" } } }, "localname": "May2024ToApril2025Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_May2025ToApril2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "May 2025 To April 2026 [Member]" } } }, "localname": "May2025ToApril2026Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_May2026ToApril2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "May 2026 To April 2027 [Member]" } } }, "localname": "May2026ToApril2027Member", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "ammj_NetIncomeLoss1": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "ammj_NetLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Net Loss" } } }, "localname": "NetIncomeLoss1", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ammj_NetLoss": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "NetLoss", "totalLabel": "NET LOSS" } } }, "localname": "NetLoss", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ammj_NondeductibleExpensesIncludingNondeductiblePremergerLosses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "NondeductibleExpensesIncludingNondeductiblePremergerLosses", "negatedLabel": "Non-deductible expenses including non-deductible pre-merger losses" } } }, "localname": "NondeductibleExpensesIncludingNondeductiblePremergerLosses", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "ammj_OperatingLeaseExpense1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense1", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ammj_OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Right-of-Use Asset/Operating Lease Liability" } } }, "localname": "OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiability" ], "xbrltype": "textBlockItemType" }, "ammj_PaymentForAcquisitionOfAssets": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "PaymentForAcquisitionOfAssets", "negatedLabel": "Acquisition of Assets" } } }, "localname": "PaymentForAcquisitionOfAssets", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ammj_PaymentsToAcquireIntangibleAsset": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "PaymentsToAcquireIntangibleAsset", "negatedLabel": "Intangible Assets" } } }, "localname": "PaymentsToAcquireIntangibleAsset", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ammj_PresentValueOfFutureMinimumLeasePayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Present value of future minimum lease payments" } } }, "localname": "PresentValueOfFutureMinimumLeasePayments", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "ammj_ProductAndEquipmentSalesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Product and Equipment Sales" } } }, "localname": "ProductAndEquipmentSalesPolicyTextBlock", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ammj_PropertyPlantAndEquipmentNet1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[custom:PropertyPlantAndEquipmentNet1-0]" } } }, "localname": "PropertyPlantAndEquipmentNet1", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "ammj_RelatedPartyTransactionsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RelatedPartyTransactionsPolicyTextBlock", "verboseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsPolicyTextBlock", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ammj_ScheduleOfStockPayableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of stock payable" } } }, "localname": "ScheduleOfStockPayableTableTextBlock", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/StockPayableTables" ], "xbrltype": "textBlockItemType" }, "ammj_StockBasedCompensationExpense": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Stock Based Compensation Expense" } } }, "localname": "StockBasedCompensationExpense", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ammj_StockBasedCompensationThirdParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Initial recognition of leases" } } }, "localname": "StockBasedCompensationThirdParty", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ammj_StockIssuedForAcquisition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Stock issued for Acquisition" } } }, "localname": "StockIssuedForAcquisition", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ammj_StockIssuedForCashlessExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock issued for cashless exercise of warrants" } } }, "localname": "StockIssuedForCashlessExerciseOfWarrants", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "ammj_StockIssuedForCashlessExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock issued for cashless exercise of warrants Shares" } } }, "localname": "StockIssuedForCashlessExerciseOfWarrantsShares", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "ammj_StockIssuedForReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Stock issued for Receivables" } } }, "localname": "StockIssuedForReceivables", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ammj_StockPayable": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock payable" } } }, "localname": "StockPayable", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ammj_StockPayableAmounts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "StockPayableAmounts", "periodEndLabel": "StockPayableAmounts", "periodStartLabel": "StockPayableAmounts" } } }, "localname": "StockPayableAmounts", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/StockPayableDetails" ], "xbrltype": "monetaryItemType" }, "ammj_StockPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "StockPayableTextBlock", "verboseLabel": "Stock Payable" } } }, "localname": "StockPayableTextBlock", "nsuri": "http://ammj/20221231", "presentation": [ "http://ammj/role/StockPayable" ], "xbrltype": "textBlockItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r411", "r413", "r414" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r411", "r413", "r414" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r411", "r413", "r414" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r411", "r413", "r414" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ammj/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndNotesReceivableNet": { "auth_ref": [ "r211", "r372" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of accounts and financing receivable. Includes, but is not limited to, notes and loan receivable.", "label": "Accounts and Financing Receivable, after Allowance for Credit Loss", "verboseLabel": "Accounts Receivable, net" } } }, "localname": "AccountsAndNotesReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "verboseLabel": "Accrued and Other Current Liabilities" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.", "label": "Accounts Payable and Other Accrued Liabilities", "verboseLabel": "Accrued and other current liabilities" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r18", "r399" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableOtherCurrent": { "auth_ref": [ "r18" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Other Accrued Expenses & Payables" } } }, "localname": "AccountsPayableOtherCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGross": { "auth_ref": [ "r138", "r211" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable \u2013 Trade" } } }, "localname": "AccountsReceivableGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r372", "r381" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, Net" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r21" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Interest" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r21", "r388" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Payroll" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r72", "r133" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r10", "r399" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r309", "r310", "r311", "r431", "r432", "r433", "r482" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r41", "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdministrativeFeesExpense": { "auth_ref": [ "r99" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for administrative services provided to the limited liability company (LLC) or limited partnership (LP) by the managing member or general partner, affiliate of managing member or general partner, or affiliate of LLC or LP, for example, but not limited to, salaries, rent, or overhead costs.", "label": "General and Admin Expenses" } } }, "localname": "AdministrativeFeesExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising and Promotion Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r315" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllOtherSegmentsMember": { "auth_ref": [ "r179", "r198", "r199", "r200", "r201", "r202" ], "lang": { "en-us": { "role": { "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.", "label": "Other Segments [Member]" } } }, "localname": "AllOtherSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r308" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Stock-based compensation to employees" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": { "auth_ref": [ "r435" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet.", "label": "Allowance for Doubtful Accounts" } } }, "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r139", "r213", "r216", "r217", "r219" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r139", "r213", "r216" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "negatedLabel": "Less: Allowance for Doubtful Accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfAcquisitionCosts": { "auth_ref": [ "r41", "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of capitalized costs associated with acquisition of business. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Acquisition Costs" } } }, "localname": "AmortizationOfAcquisitionCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionContingentConsiderationLiability": { "auth_ref": [ "r481" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized from contingent consideration in asset acquisition.", "label": "Total Consideration" } } }, "localname": "AssetAcquisitionContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionTextBlock": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for asset acquisition.", "label": "Naturaleaf Asset Acquisition" } } }, "localname": "AssetAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisition" ], "xbrltype": "textBlockItemType" }, "us-gaap_Assets": { "auth_ref": [ "r101", "r108", "r137", "r157", "r189", "r200", "r206", "r214", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r332", "r336", "r341", "r399", "r446", "r447", "r485" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r128", "r142", "r157", "r214", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r332", "r336", "r341", "r399", "r446", "r447", "r485" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "auth_ref": [ "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "verboseLabel": "Current Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r94" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment": { "auth_ref": [ "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date.", "label": "Property, Plant and Equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": { "auth_ref": [ "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.", "label": "Total Tangible Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "verboseLabel": "Goodwill" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r93", "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Identifiable intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r93", "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "verboseLabel": "Inventory" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": { "auth_ref": [ "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets", "verboseLabel": "Other Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "verboseLabel": "Long Term Deposits" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r93", "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Property, plant and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Total consideration" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationSegmentAllocationTableTextBlock": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill in a business combination.", "label": "Business Combination" } } }, "localname": "BusinessCombinationSegmentAllocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r1", "r47", "r53" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Description of Business." } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/DescriptionOfBusiness." ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalLeaseObligations": { "auth_ref": [ "r118", "r123", "r124" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.", "label": "Long-term lease obligations" } } }, "localname": "CapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r379", "r380", "r399", "r420" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r43", "r131", "r386" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r37", "r43", "r46" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "CASH AT END OF PERIOD", "periodStartLabel": "CASH AT BEGINNING OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r37", "r97" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "NET (DECREASE) INCREASE IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r76", "r241", "r242", "r382", "r445" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Income Taxes" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r431", "r432", "r482" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r9", "r78" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r9", "r399" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.00001 par value; 500,000,000 shares authorized; 92,152,938 and 81,902,938 shares issued and outstanding at December 31, 2022 and 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r106", "r176" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Significant Clients and Customers" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r96", "r389" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principal of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r6", "r102", "r110", "r117" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable", "verboseLabel": "Stock Payable" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r27", "r366" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods Sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r28", "r157", "r214", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r341", "r446" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "totalLabel": "Total Cost of Revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Revenues" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r449" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Costs of Revenues" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r430", "r479", "r480" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Income Tax Provision (Benefit)" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r90", "r324", "r329", "r430" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Total Income Tax Benefit" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r77", "r155", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Loans Payable" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/LoansPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "auth_ref": [ "r478" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.", "label": "Right of Use Asset" } } }, "localname": "DeferredTaxAssetInterestCarryforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r321" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Net Deferred Tax Assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r477" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "verboseLabel": "Total Deferred Tax Assets" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOtherTaxCarryforwards": { "auth_ref": [ "r89", "r478" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible tax carryforwards, classified as other.", "label": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOtherTaxCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r322" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation Allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r86", "r477" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Total Deferred Tax Assets" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "auth_ref": [ "r89", "r478" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.", "label": "Deferred Tax Liabilities, Leasing Arrangements", "negatedLabel": "Lease Liability Expense" } } }, "localname": "DeferredTaxLiabilitiesLeasingArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Deferred Tax Liabilities" } } }, "localname": "DeferredTaxLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_DepositAssets": { "auth_ref": [ "r421" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.", "label": "Long Term Deposits" } } }, "localname": "DepositAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositContractsPolicy": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the treatment of funds received from or paid to insureds, insurers and reinsurers on contracts for which the criteria for transferring or assuming insurance risk has not been satisfied by the insurer or reinsurer.", "label": "Deposit Contracts, Policy [Policy Text Block]", "verboseLabel": "Deposits" } } }, "localname": "DepositContractsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DepositLiabilitiesTypeTableTextBlock": { "auth_ref": [ "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of type of deposit liability.", "label": "Deposit Liabilities, Type [Table Text Block]", "verboseLabel": "Deposit Liabilities, Type" } } }, "localname": "DepositLiabilitiesTypeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DepositLiabilityCurrent": { "auth_ref": [ "r21" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The current portion, due within one year or one operating cycle, if longer, of deposits held other than customer deposits.", "label": "Additional deposits received" } } }, "localname": "DepositLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r41", "r70" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation Expense" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r48", "r49" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Loss Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for employee benefit and equity-based compensation.", "label": "Employee Benefits and Share-Based Compensation" } } }, "localname": "EmployeeBenefitsAndShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r78", "r125", "r146", "r147", "r148", "r159", "r160", "r161", "r163", "r168", "r170", "r173", "r215", "r276", "r309", "r310", "r311", "r326", "r327", "r339", "r342", "r343", "r344", "r345", "r346", "r347", "r353", "r374", "r375", "r376" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r135", "r235" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "verboseLabel": "" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "verboseLabel": "" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "verboseLabel": "" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "verboseLabel": "" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "verboseLabel": "" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r233", "r234", "r235", "r236", "r367", "r368" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r66", "r368" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r61", "r65" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r66", "r367" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible Assets", "verboseLabel": "Finite-Lived Intangible Assets, Net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets", "http://ammj/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedLicenseAgreementsGross": { "auth_ref": [ "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount as of the balance sheet date of certain rights acquired to exercise a certain privilege or pursue a particular business or occupation and which is deemed to have a finite economic life.", "label": "Licenses" } } }, "localname": "FiniteLivedLicenseAgreementsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedTrademarksGross": { "auth_ref": [ "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time.", "label": "Tradenames and Trademarks" } } }, "localname": "FiniteLivedTrademarksGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r30" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r134", "r223", "r369", "r396", "r399", "r441", "r442" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r58", "r63" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r26", "r157", "r189", "r199", "r205", "r207", "r214", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r341", "r395", "r446" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r69", "r74" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Accounting for the Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r158", "r169", "r170", "r187", "r318", "r328", "r330", "r373" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "ammj_NetLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r145", "r316", "r317", "r319", "r320", "r323", "r325" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r476" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r38", "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r40" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts Payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r40" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r40" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Payroll and Related expenses" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r40" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingLiabilities": { "auth_ref": [ "r40" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.", "label": "Operating Lease Liability" } } }, "localname": "IncreaseDecreaseInOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r40" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Accrued and other current liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r40" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "verboseLabel": "Intangible Assets" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r65", "r363", "r364", "r365", "r367", "r390" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets, net" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r59", "r64" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "verboseLabel": "Goodwill" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r98", "r105", "r149", "r183", "r349" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest (expense)" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r428" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Cash paid for interest" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r423" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished Goods \u2013 Cannabis Retail" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r426" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, Gross", "verboseLabel": "Inventory" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r141", "r387", "r399" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory", "verboseLabel": "Total Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets", "http://ammj/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r130", "r140", "r172", "r220", "r221", "r222", "r362", "r391" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r425" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw Materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r424" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work In Process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/InventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r29" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal Fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r484" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of remaining minimal annual lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r352" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "verboseLabel": "Total" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ScheduleOfRemainingMinimalAnnualLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r352" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "verboseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ScheduleOfRemainingMinimalAnnualLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r20", "r157", "r214", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r333", "r336", "r337", "r341", "r394", "r446", "r485", "r486" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r14", "r103", "r112", "r399", "r429", "r440", "r483" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r22", "r129", "r157", "r214", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r333", "r336", "r337", "r341", "r399", "r446", "r485", "r486" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r3", "r4", "r5", "r6", "r7", "r157", "r214", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r333", "r336", "r337", "r341", "r446", "r485", "r486" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Long Term Liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LONG TERM LIABILITIES" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicenseMember": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.", "label": "License [Member]" } } }, "localname": "LicenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LitigationSettlementExpense": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.", "label": "Litigation Settlement, Expense", "verboseLabel": "Litigation Settlement Expense" } } }, "localname": "LitigationSettlementExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "Accounts Receivable and Advance from Clients" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClients" ], "xbrltype": "textBlockItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r153" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash (Used in) Provided by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r153" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used in Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r37", "r39", "r42" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Used In Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r25", "r42", "r104", "r114", "r127", "r143", "r144", "r148", "r157", "r162", "r164", "r165", "r166", "r167", "r169", "r170", "r171", "r189", "r199", "r205", "r207", "r214", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r340", "r341", "r395", "r446" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "verboseLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r31" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total Other (Expense) Income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Note payable, current" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableToBankNoncurrent": { "auth_ref": [ "r6", "r102", "r109" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount due within more than 12 month, or the operating cycle if longer, on all notes payable to banks paid on an installment. This can include the amount of any loans from the applicant firm. This does not, however, include any mortgage balances.", "label": "LTD Note Payable" } } }, "localname": "NotesPayableToBankNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Total Expense", "totalLabel": "Total Operating Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r189", "r199", "r205", "r207", "r395" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Net Loss from Operations", "totalLabel": "Loss from Operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r351" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Right of Use Liabilities, all current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r351" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Right of Use Liabilities, LT" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r350" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of Use Assets - Operating Leases, net" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r119", "r121" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.", "label": "Total" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r119", "r121" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r21" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Accrued and Other Current Liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r100", "r107", "r136" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets [Default Label]", "totalLabel": "Total Other Assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherDepreciationAndAmortization": { "auth_ref": [ "r29", "r41", "r70" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.", "label": "Other Depreciation and Amortization" } } }, "localname": "OtherDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r115" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other income" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r21", "r399" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "December 31, 2022" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income (Expense)" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsToAcquireNotesReceivable": { "auth_ref": [ "r32" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.", "label": "Payments to Acquire Notes Receivable", "negatedLabel": "Payment of note payable" } } }, "localname": "PaymentsToAcquireNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r33" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r8", "r263" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r8", "r263" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r8", "r399" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, $0.01 par value, 5,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2022 and 2021" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid Expenses and Other Current Assets" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r34" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r35" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from note payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r127", "r143", "r144", "r152", "r157", "r162", "r169", "r170", "r189", "r199", "r205", "r207", "r214", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r331", "r334", "r335", "r340", "r341", "r370", "r395", "r397", "r398", "r427", "r446" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "verboseLabel": "Net Loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r75", "r383", "r384", "r385" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r71", "r132" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r73", "r113", "r371", "r399" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and Equipment - Net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r73", "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment, ne" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r151", "r218" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Allowance for Bad Debt Expenses" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock": { "auth_ref": [ "r212" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for classification and method of accounting for interest-only strips, loans, other receivables, or retained interests in securitizations that can be contractually prepaid or otherwise settled in a way that the holder would not recover substantially all of its recorded investment.", "label": "Receivables and Portions of Securitizations that can be Prepaid at Potential Loss, Policy [Policy Text Block]", "verboseLabel": "Prepaid Expenses and Other Current Assets" } } }, "localname": "ReceivablesAndPortionsOfSecuritizationsThatCanBePrepaidAtPotentialLossPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r434", "r437", "r438", "r439" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Accounts Receivable, net" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r354", "r355", "r356", "r357", "r358" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r36" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "verboseLabel": "LTD Note Payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringReserveCurrent": { "auth_ref": [ "r422", "r443", "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.", "label": "December 31, 2021" } } }, "localname": "RestructuringReserveCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r11", "r79", "r111", "r377", "r378", "r399" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r125", "r159", "r160", "r161", "r163", "r168", "r170", "r215", "r309", "r310", "r311", "r326", "r327", "r339", "r374", "r376" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r392", "r393" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionSalesReturnsReserveForSalesReturns": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of estimated sales returns.", "label": "Revenue Recognition, Sales Returns, Reserve for Sales Returns" } } }, "localname": "RevenueRecognitionSalesReturnsReserveForSalesReturns", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r150", "r157", "r180", "r181", "r198", "r203", "r204", "r208", "r209", "r210", "r214", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r341", "r370", "r446" ], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues [Default Label]", "totalLabel": "Total Revenues", "verboseLabel": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionRentExpense": { "auth_ref": [ "r120" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the current period expense recorded for use of the property in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.", "label": "Rental expense", "totalLabel": "Rental expense" } } }, "localname": "SaleLeasebackTransactionRentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "auth_ref": [ "r18" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales Tax Payable" } } }, "localname": "SalesAndExciseTaxPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Deposit Liabilities, Type" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of accrued and other current liabilities" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r91", "r92" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of purchase price as of the acquisition" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of deferred tax assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of income tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r61", "r65", "r367" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r61", "r65" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of intangible assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.", "label": "Schedule of operating leases liabilities" } } }, "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r2", "r15", "r16", "r17" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement.", "label": "Schedule of Other Operating Cost and Expense" } } }, "localname": "ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r54", "r55", "r56", "r58" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r277", "r278", "r279", "r280", "r281", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r303", "r304", "r305", "r306", "r307" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r81", "r82", "r83" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of stock based compensation" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of estimated amortization expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r210", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r239", "r240", "r396", "r487" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r192", "r193", "r194", "r195", "r196", "r197", "r209" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Information" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://ammj/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://ammj/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r282", "r301", "r302", "r303", "r304", "r307", "r312", "r313" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r298" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Stock-based Compensation" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r80", "r84" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "Stock Based Compensation" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Shares, Outstanding, Ending Balance", "periodStartLabel": "Shares, Outstanding, Beginning Balance" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingCostPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.", "label": "Shipping and Handling Costs" } } }, "localname": "ShippingAndHandlingCostPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r47", "r154" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internally developed software for sale, licensing or long-term internal use.", "label": "Software Development [Member]" } } }, "localname": "SoftwareDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r126", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r210", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r238", "r239", "r240", "r396", "r487" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r23", "r78", "r125", "r146", "r147", "r148", "r159", "r160", "r161", "r163", "r168", "r170", "r173", "r215", "r276", "r309", "r310", "r311", "r326", "r327", "r339", "r342", "r343", "r344", "r345", "r346", "r347", "r353", "r374", "r375", "r376" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r159", "r160", "r161", "r173", "r366" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDetails", "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r8", "r9", "r79" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock-issued for asset acquisition Shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.", "label": "Stock-based compentation" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock issued for services shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r8", "r9", "r78", "r79" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock issued for cash shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Shares, Other", "verboseLabel": "Stock issued for consultant" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r78", "r79" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r23", "r78", "r79" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock-issued for asset acquisition" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.", "label": "Stock-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeBenefitPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock issued for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r8", "r9", "r78", "r79" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock issued for cash" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock issued for consultant" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r9", "r12", "r13", "r57", "r399", "r429", "r440", "r483" ], "calculation": { "http://ammj/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance,\u00a0December 31, 2022", "periodStartLabel": "Balance,\u00a0December 31, 2021", "totalLabel": "Total Shareholders' Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets", "http://ammj/role/ConsolidatedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders' Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r80", "r156", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r338" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r348", "r360" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r348", "r360" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r348", "r360" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r348", "r360" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r359", "r361" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Going Concern" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL CASH FLOW INFORMATION:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r50", "r51", "r52", "r174", "r175", "r177", "r178" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates in Financial Reporting" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/BasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ammj/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=6487483&loc=d3e32239-158577", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123386454&loc=d3e45280-112737", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r401": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r402": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r403": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r404": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r405": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r406": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r407": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r408": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r409": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r411": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r412": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r413": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r414": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r415": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r416": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r417": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r418": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r419": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r436": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/subtopic&trid=2196772", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r445": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r449": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "https://asc.fasb.org/topic&trid=2122478", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r47": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r488": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r489": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r491": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r492": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(4)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r493": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(5)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r494": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1406", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r495": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(d)", "Publisher": "SEC", "Section": "1406", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r496": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(e)", "Publisher": "SEC", "Section": "1406", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r497": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(f)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r498": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(f)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r499": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(f)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(f)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(2)(i)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r501": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(f)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(2)(i)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r502": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(f)", "Publisher": "SEC", "Section": "1406", "Subparagraph": "(2)(i)(iv)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 75 0001903596-23-000316-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001903596-23-000316-xbrl.zip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

YWA#5YFAT/-;;@M8O7IS=5A.-*UDPX_>5V-08G[9N.YV6 MTVI6!]/+5&%2N]9RK?:]W>8?#J7,J'5T49YV MIP6CU-)'T_1=VA [9_5)-GM6JD]35X/XB9(5;]0C$+4G&?X^,] /\]8HTVE: MC=(%2-_"I7!X4$]5"R?\@22.1H.6.M:-MMX82 7;ZLOI*V?0O.$J#]>I\W8\ MG]M+5[K'=O;YJ7%=S)3 =]J9LSJ[?)T4&EJ%PUN^+5 M\42VJG&[>=[@8BU'5X]4:R =&);6&XP&=8F_J5U>GDZ.#C-=*7MZ>63GKJQF MLG&1.#B48KP6J^JC^$$3I*IV-;7')^5:JC*2VO7*??7Z0=3!XVDDSU1XM7&L%*]+%EILZ:)3KJB'([5F^[Q<;IW?Y]Q\NE*]7>P,6I5Q[58;WO13B6$FE3V(C3N)^L%%A1WU_Q]02P,$% @ >861 M5L*TV5I$#@ SIT !$ !A;6UJ+3(P,C(Q,C,Q+GAS9.U=67/CN!%^3JKR M'Q"E*K6IBBS+Y]AK[Y9LRS-*R99C>6:/ERV(A&3NDH0,D#[RZ]/@38($14F3 MQ8:>!P\%-!K=_0$-H &"9]^_.C9Z)HQ;U#WO]'=V.XBX!C4M=W'>^3SM#J:7 MHU$'??_=7_Z,X-_97[M==&T1VSQ%5]3HCMPY_1;=8H>!?_^R>W$SQWD=_-C%?#W\^?B/VA>=\V9V9SM/QVT]/U^,'>C#M+29[!\[N ME-^&59YQXY$X& $8+C_O"/TB]5[V=RA;]/9V=_N]'V_&TX"N$Q*>OMJ6^UL9 M>?_DY*07Y,:D$N7KC-DQZ_V>R)YA3A+.D&LIZ"V7>]@UA226C&I20ITG!@["_K<@PR@W]N+"7W>76"\3(CGF,\"IIQY7>XO ^*G M_9@<4DM)]M27@YUR K5\#T6*% SFZ0W1/9HLQN=[??W>O');'C_)H4 M$C\"OOV]?: @-G&(ZUU3YER1.?9M$/W)Q[8UMXC901YF"^*)ALF7V" 57.)6 MC5V70N.''ABEB+3ETH+6#0E_.A/-X)11FSR H$@\0+?+\Q2)O4L*+J.#+/.\ M$SZ*TL K*&^2N>5:0251O^JCKNA%OE $'H,B9[TB<8:%SXDY<;\+GI>,<"@7 M2#V&A*A@1%)1R,"VX=O-RJ2BE!:)$F+K-+27RZEMF=@CY@6V1<^9/A+B\=B& M5=EJN^Z!,84S([%A)[?3R7AT-7@87J&+P7AP>SE$TT_#X8@6Z/ MQ+- XAK;YVG50.RO#@3Z)L?X'ZT%)K$7G\PG2S%S@!I+.D0%G1J0 Q4@TP?X M[V9X"V!,KM'D;G@_>!@!P3L48.)+S!^O;?I2@T1*I@;B<'4@+@?33^AZ//GA M'8C PH_871 ^/X# >J6W"W'GXY%O>6PTTBH)JL(X:@/5IQM,I]:"Q?FQ 9VO8%A M4-_U8 E[!_W#L$CDRS;BH(;L0Q&RH"X!5K8VA%T31?6)O$R-**T2Q76V"MY; M6),S;!,\'W!. %P6#RH*@1/D:^&YJ0(3K3!XU.7Y/#&(]XYE- MH#L,S&T;(Q MFZ"])HS^B5SBM%Y8E1-3[$83 M,$*ZMJS(4QM:6E>&OCU@@[)\VF7FBF!ETUCDGK12S'+X^]\^[/6/OT4AIU89 M>.0:U"$/^)4D$^TT06W2DK6A*(J"LJTRXM2?B^G3BL&);/@M*LB!HA:1'=))[?3L22@'P6 MDV*BVNK2&CHIWDZ35@3TLP96DZC-+2VI%9'_=@)0#/;GFW9IGMKDTN):V@YH MIZ%K _X%1[\2L1**_;(MV_H]@G;"D]T:R")1DJXVNK14SVTW$QZ)*G^'O2%:MYB)X>&9; W_E*.Z(4BK M^JTV!)2(T:XF41T,R_7S>C(U>%)P0!TT:V7OK+5Q?T4L^C5@2*&#ER29-SD%*J&H*2<_+)UD\K_5O%QD[. MQC4T:HM+,0WE[D\K,2AN\10:>'FFVNI2+*)D ^C=UJ0X<%?FJJTM+?BKK=VV M8;C"HH7QMI9*;?^2#?U*^[=T]*S=S"PN.U:C5N,B+=]7W/MLI6?*;G+FP"C+ M4-N]XFQ]LOW92ONNMWN90V(S%DK,#J7%^68[H.\0-\6GOP6,:R8*A])2?BL@ MMVU.(6YQ-'V;3.;WQ,%0B[NX@;\.M@>NZV,[L!,X.T<*IZU54@VI_!I#5(?8 MTV%Q+<@)JX&13]2#[ #*95132[MK^7D$>>RK)%$CT^#,0BO-GSF=4%AQ2NEJ M0]<<6W@W;GZ)*6>HS5NREB\Q;^L&@<+;9N4+RUHJM>FEA;WTCMK_]\)2_!'W M&M^3.0KN0SX55_">=[@E;J3N1&F/C,S/.P*:;GQE[B^@VLZK8\L#M];:ALHUG356& M(L3^BKJ.!?^M*@FMKZF2A0;[E52]3&O9JL+0=9HJG.]M7TG?JZ22K+K1I=2] M]%;JZ'?QYNHS4)PR#[G2U=>JV\K#>];'U A8*8J(7]VX7%3([Z5'F2(&*Q;/ZB0O;-^ SP"-HT J;\( MOTJ4.;$N89Y#7>)!I]J" M)M*!VEB-LHRU=3 8,;^B$OD+;D/Y"VFZBCZV/&L1-- MJ;)LO14JM*T"1E*FKLI<8/.*S+SAJSBA61Z2K$$R$O.)[XGYK_BP>4Z_-0HW5CVDX &K[2R@&3&L,O]5GJ5KI\\? M58[D33I_9:ZNZ@AO.X)5%@L^='U%H .#X*G_S7KE&CIMO484V>"Y[\/E@AZ% M+&TU2=?1A>!'68:N32XZZ@UM)W-1Q60>?X@K5*B.2%N(XH/L#S00'$:,_&MV M!055=-KJ6'&GW:/%PD^_J&>F.3I=&VD@^HASGYC0!M.K GA.MPJ"/X92N<^5 MEBF5)_AC*"6^\0T@\.$K88;%R63^@S@BG''Y#>CU[H KZ!#.!)MJGI3ZW2>- MR2GP;'!_ -P83L,M=50X>HK56%LMC\'$;LN[%P_DU;NPX7?9-D8VS MV2HD)>_LT7G-&WO5T&W&33N(UU%':@J;,M&DR40!T.Q%)E-L1Y^]D;5>G5P3 M_=)@_)2P9\NHU&P50EUTBH+7*J!J:#319$S?L.V]W9,7#+-.1A<,.Q4*K4:J MB5Y5GUJLT&UUB5F\8 ;X<)Y;!*]*K.E9FNCDC[BQCBY'512Z+I4%,V-0V?Z2*G)I]2RL^VPF*%IFXMO MN]1)/^]EP,*/Y>%K9Y, M4^!R"V\GN%ZS;#V;9FGK^$PSB'=A._)F (0ACMZ9H>SIOD$MG;;!HS&!@360 M\IY$KW^+5NYZ!'ZD1_;JJ'2%,'K5_ NV?9@R7?N>STAPWXSOY&Z:27WERO2: M]K[H;.AD9D=[0/PS3']9('UZQJJ&2%8615G.(K 1 $ KV?Z'U#?3.CUPXR'?O02C MT.E-@G7X"YC!#;H$GU" (IB$T2_@-^BGY)/PQO-1!*[#S=9'"<)?[ :^!!>G M@W<0]'H*=']#@1M&7Y>3/=V')-G&E_W^T]/3:1 ^PJ J@4D: M[ZF]>7Z3_]NA?_"]X-LE^7$'8P2POH+X\CGV/IZ0S; I2"?+Z+_&*,\W[!SIXR_M83 MP)TP2/$\_5\2U( ]K%&*A53T,/I-8P?;OSPZ6!&*0*:^'R P3V*)\'J M 9OQ(?1=G$+'?Z1>\G(PYW*2[609H=B)O"VQXGQ]E<9>@.+X5,:N&*L=1U

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end

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�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